Annual Report • Feb 12, 2020
Annual Report
Open in ViewerOpens in native device viewer

Limited Liability Company (Naamloze Vennootschap) Zinkstraat 1, 2490 Balen (Belgium) Company number VAT BE 0888.728.945 RPR/RPM Turnhout
Pursuant to articles 3:5 and 3:6 of the Belgian Code of Companies and Associations, we are pleased to report to you on the operations of Nyrstar NV (the "Company") with respect to the financial year as from 1 January 2019 until 31 December 2019. This report comprises also the corporate governance statement and remuneration report in accordance with article 3:6 §2 and §3 of the Belgian Code of Companies and Associations as attached to this report in annex C and D respectively.
The Company has its registered office at Zinkstraat 1, Balen, Belgium. The Company has been listed on Euronext Brussels since 29 October 2007.
Until 31 July 2019, the Company was the holding company of the Nyrstar Group (consisting of Nyrstar NV and its subsidiaries). In addition, until 31 July 2019 the Company delivered a number of support services to the Nyrstar Group, such as, but not limited to, regional purchasing, IT, environment, innovation and development, continuous improvement and legal support services. Following the finalisation of the Nyrstar Group restructuring at 31 July 2019 (refer to point 2), the Company intended to continue trading as an investment company, holding 2% of the equity in NN2 NewCo Limited ("NN2") for the benefit of Nyrstar NV shareholders.
However, at 9 December 2019 the Extraordinary General Meeting ("EGM") of the Company was held to deliberate on the continuation of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's activities. The Board of Directors of the Company is taking the necessary measures to prepare the necessary reports (Statement of assets and liabilities and the related legal reports) and the convening of a new EGM to formally decide on the dissolution of the Company, and if approved, appoint a liquidator. As such, the 31 December 2019 financial statements of the Company are prepared on a discontinuity basis.
Under article 3:23 of the Belgian Code of Companies and Associations, a parent company that controls one or more subsidiaries is required to prepare consolidated financial statements, unless such subsidiaries have, in view of the consolidated assets, financial position or results that are only of a negligible significance. Given as at 31 December 2019 Nyrstar NV did not control any significant subsidiary, the Company was not required to prepare consolidated financial statements for the year ended 31 December 2019. In accordance with article 12, §3, final paragraph, of the Royal Decree of 14 November 2007, the Company has prepared the 31 December 2019 standalone statutory financial statements prepared in accordance with Belgian GAAP.
The Group initiated a review of its capital structure (the "Capital Structure Review") in October 2018 in response to the challenging financial and operating conditions being faced by the Group. In November 2018, the Group experienced increased working capital requirements as its liquidity position suddenly and unexpectedly deteriorated following the third quarter 2018 results announcement, negative press coverage and credit rating downgrade. In particular, a significant portion of the Group's trade financing arrangements were suspended or terminated, or required to be cash collateralised, either partly or fully. These substantial working capital and liquidity outflows experienced by the Group during the fourth quarter of 2018 and first quarter of 2019 necessitated the raising of urgent funding to enable the Company and the Nyrstar Group to continue its operations. Combined with the Group's materially reduced Underlying EBITDA performance in 2018 and the maturing of certain liabilities during 2019, these factors resulted in the need to reconsider the Group's capital structure.
The Capital Structure Review identified a very substantial additional funding requirement that the Group was unable to meet without a material reduction of the Group's indebtedness. As a consequence, the Capital Structure Review necessitated negotiations between the Group's financial creditors in order to develop a deleveraging and funding plan. Alternatives were carefully considered but no alternative to address the financial issues was viable and failure to address these financial issues would have placed the future of the Company, its subsidiaries and its stakeholders at severe risk. Accordingly, on 15 April 2019, Nyrstar announced that it had entered into a lock-up agreement dated 14 April 2019 (the "Lock-Up Agreement") with representatives of its key financial creditor groups. The Lock-Up Agreement set out the terms for the recapitalisation of the Nyrstar Group (the "Recapitalisation Terms"). These Recaptalisation Rerms included:
g. minority rights for the benefit of the Company in respect of its 2% equity in NN2 (including a tag right, a drag right, information rights and a put option at a price equal to EUR 20 million (adjusted pro rata depending on NN2's percentage holding from time to time) exercisable within certain time periods).
Subsequently, on 29 April 2019, Nyrstar announced that formal consents to the Lock-Up Agreement had been received from, inter alia, over 79% of the aggregate outstanding principal amount under the senior notes due in 2019 and due in 2024, and over 87% of the aggregate outstanding principal amount under the convertible bonds. Under the Lock-Up Agreement, implementation of the Recapitalisation Terms was subject to various conditions precedent which included various third-party regulatory approvals which were all successfully obtained.
On 14 June 2019, NN2 was incorporated in England under the name of NN2 Newco Limited. On 20 June 2019, the Company announced that various steps to implement the Restructuring had been and were being undertaken, including that NN2 had acceded to the Notes and that NN2 had published a practice statement letter in relation to a scheme of arrangement to be proposed by NN2 in respect of the Notes. The English court held the convening hearing on 4 July and ordered the NN2 scheme meetings to be held on 22 July (or such later time or date as NN2 may have decided). The NN2 scheme meetings were held on 22 July. There were two creditor classes for the NN2 scheme – the Convertible Bonds in one class, and the Notes combined into a single second creditor class. For the first scheme creditor class (the Convertible Bonds), 98.87% by value voted and 100% by value and 100% by number of those voting supported the scheme. For the second scheme creditor class (the Notes), 95.57% by value voted and 99.96% by value and 98.93% by number of those voting supported the scheme. Accordingly, the NN2 scheme was supported by an overwhelming majority of the scheme creditors and well in excess of the requisite majorities (being 75% by value and a majority by number of those creditors voting in each scheme class).
The English court sanction hearing for the NN2 scheme of arrangement was held on 26 July 2019 when the sanction order was granted. The scheme of arrangement became effective on the same day. On 29 July, a meeting of holders of the convertible bonds was held and a resolution was passed to approve the NN2 scheme (98% by value of those entitled to vote did so and 100% of those voting approved the resolution scheme). On 30 July, the United States Bankruptcy Court Southern District of New York entered an order under Chapter 15 of title 11 of the United States Bankruptcy Code granting recognition of main proceedings and related relief giving full force to the UK scheme of arrangement of NN2 in the United States.
The Restructuring subsequently took full effect on 31 July 2019. As a result of the recapitalisation, Trafigura Group Pte. Ltd. has become the ultimate parent of the Operating Group.
Implementation of the Recapitalisation Terms has ensured the continuing operations of the Operating Group for the benefit of all stakeholders; failure to implement the Recapitalisation Terms would have highly likely lead to the insolvency of the Group as well as the Company, which was anticipated to have resulted in material harm to the Group's customers, suppliers and approximately 4,100 employees of the Group, as well as very substantial loss of value to the financial stakeholders, and a total loss to shareholders.
The Lock-Up Agreement was initially entered into by the Company and its relevant subsidiaries with representative lenders across each of its key financial creditor groups, who were closely involved in the discussions on the proposed terms of the recapitalisation. Subsequently, many other creditors acceded to the Lock-Up Agreement.
By late July 2019, the Lock-Up Agreement had been signed by noteholders representing slightly over 94% in aggregate by value of the 2024 Notes, 2019 Notes and Convertible Bonds.
The Lock-Up Agreement was negotiated and agreed in full cooperation with the coordinating committee of the Group's bank lenders (the "Bank Coordinating Committee") representing the following Group facilities entered into by the Company's affiliate, Nyrstar Sales & Marketing AG ("NSM") (the "Bank Facilities"):
The Bank Coordinating Committee provided their formal approvals by entering into the Lock-Up Agreement in parallel with the Noteholder approval process.
The Lock-Up Agreement was also fully supported by Trafigura including in its capacity as lender under the USD 650 million Trade Finance Facility Agreement dated 6 December 2018 (as amended) (the "TFFA") provided to NSM, as well as in its capacity as bridge finance provider to NSM (see below) and as future majority owner of the Operating Group in accordance with the Recapitalisation Terms.
The Lock-Up Agreement obliged, subject to its terms and certain conditions, each of the parties to it to take such action and/or provide such approvals as were required to implement the Recapitalisation Terms.
The Lock-Up Agreement provided that obligations of the parties under the Lock-Up Agreement would automatically terminate on, inter alia, the earliest of:
The Lock-Up Agreement required the parties to proceed expeditiously with the steps required to implement the Recapitalisation Terms. During the period in which the Lock-Up Agreement was in effect, from the time of entry into it the parties agreed to the suspension and deferral of certain amounts otherwise falling due under the Group's debt facilities. These amounts included any principal or interest payment under the Notes and the Unsecured Facilities, including any accrued coupons or interest.
The Recapitalisation Terms are further detailed below.
In conjunction with entering into the Lock-Up Agreement, Trafigura provided up to USD 250 million through a committed term loan facility to NSM (the "Bridge Finance Facility") to strengthen the Group's liquidity position and provide for its interim funding requirements prior to completion of the implementation of the Recapitalisation Terms. Under the Lock-Up Agreement, entry into the Bridge Finance Facility and subsequent funding were subject to certain conditions.
The Bridge Finance Facility benefitted from certain asset and share security and had a final maturity date of 30 August 2019 (unless extended by the agreement of all the parties to the Bridge Finance Facility) and an interest rate of LIBOR plus a margin of 5% per annum. The Bridge Finance Facility's asset and share security included guarantees from Nyrstar NV, NSM and the Group's US, Canadian and Belgian principal operating companies, a pledge of the shares of NN2 and share pledges of and asset security over the Group's US, Canadian and Belgian principal operating companies.
The necessary Noteholder consents were sought from, and committed to by, consenting Noteholders under the Lock-Up Agreement in order to permit the incurrence of, and security interests attaching to, the Bridge Finance Facility. All these consents were successfully obtained from the Noteholders, as announced on 18 April 2019, and all the conditions precedent in the Bridge Finance Facility were satisfied.
The principal Recapitalisation Terms relating to Trafigura's ownership of the Operating Group, its obligations under existing arrangements with the Group and under new arrangements with the Group's stakeholders, were as follows:
EUR 160 million new revolving credit facility (the "New Revolving Facility") provided by lenders under the SCTF and Unsecured Facilities in the proportions described above;
The Noteholders were treated equally with one another, with each Noteholder having been issued its pro-rata share of the consideration set out below:
Under the Recapitalisation Terms, all security and guarantors supporting the TFFA was released. Its term was extended to a new 5 year maturity.
Under the Recapitalisation Terms, all security and guarantees supporting the Bridge Finance Facility were released. The Bridge Finance Facility was then replaced with an unsecured on-demand intercompany debt with no fixed maturity, and which, at Trafigura's option, was to be equitised or subordinated.
Existing debt and working capital facilities not specifically referenced above were unaffected by the Recapitalisation Terms. This includes the AUD291 million (as at 31 December 2018) perpetual securities issued by Nyrstar Port Pirie Pty Ltd which was unaffected by the Lock-Up Agreement.
The Recapitalisation Terms provided for a sale by Nyrstar NV of the Operating Group to NN2; following that, on 31 July 2019, a subsidiary of Trafigura incorporated in Malta (Nyrstar Holdings PLC) was issued 98% of the outstanding share capital of NN2. Nyrstar NV continues to be a holding company, holding 2% of the equity in the Operating Group for the benefit of Nyrstar NV shareholders. Nyrstar NV and Trafigura also agreed on certain minority protection rights for Nyrstar NV and Nyrstar NV benefits from certain information rights, including in respect of distributions. For more details refer to the related party disclosures in note C 6.20.
In the interests of all stakeholders of the Group, including the Nyrstar NV's shareholders, the Board of Directors decided to voluntarily apply the procedure provided for in article 524 of the Belgian Companies Code. Please refer to section 12 of this report for further details
During the six months ended and as at 30 June 2019, Nyrstar NV, the parent entity of the Group, had nine employees. At 30 June 2019 these employees have been transferred to the entities of the Operating Group. The continued operations of the Company have no employees following the completion of the restructuring at 31 July 2019.
As the prior year financial statements as at 31 December 2018 were prepared on other than going concern basis, certain adjustments were reflected in line with the Belgian accounting provisions (Article 3:6 of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations). As such, the estimated impact of the Restructuring on the Company's Income Statement was recognised in the 31 December 2018 Income Statement when the Company recognised a provision of EUR 101.7 million representing the expected crystallization of the contingent liabilities that were expected to be off-set in 2019 against the remaining net financial receivable at the time when the restructuring would be completed. The amount also took into consideration the expected costs of disposal of the Company until the completion of the Restructuring of EUR 41.9 million that would increase the Company's net financial receivable position at that time. At the completion of the Restructuring at 31 July 2019, the Company settled and offset various positions between it and its former subsidiaries and derecognised the liability related to its outstanding convertible bonds. The loss arising from the settlement and the offset of these receivables and liabilities has been reflected against the provision of EUR 101.7 million recognised at 31 December 2018 by the Company. As the operating losses of the Company incurred in 2019 before the completion of the Restructuring were funded by its former subsidieries, the final net receivable position of the Company at the completion of the Restructuring was lower than estimated at 31 December 2018 resulting in the release of the unutilised portion of the provision of EUR 11.4 million through the Income Statement in the year ended 31 December 2019, following the completion of the Restructuring.
Additionally, as at 31 December 2018, the Company had contingent liabilities amounting to EUR 2,768m provided or irrevocably promised by the Company for debts and commitments of third parties. As at 31 December 2019 the Company had contingent liabilities amounting to EUR 235.2 million provided or irrevocably promised by the Company for debts and commitments of third parties that are yet to be transferred to the Trafigura Group. For more details refer to the parent company guarantees disclosures in note C 6.14 and C 6.20.
At 31 December 2019, the Company has, in its current investments, a 2% investment in NN2 at the cost of EUR 15,395,000 and in its participating interests a 100% investment in NN1 valued at USD 1 representing cost of these investments for the Company through the issuance by NN2 of a 2% equity in NN2 to the Company with the remaining 98% equity stake issued to Trafigura New Holdco. The investment in NN2 as at 31 December 2019 of EUR 15,395,000 is carried at the lower of cost and fair value, taking into consideration that the Company has a put option to sell all (but not part only) of its 2% holding in NN2 to Trafigura at a price equal to EUR 20 million in aggregate payable to the Company resulting in no impairment required at 31 December 2019. This put option can be exercised by NNV between six months and three years of Trafigura or any member of the Trafigura Group becoming a parent company of NN2 or the Operating Group (i.e. between 1 February 2020 and 31 July 2022), subject to limited triggers allowing earlier exercise of the put option before 6 months or earlier termination of the put option before three years.
At 9 December 2019, the Extraordinary Shareholders' Meeting ("EGM") was held to deliberate on the continuation of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's activities. The shareholders also rejected the proposed capital reduction, as a result of which it was not carried out.
The Board of Directors of the Company is taking the necessary measures to prepare the necessary reports (Statement of assets and liabilities and other legal documents) and will convene a new EGM to consider a proposal for liquidation.
These comments are based on the balance sheet and the proposed allocation of results and are therefore subject to the approval of the proposed allocation of results by the shareholders of the Company. The statutory financial statements were prepared in accordance with Belgian accounting laws.
During the last financial year the Company generated a net loss of EUR 1,437k and has a balance sheet total as at 31 December 2019 of EUR 17,199k.
The operational result shows a loss of EUR 12,003k. This result derives from an operating income amounting to EUR 3,413k and the operating charges of EUR 15,416k.
The operating income is related to the consultancy services performed by Nyrstar NV for the other Nyrstar group entities and the recharges of the costs (e.g. long term incentive plans) before 31 July 2019.
The operating costs mainly relate to:
The financial result mainly relates to:
The income tax expense amounting to EUR 4k relates to the taxes due in relation to prior year.
The fixed assets as at 31 December 2019 consist of:
The current assets at 31 December 2019 consist of:
The equity as at 31 December 2019 amounted to EUR 10,988k.
The changes in equity for the financial year 2019 relate to the loss of EUR 1,437k.
The liabilities as at 31 December 2019 mainly relate to:
The Board of Directors proposes to allocate the current year loss of EUR 1,437k to the losses carried forward.
For information on the Company's risk management and management of uncertainties and information regarding the use by the Company of financial instruments refer to the Corporate Goivernance Statement of the Company.
At the date of authorisation of the 31 December 2019 financial statements, Nyrstar NV (the "Company") has assessed that, taking into account its available cash, cash equivalents, facilities that became available to the Company as committed facilities at the completion of the restructuring of the Company and its subsidiaries ("Group") ("Restructuring") at 31 July 2019, the ability to exercise the put option that the Company has that enables it to sell its 2% investment in the Operating Group and its cash flow projections for the next 12 months from the authorisation of the 31 December 2019 financial statements, it has sufficient liquidity to meet its present obligations and cover working capital needs. The forecast available liquidity of the Company, that at the date of this report includes the fully drawn amount of EUR 3.7 million available to the Company for the first year of the Limited Recourse Loan Facility, is dependent on various matters including the expected appointment of a liquidator (refer below) and his or her next steps, the potential existence of a legal claims against the company requiring funding of the legal proceedings and other matters not currently foreseen. As from 1 August 2020 the Company can draw further EUR 1.2 million under the Limited Recourse Loan Facility for the Company's ongoing ordinary course operating activities. The Company can also draw on the separate EUR 5 million tranche of the Limited Recourse Loan Facility intended for the payment of certain litigation defense costs, if required. Should the abovementioned funding options not provide the Company with sufficient funds when they are required, the Company can exercise its put option that enables the Company to sell its 2% investment in the Operating Group for EUR 20 million, repay the outstanding amount drawn on the Limited Recourse Loan Facility from the proceeds of the put option (refer to the Related party dislcosures in the 31 December 2019 financial statements for further details) andgenerating sufficient funding for the Company.
However, at 9 December 2019 the Extraordinary General Meeting ("EGM") of the Company was held to deliberate on the continuation of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's activities. The Board of Directors of the Company is taking the necessary measures to prepare the necessary reports (Statement of assets and liabilities and the related legal reports) and the convening of a new extraordinary shareholders' meeting to formally decide on the dissolution of the Company, and if approved, appoint a liquidator. As such, the 31 December 2019 financial statements of the Company are prepared on a discontinuity basis.
As was the case for the 31 December 2018 financial statements, which were prepared under an other than going concern basis, the Board of Directors has assessed which adjustments had to be recorded with respect to the valuation and the classification of certain balance sheet items included in a balance sheet prepared on a discontinuity basis, as required by the 3:6 of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations. The fixed and current assets have been recorded at the lower of cost and their expected probable realisation value. The decision of the 9 December 2019 EGM not to continue the Company's activities resulted in the requirement for the Company to recognize a provision for discontinuation representing the estimated costs that the Company expects to incur before the completion of the liquidation. At 31 December 2019 the Company recognised a provision for discontinuation of EUR 2.3 million
representing the estimated costs that the Company expects to incur before the completion of an orderly liquidation process that would be finalised before the end of 2020. Should the liquidation process take longer, e.g. due to the potential legal or regulatory actions as discussed in the subsequent events note, the estimated costs to be incurred by the Company before the completion of the liquidation would be significantly higher. Assuming the completion of the liquidation between the end of 2024 and 2029 the Company would need to incur estimated costs between EUR 11 million and 20 million, which may require the Company to obtain additional funding beyond the proceeds from the exercise of the EUR 20 million put option and the repayment of the outstanding amount drawn on the Limited Recourse Loan Facility from the put option proceeds. These additional costs in excess of the provision of EUR 2.3 million recognised at 31 December 2019 would further decrease the equity of the Company subsequent to 31 December 2019.
At 7 January 2020 the Company announced that the President of the Commercial Court in Antwerp rendered a judgment in the summary proceedings initiated by a group of minority shareholders representing less than 3.5% of the Company's share capital (the "Minority Shareholders"). The Minority Shareholders had requested the court to suspend the resolutions of the general meeting of 5 November 2019, and subsequently also those of the extraordinary general meeting of 9 December 2019, as well as to appoint a provisional administrator to convene a new general meeting. The Minority Shareholders had also requested to impose certain measures on Nyrstar, including the prohibition to enter into certain loans. The President rejected all claims of the Minority Shareholders in a fully reasoned judgment. The President did not grant the claim of Nyrstar to order the Minority Shareholders to pay damages but did order them to pay the legal costs, including an indemnification for legal fees for Nyrstar. The Minority Shareholders did not appeal the judgement.
There have been various press reports in Q4 2019 and in January 2020 related to potential legal or regulatory actions by minority shareholders. The press reported in Q4 2019 that three criminal complaints have been lodged by three shareholders against unknown person and in January 2020 that the minority shareholders would shortly initiate the complaints on the merit related to the Company's Restructuring. There has not been any formal notification to the Company or any director, or detail provided in relation to these alleged criminal complaints or actions. Additionally, the Company is also aware of press coverage from Q4 2019 where it was stated by the Belgian securities regulator, the FSMA, that it was conducting a regulatory investigation into the Company. The Company has not been formally advised of this or any other regulatory investigation into the Company.
At 20 January 2020 the Company disclosed that RSQ Investors (division of Quanteus Group BV), Kris Vansanten BVBA, Kris Vansanten, E3V & Partners BV and an unnamed physical person hold 5.01% of the voting rights of Nyrstar.
At 9 December 2019, the EGM was held to deliberate on the continuation of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's activities. The shareholders also rejected the proposed capital reduction, as a result of which it was not carried out. The Board of Directors of the Company will take the necessary measures to prepare the necessary reports with its statutory auditor (Statement of assets and liabilities) and will convene a new EGM to consider a proposal for liquidation.
Additionally, the press reported in Q4 2019 that three criminal complaints have been lodged by two shareholders against the Company. There has not been any formal notification to the Company or any director, or detail provided in relation to these alleged criminal complaints. The Company is also aware of press coverage from Q4 2019 where it was stated by the Belgian securities regulator, the FSMA, that it was conducting a regulatory investigation into the Company. The Company has not been formally advised of this or any other regulatory investigation into the Company.
The Company has no branches.
Until 31 July 2019 the Group undertook research and development through a number of activities at various production sites of the Group. This research and development was primarily concentrated on the production of various high margin noncommodity grade alloy products and by-products in Nyrstar's Metals Processing operations. Following the completion of the restructuring at 31 July 2019, the Company does not undertake any research or development.
The non-financial information presented in this section in the 31 December 2019 Report of the board of directors ex article 3:6 of the Belgian Code for Companies and Associations was prepared in accordance with Article 3:6 §2 of the Belgian Code for Companies and Associations and in consideration of the disclosure guidance contained in the Sustainability Accounting Standards Board's (SASB) Sustainability Accounting Standard for Metals & Mining. Given the impacts of the Restructuring on the Company, the non-financial information including the environmental or social responsibility is no longer applicable to the Company, as the Company has no employees or operations. For the same reason, the non-financial information presented also does not include information on employee matters, human rights and anti-corruption and bribery matters.
The treasury shares reserve comprises the par value of the Company's shares held by the Company. The Company held no Company's shares as at 31 December 2019 and 2018.
| Issued shares | 2019 | 2018 |
|---|---|---|
| Shares outstanding Treasury shares |
109,873,001 - |
109,033,545 - |
| As at 31 Dec | 109,873,001 | 109,873,001 |
| Movement in shares outstanding | 2019 | 2018 |
| As at 1 Jan | 109,873,001 | 109,033,545 |
| Capital increase | - | - |
| Employee shared based payment plan | - | 839,456 |
| As at 31 Dec | 109,873,001 | 109,873,001 |
Directors are expected to arrange their personal and business affairs so as to avoid conflicts of interest with the Company. Any director with a conflicting financial interest (as contemplated by article 7:96 of the Belgian Code of Companies and Associations) on any matter before the Board of Directors must bring it to the attention of both the statutory auditor and fellow directors, and take no part in any deliberations or voting related thereto. Section 1.4 of the Corporate Governance Charter sets out the procedure for transactions between Nyrstar and the directors which are not covered by the legal provisions on conflicts of interest. Section 3.2.4 of the Corporate Governance Charter contains a similar procedure for transactions between Nyrstar and members of the management committee (other than the Chief Executive Officer).
To the knowledge of the Board of Directors, there are, on the date of this report, no potential conflicts of interests between any duties to the Company of the directors and members of the management committee and their private interests and/or other duties. While this does not entail a direct personal conflict of interest, Mr. Fernandez, who was a director of the Company until his resignation on 25 February 2019, is the head of M&A at Trafigura Group Pte. Ltd. and owns a non-voting profit sharing participation in Trafigura Beheer B.V., a parent of Trafigura Group Pte Ltd. As Trafigura is a related party of Mr. Fernandez for purposes of Section 1.4 of the Corporate Governance Charter of the Company, this Section is also applicable to transactions with Trafigura. Specifically we confirm that Mr. Fernandez has represented to management that he owns non-voting profit participating shares in Trafigura Beheer BV.
In 2017 the Board assessed this ownership of non voting participating shares in Trafigura Beheer BV and has concluded that nevertheless no financial conflict of interest exists and hence the procedure of article 523 of the Belgian Companies Code (as then applicable) does not need to be followed. Mr Fernandez confirmed that until his resignation as a director at 25 February 2019, there have been no material changes in his remuneration received from Trafigura as compared to previous years, and so there have been no changes to his declarations of personal interest as compared to previous years.
There has therefore not been any non compliance with article 523 of the Belgian Companies Code (as then applicable).
Since 1 January 2019, the provisions of the Belgian Companies Code in accordance with article 523 (as then applicable) have been complied with in relation to the Retention Agreements ("Agreements") for Directors to the extent applicable to Mr Konig and Mr Rode at the Board meeting on 20 February 2019. Mr Konig and Mr Rode explained that pursuant to the Agreements, they would benefit from a payment by Nyrstar Sales & Marketing AG. As a result, under Article 523 of the Belgian Company Code (as then applicable), they both have an interest of a financial nature that could be in conflict with the proposed approval by the Board of the Agreements. Mr Konig and Mr Rode further stated that they believed that the terms of the proposed Agreements are not unusual or uncustomary, especially within the difficult context the Company finds itself in, and that they would inform the Company's Statutory Auditors of the potential conflict of interest. Mr. Konig and Mr Rode did not take part in the deliberation and decision taking relating to the Agreements to be entered into with them. The Board noted that the purpose of the Agreements is to provide additional remuneration given the specific context of the Company and increased demands resulting from the current situation (Mr Rode) and the additional role in the capital structure review (Mr Konig). The Board noted that the financial consequences of the Agreements consisted in, for Mr Rode, an immediate payment of CHF 250,000, and a further payment of CHF 1,250,000 upon completion of the capital restructure as set out in the retention letter to Mr Rode and, for Mr Konig, an immediate payment of CHF 135,000 and a further amount of CHF 765,000 upon completion of the capital restructure, all payments by the Nyrstar Sales & Marketing AG, an indirect subsidiary of the Company. Accordingly the Board deemed Agreements to be in the interest of the Company, even in these delicate times.
Since 1 January 2019, the provisions of the Belgian Companies Code in accordance with article 523 (as then applicable) have also been complied with in relation to the Lock Up Agreement, the Bridge Finance Facility and the Consent Solicitations at the Board meetings of 9, 10 and 15 April 2019. Mr Konig and Mr Rode explained that pursuant to the above Agreements entered into by each of them and Nyrstar Sales & Marketing AG (Swiss Company CH-020.3.034.867-3) with registered office at Tessinerplatz 7, 8002 Zurich (Switzerland ("NSM"), a wholly-owned subsidiary of the Company, as approved by the Board on 20 February 2019, each of them is entitled to a payment by NSM upon successful completion of the Restructuring. As a result, under Article 523 of the Belgian Company Code (as then applicable), they both have an interest of a financial nature that could be in conflict with the proposed approval by the Board of the Lock Up Agreement, the Bridge Finance Facility and the Consent Solicitations which is part of the Restructuring. Mr Konig and Mr Rode further stated that they believed that the terms of the Lock Up Agreement and the Bridge Finance Facility and the Consent Solicitations will allow the Company to proceed with, and to continue to fund its general trading and operational expenses
until completion of, the Restructuring, which they believe to be in the interest of the Company, its shareholders and other stakeholders. Mr. Konig and Mr Rode did not take part in the deliberation and decision taking relating to the Lock Up Agreement, the Bridge Finance Facility and the Consent Solicitations.
The remuneration provisions in the Agreements were subsequently clarified during the Board meeting of 19 June 2019 such that the payment by NSM which each of them is entitled to is not dependent on the successful completion of the Restructuring, but only on their continued employment until the earlier of (i) 31 December 2019 or (ii) the completion of the Restructuring. As such, Mr Konig and Mr Rode did not have a direct or indirect personal and conflicting interest within the scope of article 523 BCC in respect of the deliberations on the approval of the Lock Up Agreement, the Bridge Finance Facility and the Consent Solicitations which was a part of the Restructuring.
On 28 March 2019, Ms Carole Cable, Ms Anne Fahy and Ms Jane Moriarty, independent directors to the Board of Directors of the Company (together, the "Committee"), were requested to prepare all necessary steps to be able comply with, as a precautionary measure, article 524 of the Belgian Companies Code (as then applicable) in connection with the proposed decisions of the Board of Directors of the Company to be taken on or around 10 April 2019 with regards to the USD 250 million committed term loan bridge financing facility ("Bridge Finance Facility"), to be entered into between Nyrstar Sales & Marketing AG, a wholly-owned subsidiary of the Company prior to 31 July 2019, and Trafigura Pte. Ltd. ("Trafigura") if and when the final documentation in respect of any bridge financing and implementation of the restructuring that may be reached on the capital structure review will be considered by the Board. The Board had requested this as a precautionary measure only, as it considered that Belgian law does not deem Trafigura and its affiliates to be an affiliate because of its relatively low shareholding, the fact that it has not exercised control as defined in the Belgian Companies Code and the restrictions included in the Relationship Agreement. Pursuant to this request, the Committee prepared a report, as a precautionary measure, in line with article 524, §2 of the Belgian Companies Code (as then applicable). The Committee considered the Bridge Finance Facility and the Restructuring and all documentation and analyses related thereto made available to it by the Company.
The Company engaged Grant Thornton UK LLP ("GT") as independent expert in line with article 524, §2 of the Belgian Companies Code (as then applicable) to assess whether the Bridge Finance Facility and overall Restructuring transaction is on terms not less favourable than might have been obtained in a comparable transaction at such time on an arm's length basis from a third party that is not an "Affiliate", in accordance with an engagement letter that was agreed between GT, the Committee and the Company, which was entered into by the Company for acceptance of the fees and expenses which were payable by the Company to GT. GT confirmed that it was independent from (i) the Company and its affiliates; (ii) Trafigura and its affiliates (as the counterparty to the proposed transaction); and (iii) in respect of the proposed Bridge Finance Facility and the Restructuring. On the basis of the information provided to it by GT and the Company, the Committee established that GT satisfied the independence requirements in article 524, §2 of the Belgian Companies Code (as then applicable).
Additionally, the statutory auditor has been requested to issue an opinion on the accuracy of the information set out in the Committee's advices and the Board minutes.
As announced by the Company on 6 December 2018 and discussed by the Committee when preparing its report in connection with the TFFA, the entry into the TFFA strengthened the Group's liquidity in early December 2018, but the Group required, in order to continue its business operations, a comprehensive restructuring of its existing financial indebtedness that was implemented pursuant to schemes of arrangement under the UK Companies Act 2006 (the "Restructuring") and became effective on 31 July 2019. The Company required further interim funding to address a liquidity shortfall and to provide a stable financing platform during the implementation of the Restructuring, as, due to an increasingly challenging liquidity position since December 2018, the funding provided under the TFFA was insufficient to allow the Company to trade through to the conclusion of the Restructuring.
At 15 April 2019 the Company announced that it has entered into a lock-up agreement (the "Lock-Up Agreement") with representatives of its key financial creditor groups, including Trafigura. The Lock-Up Agreement set out the terms for the recapitalisation of the Group. In conjunction with entering into the Lock-Up Agreement, Trafigura provided up to USD 250 million through a committed term loan facility (Bridge Finance Facility) to strengthen the Group's liquidity position and provide for its interim funding requirements prior to completion of the implementation of the recapitalisation terms.
The GT opinion concluded that "Based on and subject to the foregoing, it is our opinion, as of the date hereof, that the Bridge Finance Facility is on terms not less favourable than might have been obtained in a comparable transaction at such time on an arm's length basis from a Person who is not an Affiliate."
The Committee considered the discussions by the Board of Directors since February 2019 on the Restructuring, the Group's liquidity position and the new liquidity options. The Committee understood at the time that the potential options for new liquidity, via bridging financing or interim funding, was constrained by the short timeline to liquidity shortfall, the prevailing market sentiment on the Company's credit standing, and the restrictions arising from the Company's existing debt facilities and borrowing instruments. As a consequence, the Board considered that the only viable option for obtaining bridging finance in an accelerated timeframe was through its existing debt providers, including the majority of the existing lenders of the Company ("Ad Hoc Group") and Trafigura.
The Committee understood from these discussions, and from the discussions it had with the Company's executive management, Morgan Stanley and Freshfields Bruckhaus Deringer, that the Bridge Finance Facility would enable the Company to fund its general trading and operational expenses for the period until the expected completion of the Restructuring and that, without additional debt funding, the Group would have run out of liquidity in the week ending 19 April 2019.
In view of these considerations, the Committee deemed the Bridge Finance Facility to be in the interest and to the benefit of the Company and all stakeholders. In particular, the Committee considered that time was of the essence in securing the Bridge Finance Facility, failing which the liquidity shortfall that was projected could prompt involuntary restructuring scenarios, which the Committee did not deem suited given the progress made on the Restructuring. The Committee formed the opinion that the Bridge Finance Facility was required to enable the Company to fund its general trading and operational expenses for the period until completion of the Restructuring which occurred on 31 July 2019. This was seen to be in the interest of the Company and all of its stakeholders. Based upon the Committee's consideration of the discussions within the Board, the Committee understood at the time that there was sufficient support from the various financial stakeholders for there to be a reasonable expectation that the Restructuring would be successful and that the entry into the Bridge Finance Facility was justified as a temporary measure to enable the Company to continue trading until the Restructuring was completed. As such, the Committee considered that on this basis, and on the basis of the opinion provided by GT, that the fees to be paid, security to be granted, and the undertakings and representations and warranties to be given, to Trafigura under the Bridge Finance Facility, were outweighed by the above-mentioned advantages to the Company.
The conclusion of the report of the Committee reads as follows: "On the basis of the considerations set out above, including the opinion issued by GT, the Committee is of the opinion that the Bridge Finance Facility is not such as to imply a disadvantage to the Company that, in light of its current policies, would be manifestly illegitimate.
Furthermore, the Committee is of the opinion that it is unlikely that the Bridge Finance Facility would lead to disadvantages for the Company which will not be outweighed by the benefits for the Company of the Bridge Finance Facility."
In its meeting of 15 April 2019, the Board has approved the Bridge Finance Facility. The extract of the minutes of the meeting of the Board on 15 April 2019 relating to the Bridge Finance Facility, reads as follows:
The Chairman reminded the Board of the discussions during the previous Board meeting on the Board's resolution taken during the meeting held on 28 March 2019, as a precautionary measure, to request the independent directors to prepare all necessary steps to be able comply with, article 524 BCC in connection with the proposed decisions on the Restructuring, including the USD 250 million committed term loan bridge financing facility ("Bridge Finance Facility"), to be entered into between NSM, and Trafigura.
Against this background, the Chairman explained that the independent directors appointed Grant Thornton UK LLP ("GT") as independent expert under article 524 BCC (supported by Wilkie Farr & Gallagher as legal adviser), to provide an independent opinion on the Bridge Finance Facility. To this extent, an engagement letter has been agreed between GT and the Committee, which has been countersigned by the Company for acceptance of the fees and expenses which will be payable by the Company.
GT issued its report on 15 April 2019 (the "GT Report"), which is attached to these minutes as Annex 1. The Board acknowledged the conclusion of the GT Report, stating that the Bridge Finance Facility is on terms not less favourable than might have been obtained in a comparable transaction at such time on an arm's length basis from a Person that is not an "Affiliate".
As a precautionary measure, article 524 BCC has been applied on a voluntary basis. The Chairman reminded the Board that article 524 BCC contains the following procedure:
In accordance with article 524, §2 jo. §5 BCC, prior to any decision or transaction between (a subsidiary of) a listed company and any affiliated company of a listed company, a committee of three independent directors must provide an assessment thereof. Such committee shall be assisted by one or more independent experts appointed by the committee. The expert shall be remunerated by the company.
Further pursuant to article 524, §2 BCC, the opinion must detail the nature of the decision or transaction, assess its costs and benefits for the company and its shareholders (highlighting, amongst other considerations, its financial impact) and advise whether the proposed transaction may imply a disadvantage to the company that, in light of its current policies, would be manifestly illegitimate. If the committee does not believe the decision to be manifestly illegitimate but nevertheless to create a disadvantage for the company, the report must identify the advantages of the decision that outweigh any disadvantages. The committee shall issue a written substantiated advice to the board of directors, mentioning each of the above-mentioned elements.
Pursuant to article 524, §3 BCC, after having taken note of the advice of the committee, the board of directors shall deliberate on the proposed decision or transaction. The minutes of the meeting of the board of directors must mention whether the procedure described above has been applied, and, as the case may be, on which grounds the advice of the committee has not been followed.
Further pursuant to article 524, §3 BCC, the statutory auditor shall issue an opinion on the accuracy of the information set out in the committee's advice and the board minutes. This opinion shall be attached to the board minutes. The committee's report, an extract of the board minutes and the statutory auditor's opinion shall be published in the annual report.
The Committee confirmed that it has had the opportunity to review the GT Report and discuss it with GT. The Committee confirmed, on the basis of the information provided to it by GT and the Company, that GT satisfies the independence requirements in article 524, §2 BCC. Taking into account the GT Report and the Company's considerations expressed to the Committee, the Committee has issued its report on 15 April 2019 (the "Report of the Committee"), attached to these minutes as Annex 2.
The Board confirmed to have received the Report of the Committee, including the annexes and attachments thereto, containing its advice in relation to the Bridge Finance Facility.
The Board acknowledged the conclusion of the Report of the Committee, stating that the Bridge Finance Facility is not such as to imply a disadvantage to the Company that, in light of its current policies, would be manifestly illegitimate.
Furthermore, the Committee was of the opinion that it is unlikely that the Bridge Finance Facility would lead to disadvantages for the Company which will not be outweighed by the benefits for the Company of the Bridge Finance Facility, as stated in the Report of the Committee.
As agreed, the Chairman, the CEO and Mr Christopher Cox left the call and did not participate in the vote or deliberation on this and the following agenda items. Before leaving the call, the Chairman, the CEO and Mr Christopher Cox confirmed, for the information of the remaining Board members, that they would endorse the approval of the Bridge Finance Facility […].
[Freshfields] then explained the main proposed terms of the Bridge Finance Facility.
Freshfields] explained that the Bridge Finance Facility consists of a USD 250,000,000 committed term loan facility supplied by Trafigura to NSM.
[…]
The directors also discussed the main proposed terms of the Bridge Finance Facility, including the security to be granted by the Group, taking into account the GT Report and the Report of the Committee and the LoU. The Board considered that the financial consequences of the Bridge Finance Facility consist in the following main components.
The Bridge Finance Facility consists of a USD 250 million committed term loan facility. The main proposed terms of the Bridge Finance Facility, including the guarantees and security to be granted, and the undertakings and representations and warranties to be given, to Trafigura in this respect, are also summarised in the LoU that has been prepared by GT and approved by the Board during the previous meeting.
The Bridge Finance Facility will be in the form of a committed term loan, repayable by no later than 30 August 2019, subject to certain early repayment provisions included in the final form draft of the agreement governing the Bridge Finance Facility.
Upon completion of the Restructuring, the Bridge Finance Facility (excluding any accrued interest and commitment fee) will be converted to unsecured on-demand intercompany debt with no fixed maturity, and will be either equitised or subordinated (at the option of Trafigura).
The terms and conditions of the Bridge Finance Facility are similar to the terms and conditions of the trade finance framework agreement entered into on 6 December 2018 between Trafigura and Nyrstar Sales & Marketing AG ("NSM") (as subsequently amended and supplemented on 14 January 2019 and 13 February 2019, the "USD 650M Trafigura Facility"), with certain exceptions:
The Bridge Finance Facility will have a margin of 1 month LIBOR + 500bps p.a., amount payable in cash on the last day of each month (or, if earlier, on the date on which the Restructuring becomes effective in accordance with its terms). The Bridge Finance Facility also provides for payment by NSM of a commitment fee of an amount equal to one third of the 500bps p.a., payable in cash on the last day of each month, in respect of any undrawn commitments.
In addition, all legal, out of pocket, and facility expenses in connection with the arrangement and maintenance of the Bridge Finance Facility and any bank financing linked to it (including legal cost) will be for the account of the Group.
The following Security is included in the Bridge Finance Facility:
The Bridge Finance Facility will have events of default broadly in line with those under the USD 650M Trafigura Facility. These will include an event of default if an Obligor under the Bridge Finance Facility "is deemed unable to pay its debts or to be insolvent for the purposes of any applicable law" (the "Insolvency EOD").
The Bridge Finance Facility will not contain the event of default that appears in the USD 650M Trafigura Facility, which is triggered upon certain Events of Default (as defined in the Group's commercial contracts with Trafigura or its affiliates for
the supply of metals/concentrates to the Group that are subject to deferred payment pursuant to the USD 650M Trafigura Facility and in certain of the Group's commercial contracts for the purchase of metals by Trafigura) by NSM (or its affiliates).
The Bridge Finance Facility will also not contain the limitations on Trafigura's acceleration rights (i.e. events of acceleration of payment) that appear in the USD 650M Trafigura Facility, which limit acceleration of the USD 650M Trafigura Facility to the occurrence of a payment default, a cross-default (in an aggregate amount of EUR 25 million or more), an insolvency process affecting an Obligor under the USD 650M Trafigura Facility, or a repudiation by an Obligor under the USD 650M Trafigura Facility of any security interests granted thereunder (the "Acceleration Limitations").
In contrast to the USD 650M Trafigura Facility and any other Existing Funding Agreements, the Bridge Finance Facility will contain the following two provisions: (1) a breach by the Group of the standstill provisions on debt repayment in the Lock-up Agreement will result in all outstanding amounts under the Bridge Finance Facility becoming repayable on demand by Trafigura; and (2) NSM must immediately repay or prepay all outstanding amounts under the Bridge Finance Facility automatically if the Lock-up Agreement terminates prior to the Restructuring Effective Date (together, the "Restructuring Events").
The Bridge Finance Facility will contain the following additional undertakings relating to the implementation of the Restructuring that do not appear in the USD 650M Trafigura Facility or any other Existing Funding Bridge Finance Facility: (1) each member of the Group will cooperate fully with Trafigura and provide appropriate access and information to Trafigura for the purposes of implementing the steps required to complete the Restructuring; and (2) members of the Group will be precluded (without the prior consent of Trafigura) from entering into: (i) any material contracts with a tenor longer than six months or (ii) any new commitment for an investment, disposal (other than in the ordinary course of trading) or capital expenditure for a value of USD 4 million or more.
Different from what was included in the USD 650M Trafigura Facility, the Bridge Finance Facility will not include a "right to participate", as discussed in the report prepared by the Committee in respect of the USD 650M Trafigura Facility. However, the previous "right to participate" shall continue to apply.
The Bridge Finance Facility will contain undertakings in line with those under the USD 650M Trafigura Facility, including the delivery of information comprising: (1) monthly management accounts; (2) a weekly rolling 13-week cash flow projection; (3) a monthly statement of indebtedness signed by two directors of the Company identifying in reasonable detail all material indebtedness of the Group and the key terms thereof; and (4) a weekly statement of the cash and cash equivalent position of the Group (together, the "Additional Information Undertakings").
The Bridge Finance Facility will not contain any undertaking that is specific to the security granted in favour of the USD 650M Trafigura Facility over the shares in Nyrstar Port Pirie Pty Ltd, because the security package to be granted in favour of the Bridge Finance Facility will not include any security in respect of the shares in Nyrstar Port Pirie Pty Ltd.
Different from what was included in the USD 650M Trafigura Facility, the Bridge Finance Facility will not include any financial covenants.
The Board also considered the discussions by the Board since February 2019 on the Restructuring, the Group's liquidity position and the new liquidity options. The potential options for new liquidity, via bridging financing or interim funding, w as constrained by the short timeline to liquidity shortfall, the prevailing market sentiment on the Company's credit standing, and the restrictions arising from the Company's existing debt facilities and borrowing instruments. As a consequence, while the Company considered obtaining additional liquidity through discussions with trade finance lenders through lette rs of credit facilities and sale and repurchase of concentrate, the Board considered that the only viable option for obtaining bridging finance of the required quantum and in an accelerated timeframe was through its existing debt providers, including the Ad Hoc Group and Trafigura.
The Board considered that the Bridge Finance Facility will enable the Company to fund its general trading and operational expenses for the period until expected completion of the Restructuring and that, without additional debt funding, the Group would run out of liquidity in the week ending 19 April 2019.
Upon deliberation, taking into account the GT Report and the Report of the Committee, the directors, excluding Mr Konig, Mr Rode and Mr Cox, unanimously resolved:
(b) to approve the terms of, the transactions contemplated by, and the execution, delivery and performance of the Documents, including the representations and warranties in Clauses 15.6 (No default) (to the extent relating to Clause 18.5 (Insolvency)) and 18.6 (Insolvency proceedings) the Bridge Finance Facility, and any other agreements, documents, declarations, certificates, notifications, deeds and formalities (including ancillary documents and written shareholders' resolutions) in connection with the Bridge Finance Facility and the transactions contemplated thereby;
(d) to grant a power of attorney to each director, the CFO and Peter Zmidzinski (each an "Authorised Representative"), acting alone and with power of substitution and subdelegation:
(c) […]
execution thereof by such Authorised Representative to be conclusive evidence of the approval thereof by such Authorised Representative and by the Board, without the necessity of further approval by the Board.
The Board finally resolved to fully indemnify each Authorised Representative (to the extent permitted by law), and to keep each such person fully indemnified, against any costs, claims, expenses, losses, liabilities and damages suffered by such person in connection with the powers granted to him/her in the above resolutions or in the exercise of any of the powers conferred, or purported to be conferred, on him by such resolutions."
On 20 January 2020, the statutory auditor delivered its report, which has been attached as to the minutes of the Board meeting of 15 April 2019. The conclusion of the report of the statutory auditor reads as follows:
In accordance with article 524 of the Companies Code we issue in our capacity as statutory auditor of Nyrstar NV (the "Company") our judgement on the accuracy of the information mentioned in the advice by the committee of independent directors and in the minutes of the board of directors. This report is attached to the minutes of the board of directors.
Our responsibility is to issue a judgement on the accuracy of the information mentioned in the advice by the committee of independent directors and in the minutes of the board of directors in accordance with article 524 §3 of the Companies Code. Our report is not intended to express a judgement on the fairness or opportunity of the contemplated transaction nor whether the transaction is rightful and fair ("no fairness opinion"). Our judgement relates to the information, more specifically the financial and accounting data, included in the advice by the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors.
We have performed our engagement in accordance with the standards applicable in Belgium and the procedures as recommended by the Institut des Réviseurs d'Entreprises / Instituut van de Bedrijfsrevisoren for similar engagements. In the framework of this engagement, we have to assess whether we have identified facts that suggest the financial and accounting data as a whole - included in the advice by the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors - are not accurate in all material respects. We have complied with all ethical requirements applicable in Belgium in relation to this engagement, including those regarding independence.
To make our assessment on the financial and accounting data included in the advice by the committee of independent directors and the Relevant Chapters of the minutes of the board of directors we:
not limited to the report of the independent expert, Grant Thornton UK LLP, and the bridge finance facility agreement of 16 April 2019; and
confirm that there are no material inconsistencies between these financial and accounting data and the information that we became aware of during our audit procedures as statutory auditor of the Company.
The above procedures do not constitute an audit in accordance with International Standards on Auditing. Had we performed additional procedures or had we performed an audit on the financial and accounting data in accordance with International Standards on Auditing (or relevant national standards or practices), other matters might have come to our attention that would have been reported to you. Therefore, we do not express an audit opinion on the financial and accounting data.
Based on the procedures performed and as already noted in our statutory auditor's report to the shareholders' meeting on the annual accounts for the year ended 31 December 2018 dated 27 September 2019, the combined effect of the following elements could result in information that we were not aware of that has not been reflected in the advice of the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors:
As a result we are unable to issue a judgement on the accuracy of the information included in the advice by the independent directors committee and in Relevant Chapters of the minutes of the board of directors.
Our report is solely for the purpose set forth above and is provided to you solely for the information and use by the board of directors of the Company in the framework of the application of article 524 of the Companies Code. Hence it cannot be used for any other purpose.
Antwerp, 20 January 2020
The statutory auditor
_______________________________________________________
Represented by Ine Nuyts
At 28 March 2019 Ms Carole Cable, Ms Anne Fahy and Ms Jane Moriarty, independent directors to the Board of Directors of the Company were requested to prepare all necessary steps to be able comply with, as a precautionary measure, article 524 of the Belgian Companies Code (as then applicable) in connection with the proposed decisions of the Board of Directors of the Company in respect of the terms and implementation of the debt restructuring of the Group (the "Group" being the Company and its subsidiaries) (the "Restructuring") pursuant to a lock-up agreement entered into by certain members of the
Group and certain of the Group's lenders, including Trafigura Group Pte. Ltd. (together with its affiliates, "Trafigura") on 14 April 2019 (the "Lock-up Agreement"), which contemplated, among other things:
The Board had requested this as a precautionary measure only, as it considered that Belgian law does not deem Trafigura and its affiliates to be an affiliate because of its relatively low shareholding, the fact that it has not exercised control as defined in the Belgian Companies Code (as then applicable) and the restrictions included in the Relationship Agreement.
The GT opinion concluded that "Based on and subject to the foregoing, it is our opinion, as of the date hereof, that the financial impact of the Transactions for the Company and its shareholders is a result of negotiations between its creditors (involving the Company), given the financial situation of the Company, is not less favourable than the feasible financial alternatives (if any) available with respect to the Company."
The Committee prepared a report, as a precautionary measure, in line with article 524, §2 of the Belgian Companies Code (as then applicable). The Committee has considered the Transactions, the final draft of the NNV-Trafigura Deed (note: an agreement between the Company, Trafigura PTE Ltd and Nyrstar Holdings Limited, a newly-incorporated member of the Trafigura Group ("Trafigura New HoldCo") (the "NNV-Trafigura Deed"), pursuant to which Trafigura will (among other things), upon becoming the ultimate majority owner of NN2: (i) procure that the Company becomes the holder of a 2% shareholding in NN2; (ii) provide or Trafigura New HoldCo will provide the Company with certain minority rights in respect of its 2% equity stake in NN2, including certain information rights, tag and drag rights and a put option in respect of the entirety of its 2% equity stake in NN2 for a price equal to EUR 20 million (adjusted pro rata depending on NN2's holding from time to time); and (iii) ensure that financial support, in the form of a committed facility up to a total amount of EUR 13.5 million, is provided to the Company on a limited-recourse basis for anavailability period of 5 years from the Restructuring Effective Date (subject to certain early termination events), by Trafigura procuring that such agreed financial support is provided by NN2 or a subsidiary of Trafigura which is a holding company of the Operating Group, to fund the Company's liabilities incurred in the ordinary course of business and to fund litigation defence costs incurred by the Company arising from any third party litigation (if any) (the "Funding Agreement"), the final draft of the term sheet for the Funding Agreement, the final draft of the NNV-NN2 SPA (note: an agreement for the sale and transfer by the Company of substantially all of its assets including 100% of its shareholding in Nyrstar Netherlands (Holdings) BV ("NNH") and also its holdings (direct and indirect) in NNH's subsidiaries (NNH and its subsidiaries together being the "Operating Group"), but excluding its shares in NN1, to NN2) and the final draft of the NN2 Subscription Deed (note: an agreement between Trafigura PTE Ltd and Trafigura New Holdco and NN2, whereby (i) NN2 undertakes to issue shares amounting to 98% of its equity to Trafigura New Holdco, such that Trafigura New Holdco becomes its new immediate parent company, and (ii) Trafigura and Trafigura New HoldCo will issue and/or procure the issuance of three different notes to the holders of the Notes and Convertible Bonds (the "New Trafigura Instruments")), as well as all documentation and analysis related thereto made available to it by the Company.
On the basis of the considerations set out above, the Committee was of the opinion that the Transactions were not such as to imply a disadvantage to the Company that, in light of its current policies, would be manifestly illegitimate. Furthermore, the Committee was of the opinion that it is unlikely that the Transactions would lead to disadvantages for the Company which will not be outweighed by the benefits for the Company of the Transactions.
The conclusion of the report of the Committee reads as follows: "On the basis of the considerations set out above, including LoO" (note: GT's Letter of Opinion)", the Committee is of the opinion that the Transactinos are not such as to imply a disadvantage to the Company that, in light of its current policies, would be manifestly illegitimate.
Furthermore, the Committee is of the opinion that it is unlikely that the Transactions would lead to disadvantages for the Company which will not be outweighed by the benefits for the Company of the Transaction."
The Board concluded that the restructuring options realistically available to the Group had narrowed to a single proposal. In addition, it was noted that the Ad Hoc Group and the Bank Coordinating Committee, which had access to all relevant information, agreed that the proposed Restructuring was the preferred option, notwithstanding that the proposed Restructuring crystallised losses on a significant proportion of such creditors' investments and would result in Trafigura acquiring substantive ownership of the Group.
The Board also concluded that (in contrast to some other company restructurings) none of the Company's shareholders had proposed an alternative to the Restructuring at any point. This was despite the Group having commenced its capital structure review in October 2018 and having announced on 15 March 2019 the resulting anticipated significant shareholder dilution. The Board confirmed that it was not aware of any suggestion of a restructuring proposal from a shareholder, other than Trafigura. The Board therefore concluded that it would be reasonable for the Board to regard the Group as facing a binary choice between the proposed Restructuring and multiple local insolvency filings.
In its meeting of 19 June 2019, the Board has approved the Restructuring. The extract of the minutes of the meeting of the Board on 19 June 2019 relating to the Restructuring, reads as follows:
The Chairman reminded the Board of Directors (the "Board") of the developments since the last Board meeting in respect of the lock-up agreement [of 15 April 2019] (the "Lock-up Agreement") entered into by certain members of the Group (the "Group", being composed of the Company and its subsidiaries) and certain of the Group's lenders with a view to providing certainty in respect of the requisite consents in respect of the Restructuring, and more generally the restructuring it contemplates (the "Restructuring" and the transactions of the Restructuring together, the "Transactions").
Such developments included the preparation of the Restructuring, including, among other things:
and/or procure the issuance of three different notes to the holders of the Notes and Convertible Bonds (the "New Trafigura Instruments") (the "NN2 Subscription Deed");
The Chairman reminded the Board of the discussions during the previous Board meeting on the Board's resolution taken during the meeting held on 28 March 2019 to request the independent directors to prepare all necessary steps, as a precautionary measure, to be able to comply with article 524 BCC in connection with the proposed decisions on the Restructuring, including the Restructuring Agreements to be entered into between NSM and Urion Holdings (Malta) Limited.
Against this background, the Chairman explained that the independent directors appointed Grant Thornton UK LLP ("GT") as independent expert under article 524 BCC (supported by Willkie Farr & Gallagher as GT's legal adviser), to provide an independent opinion on the Restructuring. To this extent, an engagement letter has been agreed between GT and the Committee, which has been countersigned by the Company for acceptance of the fees and expenses which will be payable by the Company.
The Chairman also explained that GT has prepared a Letter of Understanding ("LoU"), which sets out their understanding of a number of factual matters pertaining to the Group, and through which they sought confirmation from the Company as to the accuracy and completeness of this understanding, prior to delivering their report.
The independent directors informed the Board that (i) GT had completed a lot of work and was well advanced in the preparation of the LoU and its opinion, however, as the transaction documents had been negotiated until late the day before, it had not yet been able to finalise its LoU and opinion and that (ii) accordingly the Committee has not yet been able to finalise its report.
The Board agreed that a new Board meeting would be convened later today to discuss the LoU, Report of GT and the Report of the Committee and discuss and approve the various transactions. The meeting was then closed around 15:00 CEST.
The meeting reopened at 23:00 CEST. Mr Christopher Cox had given his apologies for this meeting. All other directors were present (including Carole Cable).
The directors confirmed that, together with the Company's Management and legal and financial advisors, they have reviewed the contents of the draft LoU and consider the draft LoU as accurate and complete in all material respects. The Board also reviewed the summary of key provisions of the Group's existing funding agreements prepared by GT.
The Board unanimously resolved to approve the LoU and to grant a power of attorney to each director, the CFO and Peter Zmidzinski to amend, finalise, execute, sign and deliver, on behalf and in the name of the Company, the LoU.
GT issued its report on 19 June 2019 (the "GT Report"), which is attached to these minutes as Annex 1. The Board acknowledged the conclusion of the GT Report which stated that the financial impact of the Transactions for the Company and its shareholders is a result of negotiations between its creditors (involving the Company), given the financial situation of the Company, is not less favourable than the feasible financial alternatives (if any) available with respect to the Company.
As a precautionary measure, article 524 BCC has been applied on a voluntary basis. The Chairman reminded the Board that article 524 BCC contains the following procedure:
In accordance with article 524, §2 jo. §5 BCC, prior to any decision or transaction between (a subsidiary of) a listed company and any affiliated company of a listed company, a committee of three independent directors must provide an assessment thereof. Such committee shall be assisted by one or more independent experts appointed by the committee. The expert shall be remunerated by the company.
Further pursuant to article 524, §2 BCC, the opinion must detail the nature of the decision or transaction, assess its costs and benefits for the company and its shareholders (highlighting, amongst other considerations, its financial impact) and advise whether the proposed transaction may imply a disadvantage to the company that, in light of its current policies, would be manifestly illegitimate. If the committee does not believe the decision to be manifestly illegitimate but nevertheless to create a disadvantage for the company, the report must identify the advantages of the decision that outweigh any disadvantages. The committee shall issue a written substantiated advice to the board of directors, mentioning each of the above-mentioned elements.
Pursuant to article 524, §3 BCC, after having taken note of the advice of the committee, the board of directors shall deliberate on the proposed decision or transaction. The minutes of the meeting of the board of directors must mention whether the procedure described above has been applied, and, as the case may be, on which grounds the advice of the committee has not been followed.
Further pursuant to article 524, §3 BCC, the statutory auditor shall issue an opinion on the accuracy of the informa tion set out in the committee's advice and the board minutes. This opinion shall be attached to the board minutes. The committee's report, an extract of the board minutes and the statutory auditor's opinion shall be published in the annual report.
The Committee confirmed that it has reviewed the GT Report and discussed it with GT. The Committee confirmed, on the basis of the information provided to it by GT and the Company, that GT satisfies the independence requirements in article 524, §2 BCC. Taking into account the GT Report and the Company's considerations expressed to the Committee, the Committee has issued its report on 19 June 2019 (the "Report of the Committee"), attached to these minutes as Annex 2.
The Board confirmed to have received the Report of the Committee, including the annexes and attachments thereto, containing its advice in relation to the Transactions.
The Board acknowledged the conclusion of the Report of the Committee, stating that the the Transactions are not such as to imply a disadvantage to the Company that, in light of its current policies, would be manifestly illegitimate.
Furthermore, the Committee was of the opinion that it is unlikely that the Transactions would lead to disadvantag es for the Company which will not be outweighed by the benefits for the Company of the Transactions, as stated in the Report of the Committee.
[…]
[Freshfields] then explained the main proposed terms of the Transactions and the Restructuring Agreements, as set out in detail in the Report of the Committee.
The Board considered that the Restructuring Agreements will enable the Company to (i) proceed with the Restructuring, and (ii) upon the Restructuring completing, become a viable company post-Restructuring holding a 2% interest in NN2.
The Board discussed the financial consequences of the Transactions and the Restructuring Agreements:
Having regard to the above considerations, the Committee deems the Transactions to be in the interest and to the benefit of the Company and all stakeholders. In particular, the Committee considers the following summary that was made during the Board meeting held on 9 April 2019:
"At the Board's request, [Morgan Stanley] also set out to the Board the process of, and alternatives to, the Capital Structure Review as this has been discussed and reviewed by the Board in the last months:
The Capital Structure Review was initiated primarily to address the maturity of the Group's €350,000,000 8.5% senior notes due in September 2019. At the time it was recognised that it was looking increasingly difficult to pursue a 'regular way' capital markets refinancing of those instruments given the Group's financial performance.
At the time the Capital Structure Review was initiated, it was reasonably believed that the Company should consider various options then available to it in order to arrive at a solution that best ensured the sustainability of the Company. These included (i) equity raising; (ii) asset sales in part or in full; (iii) debt refinancing; (iv) balance sheet restructuring / recapitalisation.
The announcement of the Q3 2018 results on 31 October 2018, combined with high levels of off-balance sheet financing triggered a very significant liquidity crisis in the business. The crisis was the result of, as discussed during previous Board meetings:
The liquidity crisis would have resulted in the inevitable insolvency of the Group but for the \$650m TFFA entered into with Trafigura in November and December 2018.
Notwithstanding the financing provided under the TFFA, as of 9 April 2019, the Company is again in a critical liquidity position. Without further additional funding, the Group will have no option but to place its operating assets on so-called "care and maintenance" leading to the inevitable insolvency of the Group. Significant additional funding is [also in that scenario] required within one to two weeks.
The severity of the liquidity deterioration, the urgent requirement for additional funding, and the extent of the Group's financial underperformance have effectively, immediately or after a while, ruled out a number of options as representing credible alternatives to a financial restructuring:
Options to dispose of the group and/or its assets on a going concern basis were regularly considered but were not believed to represent a viable funding solution:
So as a result, although the Board, consulting [with] its financial advisors, considered at the time going out and seeking third party offers for the business, the realities of the Company's situation and the severity of its financial position effectively ruled it out. Going through that process with no reasonable expectation that it would be successful would have resulted in more harm to the Group and not less, particularly given the liquidity constraints that the Group was under.
The Board indeed considered that:
Accordingly, an M&A / asset sale would not have been a feasible means of addressing the Company's position.
The Company would not have access to capital markets in order to facilitate a refinancing of the Group. In processes like this it is customary for a company to tend to negotiate only with the in-the-money parties, which the shareholders were clearly not. The shareholders have been kept informed of the process through the Company's public statements, but given (i) the depth of the Group's liquidity crisis and the zero economic recovery set out above as well as (ii) the lack of any known large (institutional or other) holders of the Company's equity [other than Trafigura], the shareholders cannot be reasonably viewed as a viable source for a solution.
[Morgan Stanley] concluded that the restructuring options realistically available to the Group had also narrowed down to a single proposal, even amongst those creditors that have had full access to all of the information, have been fully engaged in the process throughout, and have had a real opportunity to propose their own proposal. All of the representative creditors have agreed that this transaction is the transaction they would prefer to support, even in view of crystallising losses on a very significant amount of their own investment, and seeing Trafigura substantially take ownership of the Group."
The financial consequences of the Transactions consist in the following main components:
As part of the preparations of the annual accounts of the Company for the financial year ended 31 December 2018, Management has prepared a valuation of the Company's assets, as detailed in these draft annual accounts published on the Company's website on 26 May 2019.
The Company EPM, as referenced above, implies that each group of existing creditors will receive a better financial outcome under the terms of the Restructuring than in an insolvency scenario. It also indicates that various existing creditors have agreed to incur a material write-down of their outstanding principal debt claims against the Group as part of the Restructuring. Consequently, the Company EPM analysis confirms that the issuance of a 2% equity stake in the restructured Operating Group is a better recovery for the Company's shareholders than the anticipated recovery in an insolvency scenario of zero cents in the Euro.
2. D&P Valuation
Duff & Phelps, LLC ("D&P") has prepared a valuation of the assets of NNV at the request of the Board.
D&P's analysis within the D&P Valuation of the Group considered the following three different scenarios:
The conclusions reached by the D&P Valuation of the Group, for each of the three scenarios referred to above, is summarised in the table below:
| Overview of Equity Values | |||||
|---|---|---|---|---|---|
| Fair Value | Fair Value | Fair Value | |||
| €'k | Scenario 1 | Scenario 2 | Scenario 3 | ||
| Value of Equity | (292,874) | (327,903) | 746,785 |
Under scenarios 1 and 2 (as described above), D&P has concluded that the Company's equity has nil value. Following the conclusion of the proposed Restructuring, and the restructuring of the debt held, D&P has concluded that the equity of the Group could be valued at EUR 746.8 million.
The portion of value attributable to NNV, including the 2% interest in NN2 2 and other assets and liabilities directly held by NNV, therefore exceeds the current value attributable to the Company's shareholders according to D&P.
The Committee considers that D&P scenario 3 valuation provides an indication of the equity value in NN2 (EUR 746.8 million), following completion of the Restructuring. As such, it should not be used as the basis upon which to assess the equity value of the existing Group, pre-Restructuring.
GT has assessed the FMV of 100% of the equity in the Operating Group to inform their work on the Letter of Opinion (the "LoO").
The table below summarises the equity valuation assessment by Grant Thornton (as at 4 June 2019). GT has concluded that there is no value attributable to the equity holders of the Company as at 4 June 2019:
| €million | Low | High |
|---|---|---|
| Value of Equity (rounded) | (920) | (620) |
The 2% equity interest in the Restructured Group that is granted to NNV therefore exceeds the current value attributable to the Company's shareholders according to GT's valuation assessments of the FMV of 100% of the equity in the Operating Group.
ii. Summary of impact of the Transactions on current debt and security of creditors
This section is a summary of the comparison of the pre-Restructuring and post-Restructuring treatment of the Group's creditors under its existing debt agreements.
1. Notes and Convertible Bonds
Holders of the Notes and holders of the Convertible Bonds will be treated equally with one another under the Restructuring, with the EUR 955 million of outstanding principal debt under the Notes and Convertible Bonds being written-off and replaced by the New Trafigura Instruments, at a materially reduced aggregate principal amount of EUR 568.1 million. Holders of the Notes and Convertible Bonds will receive a pro-rata share of the New Trafigura Instruments.
In addition, certain holders of the Notes and Convertible Bonds will be entitled to receive certain fees pursuant to the Restructuring, including the "Bond Timely Consent Fee". It is a term of the Lock-Up Agreement that, on the Restructuring Effective Date and subject to certain conditions, the Company, NNH or NSM must pay, or shall procure the payment of, a fee (the "Bond Timely Consent Fee") equal to 1.5 per cent. of the aggregate principal amount of the Notes and/or Convertible Bonds that were subject to the Lock-Up Agreement on or prior to 7 May 2019:
2. SCTF
The revolving structured commodity trade finance facility (the "SCTF") will be terminated, with lenders being reinstated under a new agreement in an aggregate amount equalling the USD equivalent of between €510 million and €600 million, comprised of:
The Reinstated SCTF will be divided equally between a revolving borrowing base facility and a term loan facility, each with a five-year bullet maturity and an interest margin of LIBOR/EURIBOR + 1.00 per cent. per annum and will benefit from comprehensive security in respect of the European subsidiaries of the Operating Group and a corporate guarantee from the Trafigura Parent, in addition to the existing borrowing base security over certain inventories and receivables of NSM.
3. Amendment and Restatement of the USD 650M Trafigura Facility
The USD 650M Trafigura Facility will be reinstated in full. All security and guarantees will be released on the Restructuring Effective Date. Its term will be extended to a new five year maturity and it will have an interest margin of LIBOR/EURIBOR + 0.75 per cent. per annum (the "Reinstated USD 650M Trafigura Facility").
4. The Bridge Finance Facility
The Bridge Finance Facility will be converted to unsecured on-demand intercompany debt with no fixed maturity, which will be subordinated to the Reinstated SCTF, the Reinstated Unsecured Facilities (defined below) and the New Money Facility.
5. Reinstatement of certain unsecured facilities
Certain of the Group's unsecured facilities (the "Unsecured Facilities") will be terminated, with the lenders to the Unsecured Facilities being reinstated under a new agreement in the following amounts:
The Reinstated Unsecured Facilities will have a five year maturity and an interest margin of LIBOR + 1.5 per cent. per annum with a six month run-off period in the final year and will benefit from a corporate guarantee by the Trafigura Parent plus security over a collection account through which will flow the proceeds of certain sales by the Operating Group.
6. Unaffected facilities
Existing working capital facilities of the Group not specifically referenced above will remain unaffected by the Restructuring, save that the Company's guarantee of certain obligations will be released in full.
Under the terms of the NNV-NN2 SPA, NN2 will use reasonable endeavours to procure the release of the Company's other guarantees granted in respect of the obligations of members of the Operating Group and will indemnify the Company for any liabilities arising from such obligations to the extent they are not released.
7. Provision of New Money
The New Money Facility is a new revolving credit facility of €160 million which will be provided by participating lenders under the SCTF and Unsecured Facilities.
The New Money Facility will have a four year maturity and an interest margin of LIBOR/EURIBOR + 1.25 per cent. per annum.
The New Money Facility will share on a pari passu basis the same security and guarantee package (including the corporate guarantee from the Trafigura Parent) as the Reinstated SCTF, save for having second ranking security over the inventory and receivables securing the borrowing base which, after the discharge of the borrowing base tranche of the Reinstated SCTF, shall rank pari passu with the security for the term loan tranche of the Reinstated SCTF.
All of the lenders under the SCTF and Unsecured Facilities have been given the opportunity to participate in the New Money Facility.
Following the Restructuring, the Company will retain an indirect 2% equity stake in the Restructured Group (via its direct 2% shareholding in NN2). The Transactions will also result in:
Trafigura will procure, pursuant to its obligations under the NNV-Trafigura Deed, and NN2 will also procure, that the former operating subsidiaries of the Company will not make any demands for payment from the Company, except (i) under the Funding Agreement provided by NN2 (or a Trafigura entity), (ii) as agreed after the Restructuring, or (iii) to the extent that the Company has sufficient funds to meet such demands (excluding among other things any dividends or sale proceeds in respect of the Company's direct 2% shareholding in NN2).
1. Put option, tag and drag rights
Under the terms of the NNV-Trafigura Deed, if Trafigura New Holdco (or the relevant Trafigura entity which holds NN2) proposes at any time a transfer of any right or interest to a third party purchaser (on arms' length terms, for cash or noncash consideration), that would result in the Trafigura group holding 50% or less of the shares in NN2, then Trafigura New Holdco (or the relevant Trafigura entity which holds NN2) will have the right to oblige the Company to transfer (drag right), and the Company will have an equivalent right to participate in such transfer (tag right), of its entire 2% equity stake in NN2 on the same terms and for the same consideration per share as the Trafigura transfer.
In addition, the Company will have the right, exercisable on the earlier of: (i) 6 months following the Restructuring Effective Date; (ii) the date on which NN2 proposes any issuance of equity securities (or rights relating to equity securities); and (iii) the date on which NN2 proposes to transfer the Operating Group (or Trafigura New Holdco proposes to transfer NN2) to a third party purchaser outside of the Trafigura group, to sell all (but not part only) of its 2% equity stake in NN2 to Trafigura New Holdco at a price equal to EUR 20 million in aggregate (adjusted pro rata depending on NN2's holding from time to time (which adjustment, in the case of any issuance of equity securities (or rights relating to equity securities) can be avoided by the exercise of the put option) (the "NNV Put Option"). The NNV Put Option is exercisable until the earlier of (i) 3 years from the Restructuring Effective Date or (ii) the completion of a public takeove r bid of the Company by Trafigura New Holdco.
2. Post-Restructuring funding of the Company
As outlined above, the Funding Agreement will assist the Company in meeting its day-to-day liabilities post-Restructuring, including liabilities not effectively released under the terms of the Restructuring. In addition, NN2 will also provide certa in ongoing services for the Company for up to 3 years (subject to agreed early termination triggers) which will reduce the Company's operating costs during such period.
As a holding company, the value of the Company depends entirely on the value of its subsidiaries and their continued trading. Given the current, pre-Restructuring level of financial indebtedness of the Group, which the Group cannot afford to service without a material deleveraging, the Board (as advised by Morgan Stanley and Alvarez & Marsal) expects the Company's shareholders to recover nothing on the value of their shares in the event of the insolvency of the Company and the Group, which the Board (as advised by Morgan Stanley and Alvarez & Marsal) considers to be the only alternative to the Restructuring (see above). Existing shareholders, including Trafigura, would therefore suffer a total loss in the event of insolvency. This is the outcome shown by the Company EPM analysis, referred to above.
As announced by the Company on 15 April 2019, in view of the material principal impairment of the Group's senior ranking debt facilities, including the EUR 955 million (in aggregate principal amount) of unsecured Notes and Convertible Bonds, and the significant funding requirements of the Group, the economic effect will be that current shareholders will be materially diluted as a consequence of the Restructuring. This will result in very limited economic recovery to such shareholders, which will depend on any future distributions made to the Company on the 2% participation that the Company will hold in the Restructured Group.
On the other hand, the Company's existing shareholders will benefit (when compared with the alternative, which is to suffer a total loss in the event of the insolvency of the Company and the Group) from the fact that the Company will continue, post-Restructuring, to be a holding company, holding (directly) 2% of the equity of NN2 and, therefore, indirectly in the Restructured Group in circumstances where: (i) the Company will be released of its liabilities under pre-existing financial indebtedness and guarantees; and (ii) the Company will, subject to certain terms and conditions, be provided with up to EUR 13.5 million of committed funds under the Funding Agreement towards its continued ordinary course operating costs and costs arising from the defence of litigation.
The Company will also benefit from minority rights as provided above.
In accordance with the business plan of the Restructured Group, as published on the Company's website on 15 April 2019 and included as Annex 2, the Restructured Group will yield such EBITDA levels that will be providing a platform for distributions to shareholders. The NNV-Trafigura Deed, described above, will also contain the following provisions on NN2 shareholder distributions to ensure, as far as possible, that any NN2 profits are distributed to the NN2 shareholders: Trafigura New Holdco will procure that: (i) the board of NN2 meets at least on an annual basis to assess whether NN2 has any profits lawfully available for distribution (in which case, NN2 will make such distribution in accordance with applicable law); and (ii) NN2 and the other members of the Restructured Group will not, under the terms of any financing or other agreement to which they are or shall be party (other than financing or other agreements entered into on arm's length terms with third parties), be subject to any limitations (other than those contained in any agreements the terms of which are described in the Lock-up Agreement) on making dividends or other distributions to their respective shareholders.
In addition, the NNV-Trafigura Deed provides that, subject to compliance with applicable law, Trafigura will procure that NNV is provided with such financial or other information in relation to the New Nyrstar Group or any member of the New Nyrstar Group as is required by NNV, in its capacity as a shareholder of the New Nyrstar Group, in order to comply with its legal, regulatory or tax obligations, including for the purposes of its accounting or financial control requirements, for the purposes of enabling NNV to assess the fair market value of its equity shareholding in NN2 if a member of the Trafigura Group offers to purchase all or part of such equity shareholding, or as may otherwise be reasonably requested by NNV.
Trafigura, currently the Company's largest shareholder with a 24.42% equity stake, will take control of the Restructured Group and will indirectly (via its shareholding in NN2) hold 98% of the Restructured Group's equity, in return for procuring the issuance of the New Trafigura Instruments to replace and refinance the Group's previous bond debt. In addition, the Trafigura Parent is providing a corporate guarantee of the Reinstated SCTF, the Reinstated Unsecured Facilities and the New Money Facility.
In addition, as part of the Restructuring, Trafigura (or members of its group) will have provided the Bridge Finance Facility to enable the Group to trade through to completion of the Restructuring (and which will convert post-Restructuring into an unsecured and unguaranteed, intercompany debt), and will have agreed to:
The Committee is cognisant of the fact that the significant dilution of existing shareholders' (indirect) equity interests in the Operating Group as a result of the Restructuring appears, to retail investors, to be a negative outcome. However, as described above, the Company EPM analysis demonstrates that, in a liquidation scenario, the shareholders would receive EUR nil, due to the quantum of the Group's outstanding financial indebtedness and the priority ranking of the Group's creditors in any insolvency process. As described above, Management has explored various alternatives and discounted all but the Transactions and local insolvency filings. Given the current value of the Group's equity is nil, the Committee believes that retention of a 2% stake in a Restructured Group (which the Committee believes will be financially viable), combined with the release of the Company's liabilities in respect of financial indebtedness which is being restructured, is a better outcome for shareholders than a liquidation scenario.
The Transactions will provide the optimal outcome for the Group's employees because themajority of employee jobs will be preserved following the Restructuring Effective Date as the Restructured Group will continue to trade. While acknowledging that the Transactions will provide the optimal outcome for the Group's employees, the Committee also notes that some redundancies within the Group's executive, finance and commercial teams may be required once the transfer of majority ownership of the Restructured Group to Trafigura has taken place following the Restructuring Effective Date. The Group's corporate function in Zurich currently employs around 100 to 110 people.
Although the impact of an insolvency scenario on the Group's employees cannot be determined with any certainty, the Committee considers that an insolvency would likely place a large number of roles at risk, with some locations at risk of closure and all employees faced with greater uncertainty.
2. Local governments and communities
In the locations of certain of the Group's assets, local communities are heavily reliant on the employment provided by the Group, particularly in areas such as Hobart (Australia), Balen/ Overpelt (Belgium) and Auby (France). As such, the continuation of operations, which the Transactions would provide, is a positive outcome for these local governments and communities.
As noted above in respect of the Company's employees, an insolvency scenario would likely place a number of roles at risk, which could adversely impact employment in the communities in which the Group operates.
3. Trade creditors
Following the Restructuring Effective Date, the relevant members of the Restructured Group will continue to pay their respective trade creditors in the ordinary course of business. As such, there will be no dilution in recoveries for the Restructured Group's trade creditors as a result of the Transactions. By contrast, in an insolvency scenario, the recovery for the Group's trade creditors is uncertain because of the priority ranking of secured creditor claims. The Committee in any event believes that it is likely that such recoveries would be relatively low or non-existent.
4. Tax authorities
The taxation implications of the proposed Restructuring on the Restructured Group have been assessed and no adverse tax consequences are envisaged. To the extent required, rulings are being sought from relevant tax authorities regarding the change in the ownership of the Restructured Group. The Restructuring is deemed to be tax-neutral due to either the Transactions not being taxable, or their being sheltered by current period losses, although we understand there is a low risk of a cash tax exposure of less than EUR 10 million in Belgium.
Upon deliberation, taking into account the GT Report and the Report of the Committee, the directors, excluding Mr Cox, unanimously resolved:
The Board finally resolved to fully indemnify each Authorised Representative (to the extent permitted by law), and to keep each such person fully indemnified, against any costs, claims, expenses, losses, liabilities and damages suffered by such person in connection with the powers granted to him/her in the above resolutions or in the exercise of any of the powers conferred, or purported to be conferred, on him by such resolutions."
On 20 January 2020, the statutory auditor delivered its report, which has been attached as to the minutes of the Board meeting of 19 June 2019. The conclusion of the report of the statutory auditor reads as follows:
In accordance with article 524 of the Companies Code we issue in our capacity as statutory auditor of Nyrstar NV (the "Company") our judgement on the accuracy of the information mentioned in the advice by the committee of independent directors and in the minutes of the board of directors. This report is attached to the minutes of the board of directors.
We have taken note of:
Our responsibility is to issue a judgement on the accuracy of the information mentioned in the advice by the committee of independent directors and in the minutes of the board of directors in accordance with article 524 §3 of the Companies Code. Our report is not intended to express a judgement on the fairness or opportunity of the contemplated transaction nor whether the transaction is rightful and fair ("no fairness opinion"). Our judgement relates to the information, more specifically the financial and accounting data, included in the advice by the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors.
We have performed our engagement in accordance with the standards applicable in Belgium and the procedures as recommended by the Institut des Réviseurs d'Entreprises / Instituut van de Bedrijfsrevisoren for similar engagements. In the framework of this engagement, we have to assess whether we have identified facts that suggest the financial and accounting data as a whole - included in the advice by the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors - are not accurate in all material respects. We have complied with all ethical requirements applicable in Belgium in relation to this engagement, including those regarding independence.
To make our assessment on the financial and accounting data included in the advice by the committee of independent directors and the Relevant Chapters of the minutes of the board of directors we:
The above procedures do not constitute an audit in accordance with International Standards on Auditing. Had we performed additional procedures or had we performed an audit on the financial and accounting data in accordance with International Standards on Auditing (or relevant national standards or practices), other matters might have come to our attention that would have been reported to you. Therefore, we do not express an audit opinion on the financial and accounting data.
Based on the procedures performed and as already noted in our statutory auditor's report to the shareholders' meeting on the annual accounts for the year ended 31 December 2018 dated 27 September 2019, the combined effect of the following elements could result in information that we were not aware of that has not been reflected in the advice of the committee of independent directors and in the Relevant Chapters of the minutes of the board of directors:
As a result we are unable to issue a judgement on the accuracy of the information included in the advice by the independent directors committee and in Relevant Chapters of the minutes of the board of directors.
Our report is solely for the purpose set forth above and is provided to you solely for the information and use by the board of directors of the Company in the framework of the application of article 524 of the Companies Code. Hence it cannot be used for any other purpose.
Antwerp, 20 January 2020
The statutory auditor
_______________________________________________________
Represented by Ine Nuyts
The elements that need to be provided in accordance with article 34 of the Royal Decree dated 14 November 2007 to the extent that these elements could have consequences in the event of a public takeover bid are discussed in detail in the corporate governance statement as attached to this report as annex B.
The Audit Committee consists of at least three directors. All members of the Audit Committee are non-executive directors. According to the Belgian Code of Companies and Associations, all members of the Audit Committee must be non-executive directors, and at least one member must be independent within the meaning of the 2020 Belgian Code on Corporate Governance. The members of the Audit Committee at 31 December 2019 were Anne Fahy (Chairman), Jane Moriarty and Carole Cable. The current composition of the Audit Committee complies with the Belgian Code of Companies and Associations.
The members of the Audit Committee must have a collective competence in the business activities of the Company as well as accounting, auditing and finance. The current Chairman of the Audit Committee is competent in accounting and auditing as evidenced by her previous role as Chief Financial Officer of BP's Aviation Fuels business. According to the Board of Directors, the other members of the Audit Committee also satisfy this requirement, as evidenced by the different senior management and director mandates that they have held in the past and currently hold (see also "—Other mandates").
The role of the Audit Committee is to:
The Audit Committee regularly reports to the Board of Directors on the exercise of its missions, including when preparing the financial statements.
In principle, the Audit Committee meets as frequently as necessary for the efficiency of the operation of the Audit Committee, but at least four times a year. The members of the Audit Committee must have full access to the Chief Financial Officer.
The Board of Directors requests the shareholders of the Company to approve the statutory financial statements attached hereto and to grant discharge to the Directors of the Company and to the statutory auditor for the exercise of their mandate during this financial year of the Company.
* * *
Brussels, 12 February 2020.
On behalf of the Board of Directors,
Martyn Konig Director
___________________________ ___________________________
Anne Fahy Director
Annex A: Statutory financial statements of Nyrstar NV for the year ended 31 December 2019
Annex B: Statement of responsibility of Nyrstar NV for the year ended 31 December 2019
Annex C: Corporate governance statement in accordance with article 3:6 §2 of Belgian Code of Companies and Associations
Annex D: Remuneration Report in accordance with article 3:6 §3 of Belgian Code of Companies and Associations
[Separate document]
The undersigned, Martyn Konig, Chairman of the Board of Directors, and Anne Fahy, Director, declare that, to the best of their knowledge:
Brussels, 12 February 2020
Martyn Konig Anne Fahy Chairman of the Board of Directors Director
[Separate document]
[Separate document]
| 40 | 1 | EUR | ||||||
|---|---|---|---|---|---|---|---|---|
| NAT. | Date of the deposition | No. 0888728945 |
pp. | E. | D. | C 1 | ||
| ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE DEPOSITED IN ACCORDANCE WITH THE COMPANIES CODE IDENTIFICATION (on the date of deposition) |
||||||||
| NAME: | Nyrstar | |||||||
| Legal form: PLC Address: Zinkstraat Nr.: 1 Postal Code: 2490 City: Balen Country: Belgium Register of Legal Persons (RLP) - Office of the Business Court at: Antwerpen, Division Turnhout 1 |
||||||||
| Internet address : | Company number: | 0888728945 | ||||||
| 9/04/2019 DATE of the deposition of the partnership deed OR of the most recent document mentioning the date of publication of the partnership deed and the act changing the articles of association. |
||||||||
| ANNUAL ACCOUNTS | IN EURO (2 decimals) | 2 | ||||||
| ANNUAL ACCOUNTS approved by by the General Meeting of | 16/04/2020 | |||||||
| concerning the financial year covering the period from | 1/01/2019 | till | 31/12/2019 | |||||
| Previous period from | 1/01/2018 | till | 31/12/2018 | |||||
| 3 The amounts of the previous financial year are are not identical to those which have been previously published. / |
||||||||
| Total number of pages deposited: 47 Number of the pages of the standard form not deposited for not being of service: 6.1, 6.2.1, 6.2.2, 6.2.3, 6.2.4, 6.2.5, 6.3.1, 6.3.3, 6.3.4, 6.3.5, 6.3.6, 6.4.2, 6.5.2, 6.17, 6.18.2, 7, 8, 9, 11, 12, 13, 14, 15, 16 |
||||||||
| Signature (name and position) Martyn Konig Director |
Signature (name and position) Anne Fahy Director |
|||||||
Optional statement. 1
If necessary, adjust the unit and currency in which the amounts are expressed 2
COMPLETE LIST WITH name, first name, profession, residence-address (address, number, postal code, municipality) and position with the enterprise
Title : President of the board of directors Mandate : 5/11/2019- 27/06/2023 Zinkstraat 1, 2490 Balen, Belgium
Title : Director Mandate : 29/04/2015- 5/11/2019 Zinkstraat 1, 2490 Balen, Belgium
Title : Director Mandate : 20/04/2017- 29/06/2021 Zinkstraat 1, 2490 Balen, Belgium
Title : Director Mandate : 27/04/2016- 30/06/2020 Zinkstraat 1, 2490 Balen, Belgium
Title : Director Mandate : 27/04/2016- 24/02/2019 Zinkstraat 1, 2490 Balen, Belgium
Title : Director Mandate : 20/04/2017- 30/09/2019 Zinkstraat 1, 2490 Balen, Belgium
Moriarty Jane Title : Director Mandate : 14/03/2019- 27/06/2023 Zinkstraat 1, 2490 Balen, Belgium
Title : Auditor, Membership number : IBR 00025 Mandate : 19/04/2018- 29/06/2021 Gateway building, Luchthaven Brussel Nationaal 1, box J, 1930 Zaventem, Belgium Represented by: Nuyts Ine 1.
, Membership number : IBR A02183 Lange Lozanastraat 270 , 2018 Antwerpen 1, Belgium
The managing board declares that the assignment neither regarding auditing nor adjusting has been given to a person who was not authorised by law pursuant to art. 34 and 37 of the Law of 22nd April 1999 concerning the auditing and tax professions.
Yes / No Have the annual accounts been audited or adjusted by an external accountant or auditor who is not an statutory auditor ?
If YES, mention here after: name, first names, profession, residence-address of each external accountant or auditor, the number of membership with the professional Institute ad hoc and the nature of this engagement:
If the assignment mentioned either under A or B is performed by authorised accountants or authorised accountants-tax consultants, information will be given on: name, first names, profession and residence-address of each authorised accountant or accountant-tax consultant, his number of membership with the Professional Institute of Accountants and Tax consultants and the nature of this engagement.
| Name, first name, profession, residence-address | Number of membership |
Nature of the engagement (A, B, C and/or D) |
|---|---|---|
* Delete where appropriate.
** Optional disclosure.
| Notes | Codes | Period | Previous period | |
|---|---|---|---|---|
| ASSETS | ||||
| FORMATION EXPENSES |
6.1 | 20 | ||
FIXED ASSETS |
21/28 | 50.000,88 | 26.942.964,71 | |
Intangible fixed assets |
6.2 | 21 | ||
Tangible fixed assets |
6.3 | 22/27 | 531,94 | |
| Land and buildings | 22 | |||
| Plant, machinery and equipment | 23 | 531,94 | ||
| Furniture and vehicles | 24 | |||
| Leasing and other rights | 25 | |||
| Other tangible fixed assets | 26 | |||
| Tangible assets under construction and advance payments made |
27 | |||
| 6.4 / | ||||
| Financial fixed assets |
6.5.1 | 28 | 50.000,88 | 26.942.432,77 |
Affiliated enterprises |
6.15 | 280/1 | 0,88 | 15.395.252,57 |
| Participating interests | 280 | 0,88 | 15.395.252,57 | |
| Amounts receivable | 281 | |||
| Other enterprises linked by participating interests | 6.15 | 282/3 | ||
| Participating interests | 282 | |||
| Amounts receivable | 283 | |||
| Other financial assets | 284/8 | 50.000,00 | 11.547.180,20 | |
| Shares | 284 | |||
| Amounts receivable and cash guarantees | 285/8 | 50.000,00 | 11.547.180,20 | |
| Notes | Codes | Period | Previous period | |
|---|---|---|---|---|
CURRENT ASSETS |
29/58 | 17.148.936,52 | 378.334.332,81 | |
Amounts receivable after more than one year |
29 | 270.000.000,00 | ||
Trade debtors |
290 | |||
| Other amounts receivable |
291 | 270.000.000,00 | ||
Stocks and contracts in progress |
3 | |||
Stocks |
30/36 | |||
| Raw materials and consumables | 30/31 | |||
| Work in progress | 32 | |||
| Finished goods | 33 | |||
| Goods purchased for resale | 34 | |||
| Immovable property intended for sale | 35 | |||
| Advance payments | 36 | |||
| Contracts in progress | 37 | |||
| Amounts receivable within one year |
40/41 | 344.345,34 | 103.160.091,26 | |
Trade debtors |
40 | 3.114.771,72 | ||
| Other amounts receivable | 41 | 344.345,34 | 100.045.319,54 | |
| Current investments |
6.5.1 / 6.6 |
50/53 | 15.395.000,00 | |
Own shares |
50 | |||
| Other investments and deposits | 51/53 | 15.395.000,00 | ||
| Cash at bank and in hand |
54/58 | 1.274.246,37 | 382.010,52 | |
Deferred charges and accrued income |
6.6 | 490/1 | 135.344,81 | 4.792.231,03 |
TOTAL ASSETS |
20/58 | 17.198.937,40 | 405.277.297,52 |
| Notes | Codes | Period | Previous period | |
|---|---|---|---|---|
| EQUITY AND LIABILITIES | ||||
| EQUITY |
10/15 | 10.987.654,69 | 12.424.467,77 | |
Capital |
6.7.1 | 10 | 114.134.760,97 | 114.134.760,97 |
Issued capital 4 Uncalled capital |
100 101 |
114.134.760,97 | 114.134.760,97 | |
| Share premium account |
11 | 1.216.395.875,47 | 1.216.395.875,47 | |
Revaluation surpluses |
12 | |||
Reserves |
13 | 16.257.028,06 | 16.257.028,06 | |
Legal reserve |
130 | 16.257.028,06 | 16.257.028,06 | |
| Reserves not available | 131 | |||
| In respect of own shares held | 1310 | |||
| Others | 1311 | |||
| Untaxed reserves | 132 | |||
| Available reserves | 133 | |||
| Accumulated profits (losses) (+)/(-) |
14 | -1.335.800.009,81 | -1.334.363.196,73 | |
| Investment grants |
15 | |||
Advance to associates on the sharing 5 out of the assets |
19 | |||
PROVISIONS AND DEFERRED TAXES |
16 | 2.327.785,00 | 101.695.382,00 | |
Provisions for liabilities and charges |
160/5 | 2.327.785,00 | 101.695.382,00 | |
Pensions and similar obligations |
160 | |||
Taxation |
161 | |||
| Major repairs and maintenance | 162 | |||
| Environmental liabilities | 163 | |||
| Other risks and costs | 6.8 | 164/5 | 2.327.785,00 | 101.695.382,00 |
| Deferred taxes |
168 |
4 Amount to be deducted from the issued capital.
5 Amount to be deducted from the other components of equity.
| Notes | Codes | Period | Previous period | |
|---|---|---|---|---|
| AMOUNTS PAYABLE |
17/49 | 3.883.497,71 | 291.157.447,75 | |
Amounts payable after more than one year |
6.9 | 17 | 105.372.142,67 | |
Financial debts |
170/4 | 105.372.142,67 | ||
Subordinated loans |
170 | |||
| Unsubordinated debentures | 171 | 105.372.142,67 | ||
| Leasing and other similar obligations | 172 | |||
| Credit institutions | 173 | |||
| Other loans | 174 | |||
| Trade debts | 175 | |||
| Suppliers | 1750 | |||
| Bills of exchange payable | 1751 | |||
| Advances received on contracts in progress | 176 | |||
| Other amounts payable | 178/9 | |||
| Amounts payable within one year | 6.9 | 42/48 | 3.881.031,95 | 183.085.999,43 |
Current portion of amounts payable after more than one year falling due within one year |
42 | |||
| Financial debts | 43 | 3.000.000,00 | ||
| Credit institutions | 430/8 | |||
| Other loans | 439 | 3.000.000,00 | ||
| Trade debts | 44 | 756.917,15 | 4.052.409,68 | |
| Suppliers | 440/4 | 756.917,15 | 4.052.409,68 | |
| Bills of exchange payable | 441 | |||
| Advances received on contracts in progress | 46 | |||
| Taxes, remuneration and social security | 6.9 | 45 | 40.588,13 | 617.855,30 |
| Taxes | 450/3 | 15.970,53 | 27.450,01 | |
| Remuneration and social security | 454/9 | 24.617,60 | 590.405,29 | |
| Other amounts payable | 47/48 | 83.526,67 | 178.415.734,45 | |
| Accrued charges and deferred income |
6.9 | 492/3 | 2.465,76 | 2.699.305,65 |
TOTAL LIABILITIES |
10/49 | 17.198.937,40 | 405.277.297,52 |
| Notes | Codes | Period | Previous period |
|---|---|---|---|
| 15.211.955,20 | |||
| 6.10 | 70 | 3.412.614,97 | 15.211.955,20 |
| 71 | |||
| 72 | |||
| 6.10 | 74 | ||
| 6.12 | 76A | ||
| 60/66A | 15.415.570,39 | 124.376.483,24 | |
| 60 | |||
| 600/8 | |||
| 609 | |||
| 61 | 11.841.853,21 | 15.070.686,86 | |
| 6.10 | 62 | 1.245.586,04 | 2.251.056,84 |
| 630 | 346,14 | 4.775.391,76 | |
| 631/4 | |||
| 6.10 | 635/8 | -3.656.601,98 | |
| 6.10 | 640/8 | ||
| 649 | |||
| 6.12 | 66A | 2.327.785,00 | 105.935.949,76 |
| 9901 | -12.002.955,42 | -109.164.528,04 | |
| 70/76A | 3.412.614,97 |
| Notes | Codes | Period | Previous period | |
|---|---|---|---|---|
| Financial income |
75/76B | 115.352.998,57 | 11.509.195,69 | |
Recurring financial income |
75 | 5.412.275,83 | 11.509.195,69 | |
| Income from financial fixed assets | 750 | |||
| Income from current assets | 751 | 5.009.161,57 | 11.494.650,47 | |
| Other financial income | 6.11 | 752/9 | 403.114,26 | 14.545,22 |
| Non-recurring financial income | 6.12 | 76B | 109.940.722,74 | |
| Financial charges |
6.11 | 65/66B | 104.782.460,06 | 1.236.702.696,11 |
Recurring financial charges |
65 | 6.154.576,87 | 16.677.799,57 | |
Debt charges |
650 | 6.034.170,58 | 16.672.293,66 | |
| Amounts written down on current assets except stocks, contracts in progress and trade debtors (+)/(-) |
651 | |||
| Other financial charges | 652/9 | 120.406,29 | 5.505,91 | |
| Non recurring financial charges | 6.12 | 66B | 98.627.883,19 | 1.220.024.896,54 |
| Profit (loss) for the period before taxes (+)/(-) |
9903 | -1.432.416,91 | -1.334.358.028,46 | |
| Transfer from postponed taxes | 780 | |||
Transfer to postponed taxes |
680 | |||
Income taxes (+)/(-) |
6.13 | 67/77 | 4.396,17 | 5.168,27 |
| Income taxes | 670/3 | 4.396,17 | 5.168,27 | |
| Adjustment of income taxes and write-back of tax provisions |
77 | |||
| Profit (loss) for the period (+)/(-) |
9904 | -1.436.813,08 | -1.334.363.196,73 | |
| Transfer from untaxed reserves | 789 | |||
Transfer to untaxed reserves |
689 | |||
Profit (loss) for the period available for appropriation (+)/(-) |
9905 | -1.436.813,08 | -1.334.363.196,73 |
| Codes | Period | Previous period | |
|---|---|---|---|
| Profit (loss) to be appropriated (+)/(-) | 9906 | -1.335.800.009,81 | -1.350.013.017,73 |
| Gain (loss) to be appropriated (+)/(-) | (9905) | -1.436.813,08 | -1.334.363.196,73 |
| Profit (loss) to be carried forward (+)/(-) | 14P | -1.334.363.196,73 | -15.649.821,00 |
| Transfers from capital and reserves |
791/2 | 15.649.821,00 | |
| from capital and share premium account | 791 | 15.649.821,00 | |
| from reserves | 792 | ||
| Transfers to capital and reserves | 691/2 | ||
| to capital and share premium account | 691 | ||
| to the legal reserve | 6920 | ||
| to other reserves | 6921 | ||
| Profit (loss) to be carried forward (+)/(-) |
(14) | -1.335.800.009,81 | -1.334.363.196,73 |
| Owner's contribution in respect of losses | 794 | ||
| Profit to be distributed |
694/7 | ||
| Dividends | 694 | ||
| Director's or managers' entitlements | 695 | ||
| Workers | 696 | ||
| Other beneficiaries | 697 |
| Codes | Period | Previous period | |
|---|---|---|---|
| PLANT, MACHINERY AND EQUIPMENT | |||
| Acquisition value at the end of the period |
8192P | xxxxxxxxxxxxxxx | 6.260,00 |
Movements during the period |
|||
| Acquisitions, including produced fixed assets | 8162 | ||
| Sales and disposals | 8172 | 6.260,00 | |
| Transfers from one heading to another (+)/(-) | 8182 | ||
| Acquisition value at the end of the period | 8192 | ||
Revaluation surpluses at the end of the period |
8252P | xxxxxxxxxxxxxxx | |
Movements during the period |
|||
| Recorded | 8212 | ||
| Acquisitions from third parties | 8222 | ||
| Cancelled | 8232 | ||
| Transfers from one heading to another (+)/(-) | 8242 | ||
| Revaluation surpluses at the end of the period |
8252 | ||
| Depreciation and amounts written down at the end of the period | 8322P | xxxxxxxxxxxxxxx | 5.728,00 |
| Movements during the period | |||
| Recorded | 8272 | 346,14 | |
| Written back | 8282 | ||
| Acquisitions from third parties | 8292 | ||
| Cancelled owing to sales and disposals | 8302 | 6.074,14 | |
| Transfers from one heading to another (+)/(-) | 8312 | ||
| Depreciation and amounts written down at the end of the period | 8322 | ||
NET BOOK VALUE AT THE END OF THE PERIOD |
(23) |
............. ............. .....
| Codes | Period | Previous period | |
|---|---|---|---|
| AFFILIATED ENTERPRISES - PARTICIPATING INTERESTS AND SHARES |
|||
| Acquisition value at the end of the period |
8391P | xxxxxxxxxxxxxxx | 3.225.781.690,00 |
Movements during the period |
|||
| Acquisitions, including produced fixed assets | 8361 | 0,88 | |
| Sales and disposals | 8371 | 3.225.781.690,00 | |
| Transfers from one heading to another (+)/(-) | 8381 | ||
| Acquisition value at the end of the period | 8391 | 0,88 | |
Revaluation surpluses at the end of the period |
8451P | xxxxxxxxxxxxxxx | |
Movements during the period |
|||
| Recorded | 8411 | ||
| Acquisitions from third parties | 8421 | ||
| Cancelled | 8431 | ||
| Transfers from one heading to another (+)/(-) | 8441 | ||
| Revaluation surpluses at the end of the period | 8451 | ||
Amounts written down at the end of the period |
8521P | xxxxxxxxxxxxxxx | 3.210.386.437,00 |
Movements during the period |
|||
| Recorded | 8471 | ||
| Written back | 8481 | ||
| Acquisitions from third parties | 8491 | ||
| Cancelled owing to sales and disposals | 8501 | 3.210.386.437,00 | |
| Transfers from one heading to another (+)/(-) | 8511 | ||
| Amounts written down at the end of the period |
8521 | ||
Uncalled amounts at the end of the period |
8551P | xxxxxxxxxxxxxxx | |
Movements during the period (+)/(-) |
8541 | ||
| Uncalled amounts at the end of the period | 8551 | ||
NET BOOK VALUE AT THE END OF THE PERIOD |
(280) | 0,88 | |
AFFILIATED ENTERPRISES - AMOUNTS RECEIVABLE |
|||
| NET BOOK VALUE AT THE END OF THE PERIOD |
281P | xxxxxxxxxxxxxxx | |
| Movements during the period |
|||
| Additions | 8581 | ||
| Repayments | 8591 | ||
| Amounts written down | 8601 | ||
| Amounts written back | 8611 | ||
| Exchange differences (+)/(-) | 8621 | ||
| Other (+)/(-) | 8631 | ||
| NET BOOK VALUE AT THE END OF THE PERIOD |
(281) | ||
| ACCUMULATED AMOUNTS WRITTEN OFF ON AMOUNTS RECEIVABLE AT THE END OF THE PERIOD |
8651 |
| Codes | Period | Previous period | |
|---|---|---|---|
| OTHER ENTERPRISES - PARTICIPATING INTERESTS AND SHARES |
|||
| Acquisition value at the end of the period |
8393P | xxxxxxxxxxxxxxx | |
Movements during the period |
|||
| Acquisitions, including produced fixed assets | 8363 | ||
| Sales and disposals | 8373 | ||
| Transfers from one heading to another (+)/(-) | 8383 | ||
| Acquisition value at the end of the period | 8393 | ||
Revaluation surpluses at the end of the period |
8453P | xxxxxxxxxxxxxxx | |
Movements during the period |
|||
| Recorded | 8413 | ||
| Acquisitions from third parties | 8423 | ||
| Cancelled | 8433 | ||
| Transfers from one heading to another (+)/(-) | 8443 | ||
| Revaluation surpluses at the end of the period |
8453 | ||
| Amounts written down at the end of the period |
8523P | xxxxxxxxxxxxxxx | |
Movements during the period |
|||
| Recorded | 8473 | ||
| Written back | 8483 | ||
| Acquisitions from third parties | 8493 | ||
| Cancelled owing to sales and disposals | 8503 | ||
| Transfers from one heading to another (+)/(-) | 8513 | ||
| Amounts written down at the end of the period | 8523 | ||
Uncalled amounts at the end of the period |
8553P | xxxxxxxxxxxxxxx | |
Movements during the period (+)/(-) |
8543 | ||
| Uncalled amounts at the end of the period | 8553 | ||
NET BOOK VALUE AT THE END OF THE PERIOD |
(284) | ||
OTHER ENTERPRISES - AMOUNTS RECEIVABLE |
|||
| NET BOOK VALUE AT THE END OF THE PERIOD | 285/8P | xxxxxxxxxxxxxxx | 11.547.180,20 |
Movements during the period |
|||
| Additions | 8583 | 50.000,00 | |
| Repayments | 8593 | 11.547.180,20 | |
| Amounts written down | 8603 | ||
| Amounts written back | 8613 | ||
| Exchange differences (+)/(-) | 8623 | ||
| Other (+)/(-) | 8633 | ||
| NET BOOK VALUE AT THE END OF THE PERIOD |
(285/8) | 50.000,00 | |
ACCUMULATED AMOUNTS WRITTEN OFF ON AMOUNTS RECEIVABLE AT THE END OF THE PERIOD |
8653 |
List of both enterprises in which the enterprise holds a participating interest (recorded in the headings 280 and 282 of assets) and other enterprises in which the enterprise holds rights (recorded in the headings 284 and 51/53 of assets) in the amount of at least 10% of the capital issued.
| NAME, full address of the REGISTERED | Shares held by | Information from the most recent period for which annual accounts are available |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| OFFICE and for the enterprise governed by |
subsi directly diaries |
Primary | Mone | Capital and reserves | Net result | ||||
| Belgian law, the COMPANY NUMBER | Nature | Number | % | % | financial statement |
tary unit |
(+) of (-) (in units) |
||
| NN1 NewCo Limited Suite 1, 3rd Floor 11 , box 12 SW1Y4LB London United Kingdom 12049737 |
ordinary shares |
1 100,00 | 0,00 | 30/06/2020 | USD | 1 | 0 |
| Codes | Period | Previous period | |
|---|---|---|---|
| INVESTMENTS: OTHER INVESTMENTS AND DEPOSITS | |||
| Shares and current investments other than fixed income investments |
51 | 15.395.000,00 | |
Shares - Book value increased with the uncalled amount |
8681 | 15.395.000,00 | |
| Shares - Uncalled amount |
8682 | ||
Precious metals and works of art |
8683 | ||
Fixed income securities |
52 | ||
Fixed income securities issued by credit institutions |
8684 | ||
Fixed term accounts with credit institutions |
53 | ||
With residual term or notice of withdrawal |
|||
up to one month |
8686 | ||
between one month and one year |
8687 | ||
| over one year |
8688 | ||
Other investments not mentioned above |
8689 | ||
.. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ..
Allocation of heading 490/1 of assets if the amount is significant.
Insurance expenses 135.344,81
Period
| Codes | Period | Previous period | |
|---|---|---|---|
| STATEMENT OF CAPITAL | |||
| Social capital | |||
| Issued capital at the end of the period | 100P | XXXXXXXXXXXXXX | 114.134.760,97 |
| Issued capital at the end of the period | (100) | 114.134.760,97 | |
| Codes | Amounts | Number of shares | |
| Changes during the period | |||
| Structure of the capital Different categories of shares |
|||
| 114.134.761,00 | 109.873.001 | ||
| Registered shares | 8702 | XXXXXXXXXXXXXX | 78.864 |
| Shares dematerialized | 8703 | XXXXXXXXXXXXXX | 109.794.137 |
| Codes | Uncalled capital | Capital called, but not paid |
|
|---|---|---|---|
| Capital not paid | |||
| Uncalled capital | (101) | XXXXXXXXXXXXXX | |
| Capital called, but not paid | 8712 | XXXXXXXXXXXXXX | |
| Shareholders having yet to pay up in full | |||
| Codes | Period | |
|---|---|---|
| OWN SHARES | ||
| Held by the company itself | ||
| Amount of capital held |
8721 | |
Number of shares held |
8722 | |
Held by the subsidiaries |
||
| Amount of capital held |
8731 | |
Number of shares held |
8732 | |
| Commitments to issue shares | ||
| Owing to the exercise of conversion rights | ||
| Amount of outstanding convertible loans |
8740 | |
Amount of capital to be subscribed |
8741 | |
Corresponding maximum number of shares to be issued |
8742 | |
Owing to the exercise of subscription rights |
||
| Number of outstanding subscription rights |
8745 | |
Amount of capital to be subscribed |
8746 | |
Corresponding maximum number of shares to be issued |
8747 | |
Authorized capital, not issued |
8751 |
| Codes | Period | |
|---|---|---|
| Shared issued, not representing capital | ||
| Distribution | ||
| Number of shares held |
8761 | |
Number of voting rights attached thereto |
8762 | |
Allocation by shareholder |
||
| Number of shares held by the company itself |
8771 | |
Number of shares held by its subsidairies |
8781 | |
as shown by the notifications received by the company in accordance with the Companies Code, Article 631 §2 and Article 632 §2; the act of 2 May 2007 on the disclosure of major holdings, Article 14, paragraph four; and the Royal Decree of 21 August 2008 comprising further rules on certain multilateral trading facilities, Article 5.
Period Provision for liquidation 2.300.000,00 Provision for DSU's 27.785,00
| INCOME | Codes | Period |
|---|---|---|
| BREAKDOWN OF AMOUNTS PAYABLE WITH AN ORIGINAL PERIOD TO MATURITY OF MORE THAN ONE YEAR, ACCORDING TO THEIR RESIDUAL TERM |
||
| Current portion of amounts payable after more than one year falling due within one year | ||
| Financial debts | 8801 | |
| Subordinated loans | 8811 | |
| Unsubordinated debentures | 8821 | |
| Leasing and other similar obligations | 8831 | |
| Credit institutions | 8841 | |
| Other loans | 8851 | |
| Trade debts | 8861 | |
| Suppliers | 8871 | |
| Bills of exchange payable | 8881 | |
| Advance payments received on contracts in progress | 8891 | |
| Other amounts payable | 8901 | |
| Total amounts payable after more than one year, not more than one year |
(42) | |
| Amounts payable after more than one year, between one and five years | ||
| Financial debts | 8802 | |
| Subordinated loans | 8812 | |
| Unsubordinated debentures | 8822 | |
| Leasing and other similar obligations | 8832 | |
| Credit institutions | 8842 | |
| Other loans | 8852 | |
| Trade debts | 8862 | |
| Suppliers | 8872 | |
| Bills of exchange payable | 8882 | |
| Advance payments received on contracts in progress | 8892 | |
| Other amounts payable | 8902 | |
Total amounts payable after more than one year, between one and five years |
8912 | |
Amounts payable after more than one year, over five years |
||
| Financial debts |
8803 | |
| Subordinated loans | 8813 | |
| Unsubordinated debentures | 8823 | |
| Leasing and other similar obligations | 8833 | |
| Credit institutions | 8843 | |
| Other loans | 8853 | |
| Trade debts | 8863 | |
| Suppliers | 8873 | |
| Bills of exchange payable | 8883 | |
| Advance payments received on contracts in progress | 8893 | |
| Other amounts payable | 8903 | |
| Total amounts payable after more than one year, over five years | 8913 |
| Codes | Period | |
|---|---|---|
| AMOUNTS PAYABLE GUARANTEED (headings 17 and 42/48 of liabilities) |
||
| Amounts payable guaranteed by Belgian public authorities | ||
| Financial debts | 8921 | |
| Subordinated loans | 8931 | |
| Unsubordinated debentures | 8941 | |
| Leasing and other similar obligations | 8951 | |
| Credit institutions | 8961 | |
| Other loans | 8971 | |
| Trade debts | 8981 | |
| Suppliers | 8991 | |
| Bills of exchange payable | 9001 | |
| Advance payments received on contracts in progress | 9011 | |
| Remuneration and social security | 9021 | |
| Other amounts payable | 9051 | |
| Total amounts payable guaranteed by Belgian public authorities |
9061 | |
Amounts payable guaranteed by real guarantees given or irrevocably promised by the enterprise on its own assets |
||
| Financial debts | 8922 | 3.000.000,00 |
| Subordinated loans | 8932 | |
| Unsubordinated debentures | 8942 | |
| Leasing and other similar obligations | 8952 | |
| Credit institutions | 8962 | |
| Other loans | 8972 | 3.000.000,00 |
| Trade debts | 8982 | |
| Suppliers | 8992 | |
| Bills of exchange payable | 9002 | |
| Advance payments received on contracts in progress | 9012 | |
| Taxes, remuneration and social security | 9022 | |
| Taxes | 9032 | |
| Remuneration and social security | 9042 | |
Other amounts payable |
9052 | |
| Total amounts payable guaranteed by real guarantees given or irrevocably promised by the enterprise on its own assets |
9062 | 3.000.000,00 |
| Codes | Period | |
|---|---|---|
| AMOUNTS PAYABLE FOR TAXES, REMUNERATION AND SOCIAL SECURITY | ||
| Taxes (headings 450/3 and 178/9 of the liabilities) |
||
| Expired taxes payable | 9072 | |
| Non expired taxes payable | 9073 | 15.970,53 |
| Estimated taxes payable | 450 | |
| Remuneration and social security (headings 454/9 and 178/9 of the liabilities) | ||
| Amount due to the National Office of Social Security | 9076 | |
| Other amounts payable relating to remuneration and social security | 9077 | 24.617,60 |
Period
TR Accrued Interest Payabele 2.465,76
| Codes | Period | Previous period | |
|---|---|---|---|
| OPERATING INCOME | |||
| Net turnover | |||
| Broken down by categories of activity | |||
| Allocation into geographical markets | |||
| Other operating income | |||
| Operating subsidies and compensatory amounts received from public authorities |
740 | ||
| OPERATING COSTS | |||
| Employees for whom the company has submitted a DIMONA declaration or are recorded in the general personnel register |
|||
| Total number at the closing date | 9086 | 9 | |
| Average number of employees calculated in full-time equivalents | 9087 | 9,0 | 9,9 |
| Number of actual worked hours | 9088 | 7.786 | 15.812 |
| Personnel costs | |||
| Remuneration and direct social benefits | 620 | 937.087,34 | 1.488.668,00 |
| Employers' social security contributions | 621 | 193.991,17 | 418.516,00 |
| Employers' premiums for extra statutory insurances | 622 | 107.542,25 | 329.582,00 |
| Other personnel costs | 623 | 6.965,28 | 14.290,84 |
| Old-age and widows' pensions | 624 |
| Codes | Period | Previous period | |
|---|---|---|---|
| Provisions for pensions | |||
| Additions (uses and write-back) (+)/(-) | 635 | ||
| Amounts written off | |||
| Stocks and contracts in progress | |||
| Recorded | 9110 | ||
| Written back | 9111 | ||
| Trade debtors | |||
| Recorded | 9112 | ||
| Written back | 9113 | ||
| Provisions for risks and charges | |||
| Additions | 9115 | ||
| Uses and write-back | 9116 | 3.656.601,98 | |
| Other operating charges | |||
| Taxes related to operation | 640 | ||
| Other charges | 641/8 | ||
| Hired temporary staff and persons placed at the enterprise's disposal |
|||
| Total number at the closing date | 9096 | 1 | |
| Average number calculated as full-time equivalents | 9097 | 0,4 | 0,8 |
| Number of actual worked hours | 9098 | 756 | 1.591 |
| Charges to the enterprise | 617 | 42.843,00 | 89.088,00 |
| Codes | Period | Previous period | |
|---|---|---|---|
| RECURRING FINANCIAL INCOME | |||
| Other financial income | |||
| Subsidies granted by public authorities and recorded as income for the period |
|||
| Capital subsidies | 9125 | ||
| Interest subsidies |
9126 | ||
| Allocation of other financial income | |||
| positive foreign exchange differences | 29,99 | 14.545,00 | |
| RECURRING FINANCIAL CHARGES | |||
| Depreciation of loan issue expenses |
6501 | 949.220,00 | |
Capitalized Interests |
6503 | ||
Amounts written off current assets |
|||
| Recorded | 6510 | ||
| Written back | 6511 | ||
| Other financial charges | |||
| Amount of the discount borne by the enterprise, as a result of negotiating amounts receivable |
653 | ||
| Provisions of a financial nature | |||
| Appropriations | 6560 | ||
| Uses and write-backs | 6561 | ||
| Allocation of other financial charges | |||
| negative foreign exchange differences | 27.894,19 | 5.506,00 |
| Codes | Period | Previous period | |
|---|---|---|---|
| NON-RECURRING INCOME |
76 | 109.940.722,74 | |
| Non-recurring operating income |
(76A) | ||
Write-back of depreciation and of amounts written off intangible and tangible fixed assets |
760 | ||
| Write-back of provisions for extraordinary operating liabilities and charges |
7620 | ||
| Capital gains on disposal of intangible and tangible fixed asset | 7630 | ||
| Other non-recurring operating income | 764/8 | ||
| Non-recurring financial income |
(76B) | 109.940.722,74 | |
Write-back of amounts written down financial fixed assets |
761 | ||
| Write-back of provisions for extraordinary financial liabilities and charges |
7621 | ||
| Capital gains on disposal of financial fixed assets | 7631 | ||
Other non-recurring financial income |
769 | 109.940.722,74 | |
| NON-RECURRING EXPENSES |
66 | 100.955.668,19 | 1.325.960.846,30 |
| Non-recurring operating charges |
(66A) | 2.327.785,00 | 105.935.949,76 |
Non-recurring depreciation of and amounts written off formation expenses, intangible and tangible fixed assets |
660 | 4.240.567,76 | |
| Provisions for extraordinary operating liabilities and charges: Appropriations (uses) (+)/(-) |
6620 | -39.357.213,17 | 101.695.382,00 |
| Capital losses on disposal of intangible and tangible fixed assets | 6630 | ||
| Other non-recurring operating charges | 664/7 | 41.684.998,17 | |
| Non-recurring operating charges carried to assets as restructuring costs (-) |
6690 | ||
| Non-recurring financial charges |
(66B) | 98.627.883,19 | 1.220.024.896,54 |
Amounts written off financial fixed assets |
661 | 1.220.024.896,54 | |
| Provisions for extraordinary financial liabilities and charges - Appropriations (uses) (+)/(-) |
6621 | ||
| Capital losses on disposal of financial fixed assets | 6631 | ||
| Other non-recurring financial charges | 668 | 98.627.883,19 | |
| Non-recurring financial charges carried to assets as restructuring costs (-) |
6691 |
| Codes | Period | |
|---|---|---|
| INCOME TAXES | ||
| Income taxes on the result of the period |
9134 | 4.396,17 |
Income taxes paid and withholding taxes due or paid |
9135 | 4.396,17 |
| Excess of income tax prepayments and withholding taxes paid recorded under assets | 9136 | |
| Estimated additional taxes | 9137 | |
| Income taxes on the result of prior periods |
9138 | |
Additional income taxes due or paid |
9139 | |
| Additional income taxes estimated or provided for | 9140 | |
| In so far as taxes of the period are materially affected by differences between the profit before taxes as stated in annual accounts and the estimated taxable profit |
||
| Movement in the taxable provisions 2019 | -101.695.382,00 | |
| Other disallowed expenses |
Impact of non recurring results on the amount of the income taxes relating to the current period

| Codes | Period |
|---|---|
| 9141 | 227.396.534,71 |
| 9142 | 122.354.275,45 |
| 105.042.259,26 | |
| 9144 | |
| Codes | Period | Previous period | |
|---|---|---|---|
| VALUE ADDED TAXES AND OTHER TAXES BORNE BY THIRD PARTIES |
|||
| Value added taxes charged | |||
| To the enterprise (deductible) | 9145 | 3.402.963,59 | 2.022.371,00 |
| By the enterprise | 9146 | 12.326,27 | 1.714.951,00 |
| Amounts withheld on behalf of third party | |||
| For payroll withholding taxes | 9147 | 539.324,30 | 708.737,00 |
| For withholding taxes on investment income | 9148 | ||
| Codes | Period | |
|---|---|---|
| PERSONAL GUARANTEES PROVIDED OR IRREVOCABLY PROMISED BY THE ENTERPRISE AS SECURITY FOR DEBTS AND COMMITMENTS OF THIRD PARTIES |
9149 | 235.167.760,30 |
Of which |
||
Bills of exchange in circulation endorsed by the enterprise |
9150 | |
| Bills of exchange in circulation drawn or guaranteed by the enterprise | 9151 | |
| Maximum amount for which other debts or commitments of third parties are guaranteed by the enterprise |
9153 | |
| REAL GUARANTEES | ||
| Real guarantees provided or irrevocably promised by the enterprise on its own assets as security of debts and commitments of the enterprise |
||
| Mortgages | ||
| Book value of the immovable properties mortgaged | 9161 | |
| Amount of registration | 9171 | |
| Pledging of goodwill - Amount of the registration | 9181 | |
| Pledging of other assets - Book value of other assets pledged | 9191 | |
| Guarantees provided on future assets - Amount of assets involved | 9201 | |
| Real guarantees provided or irrevocably promised by the enterprise on its own assets as security of debts and commitments of third parties |
||
| Mortgages | ||
| Book value of the immovable properties mortgaged | 9162 | |
| Amount of registration | 9172 | |
| Pledging of goodwill - Amount of the registration | 9182 | |
| Pledging of other assets - Book value of other assets pledged | 9192 | |
| Guarantees provided on future assets - Amount of assets involved | 9202 |
| Codes | Period | |
|---|---|---|
| GOODS AND VALUES, NOT DISCLOSED IN THE BALANCE SHEET, HELD BY THIRD PARTIES IN THEIR OWN NAME BUT AT RISK TO AND FOR THE BENEFIT OF THE ENTERPRISE |
||
| SUBSTANTIAL COMMITMENTS TO ACQUIRE FIXED ASSETS | ||
| SUBSTANTIAL COMMITMENTS TO DISPOSE OF FIXED ASSETS | ||
| FORWARD TRANSACTIONS | ||
| Goods purchased (to be received) |
9213 | |
Goods sold (to be delivered) |
9214 | |
Currencies purchased (to be received) |
9215 | |
Currencies sold (to be delivered) |
9216 | |
| AMOUNT, NATURE AND FORM CONCERNING LITIGATION AND OTHER IMPORTANT COMMITMENTS |
|---|
SUPPLEMENT RETIREMENTS OR SURVIVORS PENSION PLANS IN FAVOUR OF THE PERSONNEL OR THE EXECUTIVES OF THE ENTERPRISE
Brief description
Measures taken by the enterprise to cover the resulting charges
PENSIONS FUNDED BY THE ENTERPRISE
| Estimated amount of the commitments resulting from past services 9220 |
|
|---|---|
| Methods of estimation | |
| Period | |
| NATURE AND FINANCIAL IMPACT OF SIGNIFICANT EVENTS AFTER THE CLOSING DATE NOT INCLUDED IN THE BALANCE SHEET OR THE INCOME STATEMENT |
|
| Disclosed in C 6.20 | |
| Period | |
| COMMITMENTS TO PURCHASE OR SALE AVAILABLE TO THE COMPANY AS ISSUER OF OPTIONS FOR SALE OR PURCHASE |
|
| Put option the company holds over the investment of the remaining 2% of NN2 with the strike price of EUR 20.0 million that the Company can exercise between 1 February 2020 and 31 July 2022. |
20.000.000,00 |
| Period | |
| NATURE AND COMMERCIAL OBJECTIVE OF TRANSACTIONS NOT REFLECTED IN THE BALANCE SHEET |
|
| Provided that the risks or advantages coming from these transactions are significant and if the disclosure of the risks or advantages is necessary to appreciate the financial situation of the company |
|
| We refer to the put option as described above and in C 6.20. |
COMMITMENTS RELATING TO TECHNICAL GUARANTEES IN RESPECT OF SALES OR SERVICES
Period
Period
Code Period
Parent company guarantees
Until 31 July 2019 the Company was the holding company of the Nyrstar Group. In addition, until 31 July 2019 the Company was a guarantor under the
USD 650 million Trade Finance Framework Agreements ("TFFA) and under the USD 250 million Bridge Finance Facility Agreement "("BFFA") both provided to the Company's subsidiary at that time, Nyrstar Sales & Marketing AG by Trafigura. Both guarantees have
been released on completion of the Restructuring at 31 July 2019.
Additionally, Nyrstar NV has been released of liabilities for existing financial indebtedness and obligations owed under parent company guarantees of commercial or other obligations of the current members of the Operating Group (or indemnified by NN2
to the extent such guarantee liabilities are not released). The disclosed amount represents the Parent Company guarantees to third parties that have not yet been released per 31.12.2019 for which the company is indemnified. (see 2.3 in C6.20)
Period 235.167.760,30
| Codes | Period | Previous period | |
|---|---|---|---|
| AFFILIATED ENTERPRISES | |||
| Financial fixed assets |
(280/1) | 0,88 | 15.395.252,57 |
Participating interests |
(280) | 0,88 | 15.395.252,57 |
| Subordinated amounts receivable | 9271 | ||
| Other amounts receivable | 9281 | ||
| Amounts receivable | 9291 | 377.766.800,00 | |
Over one year |
9301 | 270.000.000,00 | |
| Within one year | 9311 | 107.766.800,00 | |
Current investments |
9321 | ||
Shares |
9331 | ||
| Amounts receivable | 9341 | ||
| Amounts payable | 9351 | 179.717.273,00 | |
Over one year |
9361 | ||
| Within one year | 9371 | 179.717.273,00 | |
Personal and real guarantees |
|||
| Provided or irrevocably promised by the enterprise as security for debts or commitments of affiliated enterprises |
9381 | 2.768.400.232,00 | |
| Provided or irrevocably promised by affiliated enterprises as security for debts or commitments of the enterprise |
9391 | ||
| Other significant financial commitments | 9401 | ||
Financial results |
|||
| Income from financial fixed assets | 9421 | ||
Income from current assets |
9431 | 5.009.157,77 | 11.494.645,00 |
Other financial income |
9441 | 27.894,19 | 14.545,00 |
Debt charges |
9461 | 748.986,64 | 2.305.945,00 |
Other financial charges |
9471 | 29,99 | 5.506,00 |
Disposal of fixed assets |
|||
| Capital gains obtained |
9481 | ||
Capital losses suffered |
9491 | ||
| Codes | Period | Previous period | |
|---|---|---|---|
| ASSOCIATED ENTERPRISES | |||
| Financial fixed assets |
9253 | ||
Participating interests |
9263 | ||
| Subordinated amounts receivable | 9273 | ||
| Other amounts receivable | 9283 | ||
| Amounts receivable | 9293 | ||
Over one year |
9303 | ||
| Within one year |
9313 | ||
| Amounts payable | 9353 | ||
Over one year |
9363 | ||
| Within one year | 9373 | ||
Personal and real guarantees |
|||
| Provided or irrevocably promised by the enterprise as security for debts or commitments of associated enterprises |
9383 | ||
| Provided or irrevocably promised by associated enterprises as security for debts or commitments of the enterprise |
9393 | ||
| Other significant financial commitments |
9403 | ||
OTHER ENTERPRISES LINKED BY PARTICIPATING INTERESTS |
|||
| Financial fixed assets |
9252 | ||
Participating interests |
9262 | ||
| Subordinated amounts receivable | 9272 | ||
| Other amounts receivable | 9282 | ||
| Amounts receivable | 9292 | ||
Over one year |
9302 | ||
| Within one year | 9312 | ||
Amounts payable |
9352 | ||
Over one year |
9362 | ||
| Within one year | 9372 | ||
TRANSACTIONS WITH ENTERPRISES LINKED BY PARTICIPATING INTERESTS OUT OF MARKET CONDITIONS
Mention of these transactions if they are significant, including the amount of the transactions, the nature of the link, and all information about the transactions which should be necessary to get a better understanding of the situation of the company
The relationship with Trafigura is disclosed further in C 6.20

| Codes | Period | |
|---|---|---|
| DIRECTORS, MANAGERS, INDIVIDUALS OR BODIES CORPORATE WHO CONTROL THE ENTERPRISE WITHOUT BEING ASSOCIATED THEREWITH OR OTHER ENTERPRISES CONTROLLED BY THESE PERSONS |
||
| Amounts receivable from these persons |
9500 | |
Conditions on amounts receivable, rate, duration, possibly reimbursed amounts, canceled amounts or renounced amounts |
||
| Guarantees provided in their favour |
9501 | |
Other significant commitments undertaken in their favour |
9502 | |
| Amount of direct and indirect remunerations and pensions, included in the income statement, as long as this disclosure does not concern exclusively or mainly, the situation of a single identifiable person |
||
| To directors and managers | 9503 | 615.314,98 |
| To former directors and former managers | 9504 |
| Codes | Period | |
|---|---|---|
| AUDITORS OR PEOPLE THEY ARE LINKED TO | ||
| Auditor's fees |
9505 | 180.000,00 |
| Fees for exceptional services or special missions executed in the company by the auditor | ||
| Other attestation missions |
95061 | 75.000,00 |
Tax consultancy |
95062 | |
Other missions external to the audit |
95063 | |
| Fees for exceptional services or special missions executed in the company by people they are linked to |
||
| Other attestation missions |
95081 | |
Tax consultancy |
95082 | |
Other missions external to the audit |
95083 | |
Mentions related to article 134 from the Companies Code
The enterprise has not published a consolidated annual statement of accounts and a management report, since it is exempt for this obligation for the following reason*
The enterprise and its subsidiaries on consolidated basis exceed not more than one of limits mentioned in art. 16 of Company Law*
The enterprise only has subsidiaries which, considering the assessment of the consolidated assets, consolidated financial position or consolidated results, individual or together, are of a negligible size* (Art. 110 of Company Law)
The enterprise itself is a subsidiary of an enterprise which does prepare and publish consolidated accounts in which annual accounts of the enterprise are included*
Name, full address of the registered office and, for an enterprise governed by Belgian Law, the company number of the parent company(ies) and the specification whether the parent company(ies) prepare(s) and publish(es) consolidated annual accounts in which the annual accounts of the enterprise are included**
If the parent company(ies) is (are) (an) enterprise(s) governed by foreign law disclose where the consolidated accounts can be obtained**
* Delete where no appropriate.
** Where the accounts of the enterprise are consolidated at different levels, the information should be given for the consolidated aggregate at the highest level on the one hand and the lowest level on the other hand of which the enterprise is a subsidiary and for which consolidated accounts are prepared and published.
Valuation rules Nyrstar NV
General:
The valuation rules are drafted in accordance with the statements of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations relating to valuation rules. As a consequence of the Restructuring and the outcomes of the 9 December 2019 EGM, where the shareholders rejected the continuation of the Company's activities, and subject to the outcome of the upcoming new EGM, the Company's intention is not to continue its activity. The Board of Directors of the Company is taking the necessary measures to prepare the necessary reports (Statement of assets and liabilities and the related legal reports) and the convening of a new extraordinary shareholders' meeting to formally decide on the dissolution of the Company, and if approved, appoint a liquidator. As such, the 31 December 2019 financial statements of the Company are prepared on a discontinuity basis. For further information on the Restructuring, we refer to C 6.20.
Specific valuation rules under going concern:
Formation expenses are capitalized and depreciated over 3 years. The expenses of capital increase are also capitalized and depreciated over 3 years. The expenses of the issuance of loans are also capitalized and depreciated over the duration of the loan.
Intangible fixed assets are valued at purchase cost. The depreciations are accounted for based on the following terms: o software: 3 years
o other: 3 to 5 years
Tangible assets are accounted for at historical purchase cost including incidental expenses. The depreciations for these assets is calculated based on the economical lifetime of the related asset and based on the straight-line method. The depreciation terms are defined as follows:
Participations and receivables are accounted for at historical purchase cost. An impairment on these assets will be recognized in case of sustainable impairment that meets the requirements of prudence, honesty and fair view and is justified by the condition, profitability or outlook of the company. The impairment will be reversed in case it is no longer justified based on the current assessments. Receivables denominated in foreign currencies are valued at the closing rates on the end of the financial year. The negative (unrealized) exchange rate differences are accounted for in the income statement. As of financial year 2011, based on the principles of prudence, the positive, unrealized exchange rate differences at year end closing date are accounted for as deferred income on the balance sheet.
These are valued at nominal value. Current assets and liabilities denominated in foreign currencies are valued at the closing rates on the end of the financial year.The negative (unrealized) exchange rate differences are accounted for in the income statement. As of financial year 2011, based on the principles of prudence, the positive, unrealized exchange rate differences at balance sheet date are accounted for as deferred income on the balance sheet. An impairment on the nominal value is recognized in case of uncertainty of the receivable at balance closing date. Cashpool positions are shown seperately as other receivables (41) and other liabilities (48).
A provision is recognized to reflect liabilities and charges, resulting from a past event for which the nature is clearly defined, are considered probable or certain at balance sheet date, but for which the amount is uncertain. Provisions resulting from prior accounting years are regularly reviewed and are reversed if they are no longer required or the risks and charges are realized.
The Group operated a leveraged employee stock ownership plan and an executive long-term incentive plan, which, at the Group's discretion, were equity-settled or cash-settled share-based compensation plans. For these share-based payment transactions, the services received and the liability incurred were measured at the fair value of the liability at grant date. The initial measurement of the liability was recognised over the period that services were rendered. At each reporting date, and ultimately at settlement date, the fair value of the liability was remeasured with any changes in fair value recognised in the income statement for the period.
The income statement reflects all revenue realized and expenses incurred during the accounting period on an accrual basis, regardless the date on which these expenses and income are paid or collected.
Adjustments recorded with respect to the valuation and the classification of certain balance sheet items as a result of the Company applying the discontinuity basis for the preparation of the 31 December 2019 financial statements:
a) The formation expenses were fully depreciated as required by Article 3:6 of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations in the 2018 financial statements.
b) Explanation on determination of expected probable realization value in accordance with Article 3:6 of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations.
At 31 December 2019, the Company has, in its current investments, a 2% investment in NN2 at the cost of EUR 15,395,000 and in its participating interests a 100% investment in NN1 valued at USD 1 representing cost of these investments for the Company through the issuance by NN2 of a 2% equity in NN2 to the Company with the remaining 98% equity stake issued to Trafigura New Holdco. The investment in NN2 as at 31 December 2019 of EUR 15,395,000 is carried at the lower of cost and expected probable realisation value, taking into consideration that the Company has a put option to sell all (but not part only) of its 2% holding in NN2 to Trafigura at a price
equal to EUR 20 million in aggregate payable to the Company resulting in no impairment required at 31 December 2019. This put option can be exercised by NNV between six months and three years of Trafigura or any member of the Trafigura Group becoming a parent company of NN2 or the Operating Group (i.e. between 1 February 2020 and 31 July 2022), subject to limited triggers allowing earlier exercise of the put option before 6 months or earlier termination of the put option before three years.
c) Additionally, as at 31 December 2018, the Company had contingent liabilities amounting to EUR 2,768m provided or irrevocably promised by the Company for debts and commitments of third parties. As at 31 December 2019 the Company had contingent liabilities amounting to EUR 235.2 million provided or irrevocably promised by the Company for debts and commitments of third parties that are yet to be transferred to the Trafigura Group. For more details refer to the parent company guarantees disclosures in note C 6.14 and C 6.20.
d) The decision of the 9 December 2019 EGM not to continue the Company's activities resulted in the requirement for the Company to recognize a provision for discontinuation representing the estimated costs that the Company expects to incur before the completion of the liquidation. At 31 December 2019 the Company recognised a provision for discontinuation of EUR 2.3 million representing the estimated costs that the Company expects to incur before the completion of an orderly liquidation process that would be finalised before the end of 2020. Should the liquidation process take longer, e.g. due to the potential legal or regulatory actions as discussed in the subsequent events note, the estimated costs to be incurred by the Company before the completion of the liquidation would be significantly higher. Assuming the completion of the liquidation between the end of 2024 and 2029 the Company would need to incur estimated costs between EUR 11 million and 20 million, which may require the Company to obtain additional funding beyond the proceeds from the exercise of the EUR 20 million put option and the repayment of the outstanding amount drawn on the Limited Recourse Loan Facility from the put option proceeds. These additional costs in excess of the provision of EUR 2.3 million recognised at 31 December 2019 would further decrease the equity of the Company subsequent to 31 December 2019.
At the date of authorisation of the 31 December 2019 financial statements, Nyrstar NV (the "Company") has assessed that, taking into account its available cash, cash equivalents, facilities that became available to the Company as committed facilities at the completion of the restructuring of the Company and its subsidiaries ("Group") ("Restructuring") at 31 July 2019, the ability to exercise the put option that the Company has that enables it to sell its 2% investment in the Operating Group and its cash flow projections for the next 12 months from the authorisation of the 31 December 2019 financial statements, it has sufficient liquidity to meet its present obligations and cover working capital needs. The forecast available liquidity of the Company, that at the date of this report includes the fully drawn amount of EUR 3.7 million available to the Company for the first year of the Limited Recourse Loan Facility, is dependent on various matters including the expected appointment of a liquidator (refer below) and his or her next steps, the potential existence of legal claims against the company requiring funding of the legal proceedings and other matters not currently foreseen. As from 1 August 2020 the Company can draw further EUR 1.2 million under the Limited Recourse Loan Facility for the Company's ongoing ordinary course operating activities. The Company can also draw on the separate EUR 5 million tranche of the Limited Recourse Loan Facility intended for the payment of certain litigation defense costs, if required. Should the abovementioned funding options not provide the Company with sufficient funds when they are required, the Company can exercise its put option that enables the Company to sell its 2% investment in the Operating Group for EUR 20 million, repay the outstanding amount drawn on the Limited Recourse Loan Facility from the proceeds of the put option (refer to the Related party dislcosures hereafter for further details) andgenerating sufficient funding for the Company.
However, at 9 December 2019 the Extraordinary General Meeting ("EGM") of the Company was held to deliberate on the continuation of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's activities. The Board of Directors of the Company is taking the necessary measures to prepare the necessary reports (Statement of assets and liabilities and the related legal reports) and the convening of a new extraordinary shareholders' meeting to formally decide on the dissolution of the Company, and if approved, appoint a liquidator. As such, the 31 December 2019 financial statements of the Company are prepared on a discontinuity basis.
As was the case for the 31 December 2018 financial statements, which were prepared under an other than going concern basis, the Board of Directors has assessed which adjustments had to be recorded with respect to the valuation and the classification of certain balance sheet items included in a balance sheet prepared on a discontinuity basis, as required and described under the valuation rules a) to d). The fixed and current assets have been recorded at the lower of cost and their expected probable realisation value. The decision of the 9 December 2019 EGM not to continue the Company's activities resulted in the requirement for the Company to recognize a provision for discontinuation representing the estimated costs that the Company expects to incur before the completion of the liquidation. At 31 December 2019 the Company recognised a provision for discontinuation of EUR 2.3 million representing the estimated costs that the Company expects to incur before the completion of an orderly liquidation process that would be finalised before the end of 2020. Should the liquidation process take longer, e.g. due to the potential legal or regulatory actions as discussed in the subsequent events note, the estimated costs to be incurred by the Company before the completion of the liquidation would be significantly higher. Assuming the completion of the liquidation between the end of 2024 and 2029 the Company would need to incur estimated costs between EUR 11 million and 20 million, which may require the Company to obtain additional funding beyond the proceeds from the exercise of the EUR 20 million put option and the repayment of the outstanding amount drawn on the Limited Recourse Loan Facility from the put option proceeds. These additional costs in excess of the provision of EUR 2.3 million recognised at 31 December 2019 would further decrease the equity of the Company subsequent to 31 December 2019.
The Group initiated a review of its capital structure (the "Capital Structure Review") in October 2018 in response to the challenging financial and operating conditions being faced by the Group. In November 2018, the Group experienced increased working capital requirements as its liquidity position suddenly and unexpectedly deteriorated following the third quarter 2018 results announcement, negative press coverage and credit rating downgrade. In particular, a significant portion of the Group's trade financing arrangements were suspended or terminated, or required to be cash collateralised, either partly or fully. These substantial working capital and liquidity outflows experienced by the Group during the fourth quarter of 2018 and first quarter of 2019 necessitated the raising of urgent funding to enable the Company and the Nyrstar Group to continue its operations. Combined with the Group's materially reduced Underlying EBITDA performance in 2018 and the maturing of certain liabilities during 2019, these factors resulted in the need to reconsider the Group's capital structure.
The Capital Structure Review identified a very substantial additional funding requirement that the Group was unable to meet without a material reduction of the Group's indebtedness. As a consequence, the Capital Structure Review necessitated negotiations between the Group's financial creditors in order to develop a deleveraging and funding plan. Alternatives were carefully considered but no alternative to address the financial issues was viable and failure to address these financial issues would have placed the future of the Company, its subsidiaries and its stakeholders at severe risk. Accordingly, on 15 April 2019, Nyrstar announced that it had entered into a lock-up agreement dated 14 April 2019 (the "Lock-Up Agreement") with representatives of its key financial creditor groups including Trafigura. The Lock-Up Agreement set out the terms for the recapitalisation of the Nyrstar Group (the "Recapitalisation Terms"). These Recapitalisation Terms included:
a transfer by Nyrstar NV of (i) all its subsidiaries, excluding NN1 (as defined below) (the "Operating Group"), and (ii) all receivables owed to Nyrstar by the Operating Group to NN2 for a consideration of USD 1; and
the subsequent transfer of majority ownership of NN2 (as sole owner of the underlying Operating Group) to a newly incorporated holding company ("Trafigura New Holdco") owned by Trafigura through the issuance by NN2 of a 98% equity stake in itself to Trafigura New Holdco (with the remaining 2% of equity in NN2 issued directly to Nyrstar), in connection with the coming into effect of all other steps that are fundamental to the implementation the Restructuring, including (but not limited to):
a. the release of the outstanding EUR 115 million convertible bonds due in 2022 issued by the Company (the "Convertible Bonds") and the
Operating Group's existing EUR 500 million 6.875% senior notes due in 2024 (the "2024 Notes") and EUR 340 million 8.5% senior notes due in 2019 (the "2019 Notes" and, together with the 2024 Notes, the "Notes" and any holder of the Notes and the Convertible Bonds, a "Noteholder") which were guaranteed by the Company in exchange for new debt instruments issued to those Noteholders by certain Trafigura entities (the "New Trafigura Instruments");
b. the restructuring of certain facilities entered into by the Operating Group and the release of the Company and NN1 from any guarantee obligations in respect of such facilities;
c. the provision of a EUR 160 million secured new money facility (by certain participating lenders under the Operating Group's existing facilities) to fund the general working capital of the restructured Operating Group (the "New Money Facility");
d. commitment by NN2 to use reasonable endeavours to procure the release of obligations owed by the Company to third parties in respect of financial, commercial or other obligations of the current members of the Operating Group (the "PCGs") (and an indemnity by NN2 to the extent such PCGs are not released);
e. the provision by NN2 of indemnities to the Company in respect of certain specified liabilities, including certain liabilities arising in relation to certain historic disposals by the Group and/or from certain historic mine closures;
f. the provision by NN2 and/or a Trafigura entity which is a holding company of the Operating Group of a limited recourse loan to the Company to fund its forecast ordinary course operating costs and any defence costs arising from any third-party litigation for a number of years following the restructuring; and
g. minority rights for the benefit of the Company in respect of its 2% equity in NN2 (including a tag right, a drag right, information rights and a put option at a price equal to EUR 20 million (adjusted pro rata depending on NN2's percentage holding from time to time) exercisable within certain time periods).
Subsequently, on 29 April 2019, Nyrstar announced that formal consents to the Lock-Up Agreement had been received from, inter alia, over 79% of the aggregate outstanding principal amount under the senior notes due in 2019 and due in 2024, and over 87% of the aggregate outstanding principal amount under the convertible bonds. Under the Lock-Up Agreement, implementation of the Recapitalisation Terms was subject to various conditions precedent which included various third-party regulatory approvals which were all successfully obtained.
On 14 June 2019, NN2 was incorporated in England under the name of NN2 Newco Limited. On 20 June 2019, the Company announced that various steps to implement the Restructuring had been and were being undertaken, including that NN2 had acceded to the Notes and that NN2 had published a practice statement letter in relation to a scheme of arrangement to be proposed by NN2 in respect of the Notes. The English court held the convening hearing on 4 July and ordered the NN2 scheme meetings to be held on 22 July (or such later time or date as NN2 may have decided). The NN2 scheme meetings were held on 22 July. There were two creditor classes for the NN2 scheme the Convertible Bonds in one class, and the Notes combined into a single second creditor class. For the first scheme creditor class (the Convertible Bonds), 98.87% by value voted and 100% by value and 100% by number of those voting supported the scheme. For the second scheme creditor class (the Notes), 95.57% by value voted and 99.96% by value and 98.93% by number of those voting supported the scheme. Accordingly, the NN2 scheme was supported by an overwhelming majority of the scheme creditors and well in excess of the requisite majorities (being 75% by value and a majority by number of those creditors voting in each scheme class).
The English court sanction hearing for the NN2 scheme of arrangement was held on 26 July 2019 when the sanction order was granted. The scheme of arrangement became effective on the same day. On 29 July, a meeting of holders of the convertible bonds was held and a resolution was passed to approve the NN2 scheme (98% by value of those entitled to vote did so and 100% of those voting approved the resolution scheme). On 30 July, the United States Bankruptcy Court Southern District of New York entered an order under Chapter 15 of title 11 of the United States Bankruptcy Code granting recognition of main proceedings and related relief giving full force to the UK scheme of arrangement of NN2 in the United States.
The Restructuring subsequently took full effect on 31 July 2019. As a result of the recapitalisation, Trafigura Group Pte. Ltd. has become the ultimate parent of the Operating Group.
Implementation of the Recapitalisation Terms has ensured the continuing operations of the Operating Group for the benefit of all stakeholders; failure to implement the Recapitalisation Terms would have highly likely lead to the insolvency of the Group as well as the Company, which was anticipated to have resulted in material harm to the Group's customers, suppliers and approximately 4,100 employees of the Group, as well as very substantial loss of value to the financial stakeholders, and a total loss to shareholders.
The agreements to which the Company is a party are discussed in further detail below.
1.2.Impact of the Restructuring on the 31 December 2019 financial statements
As the prior year financial statements as at 31 December 2018 were prepared on other than going concern basis, certain adjustments were reflected in line with the Belgian accounting provisions (Article 3:6 of the Royal Decree dd. 29 April 2019 to the execution of the Code of Companies and Associations). As such, the estimated impact of the Restructuring on the Company's Income Statement was recognised in the 31 December 2018 Income Statement when the Company recognised a provision of EUR 101.7 million representing the expected crystallization of the contingent liabilities that were expected to be off-set in 2019 against the remaining net financial receivable at the time when the restructuring would be completed. The amount also took into consideration the expected costs of disposal of the Company until the completion of the Restructuring of EUR 41.9 million that would increase the Company's net financial receivable position at that time. At the completion of the Restructuring at 31 July 2019, the Company settled and offset various positions between it and its former subsidiaries and derecognised the liability related to its outstanding convertible bonds. The loss arising from the settlement and the offset of these receivables and liabilities has been reflected against the provision of EUR 101.7 million recognised at 31 December 2018 by the Company. As the operating losses of the Company incurred in 2019 before the completion of the Restructuring were funded by its former subsidieries, the final net receivable position of the Company at the completion of the Restructuring was lower than estimated at 31 December 2018 resulting in the release of the unutilised portion of the provision of EUR 11.4 million through the Income Statement in the
year ended 31 December 2019, following the completion of the Restructuring.
Additionally, as at 31 December 2018, the Company had contingent liabilities amounting to EUR 2,768m provided or irrevocably promised by the Company for debts and commitments of third parties. As at 31 December 2019 the Company had contingent liabilities amounting to EUR 235.2 million provided or irrevocably promised by the Company for debts and commitments of third parties that are yet to be transferred to the Trafigura Group. For more details refer to the parent company guarantees disclosures in note C 6.14 and C 6.20.
At 31 December 2019, the Company has, in its current investments, a 2% investment in NN2 at the cost of EUR 15,395,000 and in its participating interests a 100% investment in NN1 valued at USD 1 representing cost of these investments for the Company through the issuance by NN2 of a 2% equity in NN2 to the Company with the remaining 98% equity stake issued to Trafigura New Holdco. The investment in NN2 as at 31 December 2019 of EUR 15,395,000 is carried at the lower of cost and their expected probable realisation value, taking into consideration that the Company has a put option to sell all (but not part only) of its 2% holding in NN2 to Trafigura at a price equal to EUR 20 million in aggregate payable to the Company resulting in no impairment required at 31 December 2019. This put option can be exercised by NNV between six months and three years of Trafigura or any member of the Trafigura Group becoming a parent company of NN2 or the Operating Group (i.e. between 1 February 2020 and 31 July 2022), subject to limited triggers allowing earlier exercise of the put option before 6 months or earlier termination of the put option before three years.
In the interests of all stakeholders of the Nyrstar group, including the Company's shareholders, in 2019 the Board of Directors voluntarily decided to apply the procedure provided for in article 524 of the Belgian Companies Code (the "Art. 524 Procedure") to the following steps of the Restructuring:
1.the transfer by the Company of (i) all its subsidiaries, excluding NN1 NewCo Limited ("NN1") (the "Operating Group"), and (ii) all receivables owed to the Company by the Operating Group, to NN2 (the Intragroup Reorganisation) at a nominal amount of USD 1, taking into account the fair market value of the assets (as adjusted by liabilities within the Operating Group). The Intragroup Reorganisation was undertaken pursuant to a deed of sale and purchase dated 19 June 2019 between the Company and NN2 (the NNV-NN2 SPA), further details of which are discussed below; and
2.the subsequent transfer of majority ownership of NN2 to Trafigura on the Restructuring Effective Date, through the issuance by NN2 of a 98% equity stake in itself to Nyrstar Holdings (with the remaining 2% issued directly to the Company) in connection with the coming into effect of certain other steps regarding implementation of the Restructuring.
The Art. 524 Procedure was voluntarily applied by the Board on 19 June 2019 and the independent expert appointed during this process included a review of the quantum of the consideration for the Intragroup Reorganisation.
The Lock Up Agreement envisaged that the Company, Trafigura and Nyrstar Holdings Limited ("Nyrstar Holdings", a Trafigura special-purpose vehicle incorporated, amongst other things, for the purpose of implementing the Restructuring) would enter into a deed confirming their agreement in respect of (i) certain steps necessary for the implementation of the Restructuring as envisaged in the Lock Up Agreement and (ii) the terms of the ongoing relationship between the Company and the Trafigura group (the "NNV-Trafigura Deed"). The NNV-Trafigura Deed was duly executed on 19 June 2019. Certain key terms of the NNV-Trafigura Deed can be summarised as follows.
"Distribution policy: under the NNV-Trafigura Deed, Trafigura and Nyrstar Holdings have assumed obligations which are intended to ensure, as far as possible, that any profits realised by the former subsidiaries of the Company (referred to, prior to the Restructuring Effective Date, as the "Operating Group", and following the Restructuring Effective Date, which form part of the Trafigura group via Nyrstar Holding's 98% majority shareholding in NN2 NewCo Limited ("NN2") and are referred to as the "Restructured Operating Group") are distributed to the shareholders of NN2 (including the Company as 2% minority shareholder). To this end, Nyrstar Holdings has agreed to procure that: (i) the board of NN2 will meet at least on an annual basis to assess whether NN2 has any profits lawfully available for distribution (in which case, NN2 will make such distribution in accordance with applicable law); and (ii) NN2 and the other members of the Restructured Operating Group will not, under the terms of any financing or other agreement to which they are or shall be party (other than financing or other agreements entered into on arm's length terms with third parties), be subject to any limitations on making dividends or other distributions to their respective shareholders.
"Drag / tag rights: under the terms of the NNV-Trafigura Deed, if Nyrstar Holdings or any Trafigura entity or entities which hold(s) the 98% stake in NN2 (being the "Majority Shareholder(s)") proposes at any time a transfer of any right or interest to a third party purchaser (on arms' length terms, for cash or non-cash consideration) that would result in a member of the Trafigura group holding 50% or less of the shares in NN2, then the Majority Shareholder(s) proposing the transfer will have the right to oblige the Company to transfer (a "drag right"), and the Company will have an equivalent right to participate in such transfer (a "tag right"), its entire 2% equity stake in NN2 on the same terms and for the same consideration per share as for the Majority Shareholder(s).
"NN2 change of control: the NNV-Trafigura Deed places obligations on Trafigura and Nyrstar Holdings to procure that the Trafigura group shall only implement any intragroup reorganisation within the Trafigura group which would result in at least 75% of the net assets (by value) of the Restructured Operating Group no longer being held by NN2 but being held by another member of the Trafigura group (the "Replacement HoldCo"), if (i) it is bona fide and undertaken in good faith, (ii) the financial position of Replacement Holdco is substantially the same as that of NN2 immediately prior to such intragroup reorganisation, (iii) arrangements are put in place such that shareholders in Replacement Holdco (including the Company) have substantially equivalent rights and obligations with respect to Replacement Holdco as they did with respect to NN2, and (iv) the Company has an equity interest in Replacement Holdco equivalent to its equity interest n NN2 immediately prior to the intragroup reorganisation, with substantially the same rights and protections. If such conditions are met, then the Company shall take all steps and provide such reasonable assistance as is necessary to effectuate the intragroup reorganisation, and shall cooperate in good-faith. Any costs reasonably incurred by the Company in doing so (including reasonable advisor fees), shall be borne by Trafigura.
Pursuant to the NNV-Trafigura Deed, the Company and Trafigura also agreed that Trafigura shall grant to the Company an option to require a Trafigura entity to purchase the Company's entire interest in NN2, the terms of which are set in a separate deed, dated 25 June 2019, between the Company, Trafigura and Nyrstar Holdings (the "Put Option Deed"). Under the terms of the Put Option Deed, the Company can put all (but not only a part) of its 2% holding in NN2 to Trafigura at a price equal to EUR 20 million (the "Put Option"). The Put Option can be exercised by the Company between six months and three years of the completion of the Restructuring (i.e. between 1 February 2020 and 31 July 2022), subject to limited triggers allowing earlier exercise of the Put Option before 6 months, or earlier termination of the Put Option before 3 years.
2.2.Release from parent company guarantees in favour of Trafigura
As stated above, prior to the Restructuring Effective Date, the Company was ultimate parent company of the Nyrstar group, and had previously issued various parent company guarantees in respect of the obligations of its subsidiaries, including, but not limited to, two parent company guarantees (the "Trafigura PCGs") granted in respect of the primary financial obligations of the Company's indirect subsidiary at that time, Nyrstar Sales & Marketing AG ("NSM"), to Trafigura, namely under the USD 650 million Trade Finance Framework Agreements ("TFFA") and the USD 250 million Bridge Finance Facility Agreement ("BFFA"). The Trafigura PCGs as well as all other security and / or guarantees provided to Trafigura by the Operating Group in respect of the TFFA and BFFA, were released in full on the Restructuring Effective Date.
In the interests of all stakeholders of the Group, including the Company's shareholders, the Board of Directors decided voluntarily to apply the Art. 524 Procedure to the TFFA in 2018 and to the BFFA in 2019.
2.3.The Company's Release from parent company guarantees in favour of third-parties and the Company's rights to indemnification by NN2 under the NNV-NN2 SPA
In addition to the release of the Trafigura PCGs, the Company benefits from contractual agreements with NN2 and Trafigura in respect of its release from, or indemnification for, liabilities for existing financial indebtedness and obligations owed to third parties in respect of financial, commercial or other obligations of the then current members of the Operating Group (the "PCGs"), such that those third parties should no longer have recourse to the Company. The release and / or indemnification obligations of NN2 from which the Company benefits can be summarised as follows.
"Release of PCGs and general indemnity: As part of the Intragroup Reorganisation, the NNV-NN2 SPA includes a commitment by NN2 to use reasonable endeavours to procure the release of obligations owed by the Company under Third-party PCGs. This procurement obligation is combined with an obligation on NN2 to indemnify the Company, to the extent such PCGs are not released, for any and all liabilities in relation to such PCGs in respect of the failure by the applicable member of the Operating Group to comply fully with its principal obligations.
"Indemnity for specified historic liabilities: Further, the NNV-NN2 SPA also contains an obligation on NN2 to indemnify the Company, to the extent not covered by the release and/or indemnification of PCGs mentioned above, in respect of certain specified liabilities, including certain liabilities arising in relation to certain historic disposals by the Nyrstar group and/or from certain historic mine closures, which are specified in a schedule to the NNV-NN2 SPA.
"Limitation on recourse to the Company of former subsidiaries: To limit and release further any financial obligations on the Company, the NNV-NN2 SPA obliges NN2 to procure that, and the NNV-Trafigura Deed obliges Trafigura to procure that no former subsidiaries of the Company will make any demands for payment from the Company except (i) under the Limited Recourse Loan Facility, (ii) as otherwise agreed following the completion of the Restructuring; or (iii) to the extent that the Company has sufficient funds available (excluding any dividends or sale proceeds in respect of the Company's direct 2% shareholding in NN2).
2.4.Financial transactions with Trafigura entities - the Limited Recourse Loan Facility
On the Restructuring Effective Date, the Company entered into a EUR 13.5 million committed, limited recourse, loan facility (the "Limited Recourse Loan Facility") provided to it by NN2 (as "Lender"). The key terms of the Limited Recourse Loan Facility are described below. The Limited Recourse Loan Facility is made available in two separate tranches: (i) up to EUR 8.5 million to be applied towards the Company's ongoing ordinary course operating activities ("Facility A"); and (ii) up to EUR 5 million intended for the payment of certain litigation defense costs ("Facility B"). No security, collateral or guarantees have been granted in respect of the Company's obligations under the Limited Recourse Loan Facility.
As at 31 December 2019, the Company owed EUR 3.0 million under Facility A. Facility A can be used by the Company, amongst other things, to cover reasonable director and employee costs, D&O insurance premium (to the extent not paid prior to the Restructuring Effective Date), audit fees, legal costs (except those relating to litigation or other actual or threatened proceedings against the Company, which should be funded from Facility B (defined below)), listing fees and investor relations costs. The funding under Facility A is provided to the Company based on the quarterly cash flow forecast prepared by the Company and provided to Trafigura as a condition of the funding. The total quantum of funds to be made available under Facility A was agreed based on the Company's forecast operating costs for a five year period following the completion of the Restructuring, taking into account the ongoing operational services provided to the Company by NN2, as agreed in the NNV-NN2 SPA, for a period of three years (subject to agreed early termination triggers) (the "Ongoing Services"). The Ongoing Services to be provided by NN2 to the Company include finance, tax, corporate counsel, IT and administration services. The provision of the Ongoing Services to the Company is intended to reduce the Company's operating costs in the period following the Restructuring Effective Date.
As at 31 December 2019, the Company had not drawn any amount under Facility B. Subject to the restrictions detailed below, Facility B can be applied by the Company towards payment or reimbursement of costs in respect of any litigation, proceeding, action or claims (including tax claims) made, asserted or threatened against the Company, NN1 Newco Limited ("NN1") or any of their current or former directors or officers (each being a "Claim").
Under Facility A, the Company can borrow up to EUR 3.7 million before 31 July 2020 and then up to a further EUR 1.2 million annually until 2024. Funding under Facility B can be drawn based on costs incurred in respect of any litigation, proceeding, action or claims (subject to the restrictions detailed below, and on the delivery of an invoice for such costs). Utilisation of each Facility is limited to a maximum of three drawings per financial quarter per Facility (excluding any PIK Loans (defined below)). As at the date of this report, the Company has drawn EUR 3.7 million under Facility A and nil under Facility B.
The rate of interest on amounts outstanding under the Limited Recourse Loan Facility is the aggregate of EURIBOR plus a margin of 0.5%. It shall be payable within 10 business days of the anniversary of the date on such amount was made available, provided that such interest will be capitalised if it has accrued for a period of one year or more and the Company has given a notice in the form prescribed by the Limited Recourse Loan Facility. Any interest which is capitalised shall be treated as a new loan (a "PIK Loan") under the relevant Facility. Any PIK Loan shall itself accrue interest, and that interest may also be capitalised.
The Company must not use any amount borrowed under either Facility A or Facility B for funding (directly or indirectly) any of the costs related to asserting or bringing or assisting in the pursuit of claims (including any counterclaim or defence) against Trafigura, other members of the Trafigura group, NN2 and / or any Replacement Holdco, and / or any other member of the Restructuring Operating Group), against any of such entities' current or former directors, officers, or advisers, against any creditor in respect of such entities (other than with the consent of NN2, such consent not to be unreasonably withheld or delayed) or in connection with any challenge to the Restructuring, including in relation to the TFFA and the BFFA or any other document contemplated by the Restructuring Implementation Deed.
If at any time after 31 July 2020, the amount of the available cash, after allowing for the minimum headroom amount of EUR 2 million in the first year and EUR 1 million in the second year, of the Company (less any amount of the proceeds of any Facility B intended to be applied towards costs incurred by the Company to which Facility B Loan relates, but not yet so applied) exceeds EUR 1.5 million, the Company has to apply, within five business days of the excess cash arising, the relevant excess cash to prepay any amounts outstanding under Facility B. If any excess cash remains after such repayment, the Company shall apply 50% of that remaining excess cash to repay the outstanding amount under Facility A, and shall (to the extent permitted under applicable law and regulation) apply the remaining 50% of that excess cash towards payment of dividends to the Company's shareholders. The above only applies until the later of (i) the date on which the Company ceases to own its 2% equity interest in the Restructured Operating Group (such equity interest being as a result either of a direct shareholding in NN2 or Replacement Holdco (as defined above) - the "Company Equity Interest", and such date being the "Company Exit Date") and (ii) the receipt of all proceeds (subject to any deductions permitted / required under the terms of the Limited Recourse Loan Facility) from any disposal(s) of the Company Equity Interest which result in the occurrence of the Company Exit Date (the "Disposal Proceeds").
Immediately upon receipt of any Disposal Proceeds, the Company shall procure that these shall be applied first to prepay any amount outstanding under Facility B, and secondly, if (i) any Disposal Proceeds remain after any required prepayment of Facility B, and (ii) the aggregate amount of all amounts outstanding under Facility A exceeds EUR 5 million, to prepay such Facility A amounts to or towards an aggregate amount of EUR 5 million.
The Company shall ensure that, if any distribution is paid to the Company's shareholders on or after the Company Exit Date, an amount equal to that distribution is applied to repay or prepay amount outstanding under Facility A before or simultaneously with such distribution.
The Company has agreed also that, if it receives any amounts from costs awards, damages awards and / or any other recovery from any counterparty to a Claim (as defined above) (such amounts constituting "Claims Proceeds"), then such Claims Proceeds must be used immediately to repay or prepay any amounts outstanding under Facility B.
Additionally, there are customary provisions that require mandatory prepayment of amounts outstanding under either or both Facility A and B in the case of an event of default followed by acceleration by the Lender.
2.4.5.Information, consultation and litigation strategy undertakings
If any Claim arises as a result of which the Company reasonably anticipates that it may make a utilisation under Facility B, the Company must:
subject to compliance with applicable law or confidentiality obligations to third parties, make available to NN2 and Trafigura all information in its possession and control as reasonably requested by NN2 or Trafigura in connection with assessing, contesting, disputing, defending, appealing or compromising the Claim, provided that NN2 and Trafigura shall maintain confidentiality and/or privilege with regard to such information;
keep NN2 and Trafigura informed of the progress / developments in respect of the Claim, and promptly provide any correspondence or other information received in connection with the Claim;
consult and take into account the views of NN2 and Trafigura as to the applicable legal advisors that will represent the Company, NN1, or the applicable directors or officers. NNV shall also procure that such legal advisors provide fee estimates as requested by NN2 or Trafigura;
consult with and take into account the views of NN2 and Trafigura in relation to the conduct of the defence / negotiations / settlements in respect of the Claim; and
whilst any amount is outstanding under Facility B in relation to a civil Claim, not make any admission of Liability, agreement, settlement or compromise in relation to that Claim without the prior written approval of Trafigura.
The Company must consult with Trafigura prior to taking any action relating to insolvency or bankruptcy proceedings, including under Book XX of the Belgian Code of Economic Law.
The Company is also obliged to provide NN2 with certain financial information, including quarterly cashflow forecasts (and any revisions thereto required under the terms of the Limited Recourse Loan Facility), half-yearly financial statements and audited annual financial statements, drawn up on a consolidated basis (to the extent the Company has subsidiaries) and in accordance with the accounting principles agreed under the terms of the Limited Recourse Loan Facility.
At the completion of the Restructuring at 31 July 2019, the "Relationship Agreement" between Trafigura Group Pte Ltd and the Company (dated 9 November 2015) was terminated. The Relationship Agreement governed the relationship between the Company (and the broader Nyrstar Group) and Trafigura Group Pte. Ltd. and its affiliated persons between its execution on 9 November 2015 and the completion of the Restructuring on 31 July 2019.
The Company has not entered into any commercial transactions with Trafigura.
At 7 January 2020 the Company announced that the President of the Commercial Court in Antwerp rendered a judgment in the summary proceedings initiated by a group of minority shareholders representing less than 3.5% of the Company's share capital (the "Minority Shareholders"). The Minority Shareholders had requested the court to suspend the resolutions of the general meeting of 5 November 2019, and subsequently also those of the extraordinary general meeting of 9 December 2019, as well as to appoint a provisional administrator to convene a new general meeting. The Minority Shareholders had also requested to impose certain measures on Nyrstar, including the prohibition to enter into certain loans. The President rejected all claims of the Minority Shareholders in a fully reasoned judgment. The President did not grant the claim of Nyrstar to order the Minority Shareholders to pay damages but did order them to pay the legal costs, including an indemnification for legal fees for Nyrstar. The Minority Shareholders did not appeal the judgement.
There have been various press reports in Q4 2019 and in January 2020 related to potential legal or regulatory actions by minority shareholders. The press reported in Q4 2019 that three criminal complaints have been lodged by three shareholders against unknown person and in January 2020 that the minority shareholders would shortly initiate the complaints on the merit related to the Company's Restructuring. There has not been any formal notification to the Company or any director, or detail provided in relation to these alleged criminal complaints or actions. Additionally, the Company is also aware of press coverage from Q4 2019 where it was stated by the Belgian securities regulator, the FSMA, that it was conducting a regulatory investigation into the Company. The Company has not been formally advised of this or any other regulatory investigation into the Company.
At 20 January 2020 the Company disclosed that RSQ Investors (division of Quanteus Group BV), Kris Vansanten BVBA, Kris Vansanten, E3V & Partners BV and an unnamed physical person hold 5.01% of the voting rights of Nyrstar.
Number of joint industrial committee:
| During the current period | Codes | Total | 1. Men | 2. Women |
|---|---|---|---|---|
| Average number of employees | ||||
| Full-time |
1001 | 9,0 | 5,0 | 4,0 |
| Part-time |
1002 | |||
| Total in full-time equivalents |
1003 | 9,0 | 5,0 | 4,0 |
| Number of hours actually worked | ||||
| Full-time |
1011 | 7.786 | 4.412 | 3.374 |
| Part-time |
1012 | |||
| Total |
1013 | 7.786 | 4.412 | 3.374 |
| Personnel costs | ||||
| Full-time |
1021 | 1.245.586,04 | 705.821,42 | 539.764,62 |
| Part-time |
1022 | |||
| Total | 1023 | 1.245.586,04 | 705.821,42 | 539.764,62 |
| Advantages in addition to wages |
1033 |
| During the preceding period | Codes | P. Total | 1P. Men | 2P. Women |
|---|---|---|---|---|
| Average number of employees in FTE Number of hours actually worked Personnel costs Advantages in addition to wages |
1003 1013 1023 1033 |
9,9 15.812 2.251.056,00 |
6,0 9.705 1.430.546,00 |
3,9 6.107 820.510,00 |
| Codes | 1. Full-time | 2. Part-time | 3. Total full-time equivalents |
|
|---|---|---|---|---|
| At the closing date of the period | ||||
| Number of employees |
105 | |||
By nature of the employment contract |
||||
| Contract for an indefinite period | 110 | |||
| Contract for a definite period | 111 | |||
| Contract for the execution of a specifically assigned work | 112 | |||
| Replacement contract | 113 | |||
| According to gender and study level | ||||
| Men | 120 | |||
| primary education | 1200 | |||
| secondary education | 1201 | |||
| higher non-university education | 1202 | |||
| university education | 1203 | |||
| Women | 121 | |||
| primary education | 1210 | |||
| secondary education | 1211 | |||
| higher non-university education | 1212 | |||
| university education | 1213 | |||
| By professional category | ||||
| Management staff | 130 | |||
| Employees | 134 | |||
| Workers | 132 | |||
| Others | 133 |
| During the period | Codes | 1. Hired temporary staff |
2. Persons placed at the enterprise's disposal |
|---|---|---|---|
| Average number of persons employed |
150 | 0,4 | |
Number of hours actually worked |
151 | 756 | |
Costs for the enterprise |
152 | 42.843,00 | |
| ENTRIES | Codes | 1. Full-time | 2. Part-time | 3. Total full-time equivalents |
|---|---|---|---|---|
| Number of employees for whom the entreprise submitted a DIMONA declaration or who have been recorded in the general personnel register during the financial year |
205 | |||
| By nature of employment contract | ||||
| Contract for an indefinite period | 210 | |||
| Contract for a definite period | 211 | |||
| Contract for the execution of a specifically assigned work | 212 | |||
| Replacement contract | 213 |
| DEPARTURES | Codes | 1. Full-time | 2. Part-time | 3. Total full-time equivalents |
|---|---|---|---|---|
| Number of employees whose contract-termination date has been entered in DIMONA declaration or in the general personnel register during the financial year |
305 | 9 | 9,0 | |
By nature of employment contract |
||||
| Contract for an indefinite period | 310 | 9 | 9,0 | |
| Contract for a definite period | 311 | |||
| Contract for the execution of a specifically assigned work | 312 | |||
| Replacement contract | 313 | |||
| By reason of termination of contract | ||||
| Retirement | 340 | |||
| Unemployment with extra allowance from enterprise | ||||
| Dismissal | ||||
| Other reason | 9 | 9,0 | ||
| Of which the number of persons who continue to render services to the enterprise at least half-time on a self-employed basis |
350 |
| Total of initiatives of formal professional training at the expense of the employer |
Codes | Men | Codes | Women |
|---|---|---|---|---|
| Number of employees involved | 5801 | 1 | 5811 | 1 |
| Number of actual training hours | 5802 | 33 | 5812 | 8 |
| Net costs for the enterprise | 5803 | 2.906,00 | 5813 | 1.055,00 |
| of which gross costs directly linked to training | 58031 | 2.906,00 | 58131 | 1.055,00 |
| of which fees paid and paiments to collective funds | 58032 | 58132 | ||
| of which grants and other financial advantages received (to deduct) | 58033 | 58133 | ||
| Total of initiatives of less formal or informal professional training at the expense of the employer Number of employees involved Number of actual training hours Net costs for the enterprise |
5821 5822 5823 |
5831 5832 5833 |
||
| Total of initiatives of initial professional training at the expense of the employer |
||||
| Number of employees involved | 5841 | 5851 | ||
| Number of actual training hours Net costs for the enterprise |
5842 5843 |
5852 5853 |


Nyrstar NV (the 'Company') has prepared this Corporate Governance Statement in accordance with the Belgian Code on Corporate Governance of 12 March 2009 (the "Belgian Code on Corporate Governance") for this reporting year, ending on 31 December 2019.
The Company is currently reviewing its governance structure to comply with the Belgian Code on Corporate Governance of 9 May 2019 (the '2020 Belgian Code on Corporate Governance'), which applies compulsorily to reporting years beginning on or after 1 January 2020. This review will be conducted duly considering all circumstances, including the current operations of the Company, the Company's holding company status and the fact that the shareholders meeting of the Company, on 9 December 2019, resolved on the discontinuation of the activities of the Company (the "9 December Resolution") such that the Company is now preparing to convene the extraordinary shareholders' meeting to deliberate upon the dissolution of the Company.
This Corporate Governance Statement is included in the Company's report of Board of Directors on the statutory accounts for the financial year ended on 31 December 2019 in accordance with article 96 of the Belgian Companies Code (article 3:6§2 of the Belgian Code of Companies and Association).
The Company adopted a Corporate Governance Charter in accordance with the Belgian Code on Corporate Governance. The Company applies the nine corporate governance principles contained in the Belgian Code on Corporate Governance. The Company also complies with the corporate governance provisions set forth in the Belgian Code on Corporate Governance, except as provided and explained below.
As an exception to the foregoing, the general shareholders' meeting held on 19 April 2018 approved that certain non-executive directors would be remunerated fully or partly in deferred shares units, and not in cash (see further in the Remuneration Report). This is a deviation from the provisions of section 7.7 of the Belgian Code on Corporate Governance, which provides that non-executive board members should not be entitled to performance-related remuneration such as bonuses, stock related long-term incentive schemes, fringe benefits or pension benefits. The Board of Directors sought the approval from the general shareholders' meeting for such remuneration in deferred shares, as it believed that granting non-executive directors the opportunity to be remunerated in whole or in part in deferred Shares of the Company rather than in cash enables the non-executive directors to link their effective remuneration to the future performance of Nyrstar and to strengthen the alignment of their interest with the interest of the Company's shareholders. Given the completion of the Restructuring on 31 July 2019, the Board of Directors did not seek a similar resolution by the general shareholders' meeting held on 5 November 2019.
As announced on 18 January 2019, Mr Konig assumed the role of Executive Chairman. The role of Mr Konig as Chairman of the Board of Directors remained the same. Mr Konig remained responsible for the leadership and the proper and efficient functioning of the Board as per section 1.9 of the Corporate Governance Charter. As an additional responsibility, Mr Konig was, in his capacity of Executive Chairman, more closely involved in the Restructuring. As a consequence, until the completion of the Restructuring on 31 July 2019, the Company's executive management was composed of the Executive Chairman (from 18 January 2019 until completion of the Restructuring), Chief Executive Officer and the other members of the Management Committee (as detailed below in "—Management Committee"). In deviation from section 1.5 of the Belgian Code on Corporate Governance, the Chairman of the Board of Directors partially performed tasks that a CEO could have theoretically performed. It was however practically impossible for Mr. Rode to combine the CEO function of Nyrstar with the Restructuring. The Board therefore resolved and agreed on a clear division of responsibilities between Mr. Rode (operational CEO-ship) and Mr. Konig (capital review process), as required by section 1.5 of the Belgian Code on Corporate Governance.
Following the completion of the Restructuring, Mr. Konig again became a Non-Executive Director, in light of the more limited operations of the Company and its sole functioning as a holding company.. Following the changed circumstances in which the Company operates after the Restructuring, i.e. the current operations of the Company, the Company's holding company status and, later, the 9 December Resolution, the Board of Directors deemed it in the Company's best interest to continue operations and not to search and add for the time being a new CEO since Mr. Rode's departure on 30 September 2019.Our view is that, given Mr. Konig's focus on the Restructuring (and not day-to-day operational matters) until the Restructuring and considering the current activities of the Company since the Restructuring, Mr Konig's role as Executive Chairman as from 18 January 2019 until 31 July 2019, does not conflict with the Belgian Code on Corporate Governance.
Further, as a result of this additional role, Mr Konig no longer qualified as an independent director, as a consequence of which Ms Jane Moriarty was appointed as an additional independent director on 14 March 2019. Mr. Konig was the chairman of the Nomination and Remuneration committee until his appointment as Executive Chairman on 18 January 2019 where he was replaced as Chairman by Ms Moriarty on her appointment to the board of directors. Following the completion of the Restructuring, Mr. Konig again became the chairman of the Nomination and Remuneration committee and Ms. Moriarty also remained a member of the committee. During 2019, Mr Konig remained a member of the Special Committee and the Health, Safety, Environment and Community Committee.
The Corporate Governance Charter describes the main aspects of the corporate governance of the Company including its governance structure, the terms of reference of the Board of Directors and its Committees and other important topics.
What constitutes good corporate governance will evolve with the changing circumstances of a company and with the standards of corporate governance globally and must be tailored to meet those changing circumstances. The Board of Directors intends to update the Corporate Governance Charter as often as required to reflect changes to the Company's corporate governance. In light of the applicability of the 2020 Belgian Code of Corporate as of 1 January 2020, the current operations of the Company, the Company's holding company status and the 9 December Resolution, the Company is also reviewing its Corporate Governance Charter. The Corporate Governance Charter is available on the Company's website at www.nyrstar.be. The Board of Directors approved the initial charter on 5 October 2007. There were updated versions approved on several occasions. The current version was approved by the Board of Directors on 13 December 2016. A copy of the Belgian Code on Corporate Governance and of the 2020 Belgian Code on Corporate Governance can be found on www.corporategovernancecommittee.be.
Nyrstar adopted a code of business conduct for all of Nyrstar's personnel and sites which was applied until the completion of the Restructuring. Post completion of the Restructuring, the Company has no such work force and only has a 2% shareholding in the operating group of companies. As such, as at the date of this Corporate Governance Statement, the code of business conduct is no longer applied by the Company in this respect.
The code of business conduct is based on the Nyrstar Values, providing a frame of reference for Nyrstar sites to establish more specific guidelines to address local and territorial issues. Up until the completion of the Restructuring, Nyrstar also employed a code of business conduct development program which supported the code of business conduct and aimed to increase awareness in relation to some key risks to Nyrstar's business. The development program includes specially designed training modules for Nyrstar employees. The training modules were conducted by Nyrstar's Compliance Officer with the assistance of local expertise (where required). If employees had issues or concerns (for example, they were concerned that others were not complying with the letter and the spirit of the code of business conduct), they could raise the issue or concern with their supervisor or manager or Nyrstar's Compliance Officer. The code of business conduct remains available on Nyrstar's website (www.nyrstar.be) and, following the completion of the Restructuring on 31 July 2019, is also available on the website of the Nyrstar operating group at www.nyrstar.com.
The table below gives an overview of the current members of the Company's Board of Directors and their terms of office:
| Name | Principal Function within the Company |
Nature of Directorship | Start of Term | End of Term |
|---|---|---|---|---|
| Martyn Konig(1) | Chairman | Non-Executive(1) | 2015 | 2023 |
| Hilmar Rode (2) | Chief Executive Officer, Director |
Executive | 2017 | Resigned effective 30 |
BRU12274377/7 167729-0002 2
| September 2019 | ||||
|---|---|---|---|---|
| Carole Cable | Director | Non-Executive, Independent |
2017 | 2021 |
| Christopher Cox(2) | Director | Non-Executive | 2015 | 2019 (5 November 2019) |
| Anne Fahy | Director | Non-Executive, Independent |
2016 | 2020 |
| Jesús Fernandez (2) | Director | Non-Executive | 2016 | Resigned 24 February 2019 |
| Jane Moriarty | Director | Non-Executive, Independent |
2019 | 2023 |
(1) Martyn Konig was non-executive and independent director until 18 January 2019 when he took on the additional role of Executive Chairman in the content of the Restructuring. Following completion of the Restructuring, Martyn Konig again became a Non-Executive Director and the general shareholders' meeting of 5 November 2019 resolved to reappoint Martyn Konig.
(2) Hilmar Rode, Chief Executive Officer and Executive Director, resigned from the Board effective 30 September 2019. Christopher Cox, Non-Executive Director, concluded his mandate upon the conclusion of the general shareholders' meeting on 5 November 2019. Jesus Fernandez, Non-Executive Director, tendered his resignation on 24 February 2019, effective immediately.
Martyn Konig, Non-Executive Chairman, was appointed chairman in April 2016. Between 18 January 2019 and 31 July 2019, Mr Konig did not qualify as independent director pursuant to article 526ter of the Belgian Companies Code because of his executive role within the Company. He is also non-executive director of Euromax Resources Ltd (since May 2012) and non-executive chair of Stemcor Group (since 2018). Mr Konig is a consultant advisor to T Wealth Management SA, which has been separate from Galena Asset Management (a Trafigura affiliate) since June 2015.Previously, from 2008, he was Executive Chairman and President of European Goldfields until its friendly takeover by Eldorado Gold Corp for US\$ 2.5 billion in 2012. He has also been a main board director of NM Rothschild and Sons Ltd. for 15 years and held senior positions at Goldman Sachs and UBS. He was a member of the Special Committee. Mr. Konig is a barrister and also a Fellow of the Chartered Institute of Bankers.
Carole Cable, Non-Executive Director, is currently a Partner of the Brunswick Group, an international communications firm, where she is the Joint Head of the energy and resources practice specialising in the metals and mining sector. Prior to her current position, she worked at Credit Suisse and JPMorgan where she was a Mining Analyst and then moved into institutional equity sales covering the global mining sector as well as Asia ex Japan. Before that, she worked for an Australian listed mining company. She is a Member of the Audit Committee, Nomination and Remuneration Committee, the Health, Safety, Environment and Community Committee and the Special Committee. Ms. Cable holds a Bachelor of Science degree from the University of New South Wales, Australia and is currently on the Board of Women in Mining UK and CQS Natural Resources Growth and Income plc.
Anne Fahy, Non-Executive Director, currently sits on the board of SThree Plc and chairs its Audit Committee. Furthermore she sits on the Board, the Audit and Risk Committee, and the Nomination Committee of Coats Group Plc (effective 1 March 2018). She is also a Trustee of Save the Children. Previously, she was chief financial officer of BP's Aviation Fuels business, having worked in a variety of finance and finance-related roles in her 27 years at BP. She is the Chair of the Audit Committee, and Member of the Nomination and Remuneration Committee, the Health, Safety, Environment and Community Committee and the Special Committee. She is a Fellow of the Institute of Chartered Accountants in Ireland and worked at KPMG in Ireland and Australia prior to joining BP in 1988. She holds a Bachelor of Commerce from the University College Galway, Ireland.
Jane Moriarty, Non-Executive Director, currently sits on the Boards of The Quarto Group Inc, where she is the Senior Independent Director and Audit Chair; NG Bailey Group Limited where she is Audit and Risk Chair and the Martin's Property Group where she is Deputy Chairman, Audit and Risk Chair and Remuneration Chair. She was previously a senior Restructuring partner with KPMG LLP in the UK where she worked for 29 years. She is a Member of the Audit Committee, Chair of the Nomination and Member of the Special Committee. She is a Fellow of the Institute of Chartered Accountants in Ireland and holds a Bachelor of Business Studies from Trinity College Dublin.
The business address of each of the Directors is for the purpose of their directors' mandate, Zinkstraat 1, 2490 Balen, Belgium.
Virginie Lietaer was appointed Company Secretary to the Company effective 10 March 2008 until 5 November 2019.
Anthony Simms, Head of External Affairs for the Company, was appointed interim Company Secretary to the Company effective 6 November 2019. These services are provided by Mr. Simms as ongoing services in accordance with the deed for the sale and purchase of shares and assets held by the Company dated 19 June 2019.
The role of the Company Secretary includes supporting the Board and its committees on all governance matters, ensuring, under the direction of the Chairman, good information flow within the Board and its committees, as well as facilitating induction and assisting with professional development as required. The Company Secretary regularly reports to the Board, under the direction of the Chairman, on how Board procedures, rules and regulations are being followed and complied with.
The Board is responsible for appointing and dismissing the Company Secretary. It oversees that the person appointed as the Company Secretary has the necessary skills and knowledge of corporate governance matters.
Until 31 July 2019, which was the completion of the Restructuring, the Company's Management Committee consisted of five members (including the Chief Executive Officer), as further set forth hereinafter:
| Title |
|---|
| Chief Executive Officer |
| Interim Chief Financial Officer |
| Chief Technical Officer |
| Chief Commercial Officer |
| Chief HR Officer |
(1) Hilmar Rode, Chief Executive Officer and Executive Director, resigned from the Board effective 30 September 2019.
(2) Roman Matej, Interim Chief Financial Officer, was appointed in January 2019, following the resignation of Michel Abaza. Mr. Roman Matej is an experienced senior finance executive who has been with Nyrstar for approximately 8 years. Mr. Matej's previous role at Nyrstar was as Group Controller, prior to which he worked at Ernst & Young in Switzerland, Australia and the Czech Republic.
Following the completion of the Restructuring on 31 July 2019, all members of the Management Committee transferred to the operating group of companies and ceased to be employees of the Company or of subsidiaries of the Company. As to date, the Company no longer has a Management Committee. Until the completion of the Restructuring on 31 July 2019, the Company's executive management was composed of the Executive Chairman (from 18 January 2019), Chief Executive Officer and the other members of the Management Committee, as detailed above. During H2 2019, the Company retained the services of Mr. Roman Matej as Chief Financial Officer and Mr. Anthony Simms as Head of External Affairs under a secondment agreement from Nyrstar Sales & Marketing AG. The executive services which are provided by these two secondees are beyond the scope of executive services provided under the terms of the deed for the sale and purchase of shares and assets held by the Company dated 19 June 2019 (the "Sale Deed") and, as such, the costs of these seconded services are borne by the Company.
No Director or member of the Management Committee has:
BRU12274377/7 167729-0002 4 (a) any convictions in relation to fraudulent offences or any offences involving dishonesty;
The Company can only provide such statement as until the date Directors or members of the Management Committee resigned or ceased to act for the Company or its subsidiaries.
Other than set out in the table below, no Director or member of the Management Committee has, at any time in the previous five years been a member of the administrative, management or supervisory body or partner of any companies or partnerships. Over the five years preceding the date of this report the Directors and members of the Management Committee hold or have held in addition to their function within Nyrstar, the following main directorships or memberships of administrative, management or supervisory bodies and/or partnerships:
| Name | Current | Past |
|---|---|---|
| Martyn Konig | Euromax Resources Stemcor Group NN1 Newco Limited |
Newgold NN2 Newco Limited |
| Carole Cable | Brunswick Group Women in Mining UK CQS Natural Resources Growth and Income plc |
|
| Christopher Cox | N/A | Trafigura Beheer B.V. |
| Anne Fahy | SThree Plc Save The Children Coats Group Plc |
Interserve Plc(1) |
| Jane Moriarty | NG Bailey Group Limited Martin's Investments Limited Martin's DevCo Limited Martin's Financial Holdings Limited ( in the process of being appointed) The Quarto Group Inc (listed on LSE) Mitchells & Butlers plc (listed on LSE) NN1 Newco Limited |
Martin's Financial No 1 Ltd Martin's Financial No 2 Ltd Martin's Properties Holdings Ltd Martin's Properties (Chelsea) Limited NN2 Newco Limited Ince & Co ( members of the supervisory board) KPMG LLP |
| Name | Current | Past |
|---|---|---|
| Hilmar Rode | N/A Consejo Minero de Chile AG Minera Escondida Ltda. Fundación Minera Escondida Centro de Entrenamiento Industrial y Minero – CEIM |
|
| Roman Matej | N/A | N/A |
| Frank Rittner | N/A | N/A |
| Cristiano Melcher | N/A | N/A |
| Willie Smit | Tenon Engineering | Subsidiaries of ArcelorMittal |
(1) Interserve Plc was placed into administration in March 2019 whereby its business and assets (i.e. the entire group) were sold to a newly-incorporated company, to be owned by the then existing lenders to the group.
The Company can only provide such statement as until the date Directors or members of the Management Committee resigned or ceased to act for the Company or its subsidiaries.
The Company has opted for a "one-tier" governance structure whereby the Board of Directors is the ultimate decision-making body, with the overall responsibility for the management and control of the Company, and is authorised to carry out all actions that are considered necessary or useful to achieve the Company's purpose. The Board of Directors has all powers except for those reserved to the shareholders' meeting by law or the Company's articles of association. At least once every five years, the Board of Directors reviews whether the chosen governance structure is still appropriate, and if not, it should propose a new governance structure to the general shareholders' meeting. The Company is also currently reviewing its governance structure to comply with the 2020 Belgian Code on Corporate Governance, which applies compulsorily to reporting years beginning on or after 1 January 2020. Such will be reviewed in light of the limited operations of the Company, its functioning as a holding company and the 9 December Resolution.
Pursuant to Section 1.1 of the Company's Corporate Governance Charter, the role of the Board of Directors is to pursue the long-term success of the Company by providing entrepreneurial leadership and enabling risks to be assessed and managed. The Board of Directors decides on the Company's values and strategy, its risk appetite and key policies.
The Board of Directors is assisted by a number of committees to analyse specific issues. The committees advise the Board of Directors on these issues, but the decision-making remains with the Board of Directors as a whole (see also "—Committees of the Board of Directors" below).
The Board of Directors appoints and removes the Chief Executive Officer. Following 30 September 2019, the Company no longer employed a Chief Executive Officer. The role of the Chief Executive Officer was to implement the mission, strategy and targets set by the Board of Directors and to assume responsibility for the day-to-day management of the Company. The Chief Executive Officer reports directly to the Board of Directors. On 18 January 2019, Mr Martyn Konig was appointed Executive Chairman to take greater responsibility in representing the Company during negotiations between stakeholders in the Restructuring while Mr. Hilmar Rode continued to supervise the day-to-day operations of the Company.
Prior to the completion of the Restructuring, in order to provide a group-wide support structure, the Company had corporate offices in Balen, Belgium and Zurich, Switzerland. These offices provided a number of corporate and support functions including finance, treasury, human resources, safety and environment, legal, tax, information technology, corporate development, investor relations and communications. Following the completion of the Restructuring on 31 July 2019, the Company has a 2% shareholding in the Nyrstar operating group. As such, the Company has a passive investment in the Nyrstar operating group and is no longer required to provide group-wide support. As at 31 December 2019, the Company no longer has a Management Committee and the corporate office in Zurich, Switzerland was in the process of being closed.
Pursuant to the Company's articles of association and the Belgian Code of Companies and Associations, the Board of Directors must consist of at least three directors. The Company's Corporate Governance Charter provides that the composition of the Board of Directors should ensure that decisions are made in the corporate interest. It should be determined on the basis of diversity, as well as complementary skills, experience and knowledge. Pursuant to the Belgian Code on Corporate Governance, at least half of the directors must be non-executive and at least three directors must be independent in accordance with the criteria set out in the Belgian Code of Companies and Associations and in the Belgian Code on Corporate Governance. Pursuant to the Belgian Code of Companies and Associations, at least one third of the members of the Board of Directors must be of the opposite gender, where the minimum number required is rounded to the nearest whole number. Such provisions are complied with.
The directors are appointed for a term of no more than four years by the general shareholders' meeting. They may be re-elected for a new term. Proposals by the Board of Directors for the appointment or re-election of any director must be based on a recommendation by the Nomination and Remuneration Committee. In the event the office of a director becomes vacant, the remaining directors can appoint a successor temporarily filling the vacancy until the next general shareholders' meeting. The shareholders' meeting can dismiss the directors at any time.
BRU12274377/7 167729-0002 7 On 9 November 2015, the Company entered into an Agreement with Trafigura Group Pte. Ltd., Urion Holding (Maltas) Ltd's 100% parent company, to govern Nyrstar's relationship with Trafigura. This Relationship Agreement was terminated as of 31 July 2019 as part of the Restructuring. The Relationship Agreement provided amongst other things that Trafigura would be able to nominate or propose the nomination of such number of directors to the Board of Directors as it determines, but limited to a number that does not constitute a majority of the Board of Directors (such directors being "Trafigura Directors"). No independent director would be nominated or proposed for nomination unless with the approval of a majority of the directors other than the Trafigura Directors. On the date of this report, the Company does not have any Trafigura Directors. Furthermore, the Relationship Agreement provided that the attendance quorum for a board meeting includes at least one independent director and one Trafigura Director, but if this attendance quorum is not met, a subsequent meeting can be held with the same agenda if at least any two directors are present. The Relationship Agreement was to have effect for as long as Trafigura held at least 20% or more but less than 50% of the shares in the Company. As mentioned above, as part of the implementation of the Restructuring, the Relationship Agreement was terminated.
The Board of Directors elects a chairman from among its non-executive members on the basis of his knowledge, skills, experience and mediation strength. If the Board of Directors envisages appointing a former Chief Executive Officer as chairman, it should carefully consider the positive and negative aspects in favour of such a decision and disclose why such appointment is in the best interest of the Company. The chairman is responsible for the leadership and the proper and efficient functioning of the Board of Directors.
The Board of Directors meets whenever the interests of the Company so require or at the request of one or more directors. In principle, the Board of Directors will meet sufficiently regularly and at least six times per year. The decisions of the Board of Directors are made by a simple majority of the votes cast. The chairman of the Board of Directors has a casting vote. In 2019, the Chairman at no time used his casting vote and all decisions of the Board were taken unanimously.
During 2019, 60 formal meetings of the Board of Directors were held. Before such meetings, the Chairman of the Board, assisted by the Company Secretary, ensures that Board members are provided with accurate, concise, timely and clear information before the meetings and, where necessary, between meetings so that they can make a knowledgeable and informed contribution to Board discussions.
The Board of Directors has set up an Audit Committee, a Nomination and Remuneration Committee, a Health, Safety, Environment and Community Committee and a Special Committee. Following the completion of the Restructuring, the Board of Directors only has an Audit Committee and a Nomination and Remuneration Committee, which is compliant with the Belgian Code on Corporate Governance.
The Audit Committee consists of at least three directors. All members of the Audit Committee are non-executive directors. According to the Belgian Code of Companies and Associations, all members of the Audit Committee must be non-executive directors, and at least one member must be independent within the meaning of the 2020 Code for Corporate Governance. The current members of the Audit Committee are Anne Fahy (Chairman), Jane Moriarty and Carole Cable. The current composition of the Audit Committee complies with the Belgian Code of Companies and Associations. Ms. Jane Moriarty became a member of the Audit Committee on her appointment as a director of the Company on 14 March 2019 and Mr. Christopher Cox ceased to be a member of the Audit Committee at the end of his term as a director of the Company on 5 November 2019.
The members of the Audit Committee have a collective competence in the business activities of the Company as well as accounting, auditing and finance. The current Chairman of the Audit Committee is competent in accounting and auditing as evidenced by her previous role as Chief Financial Officer of BP's Aviation Fuels business. According to the Board of Directors, the other members of the Audit Committee also satisfy this requirement, as evidenced by the different senior management and director mandates that they have held in the past and currently hold (see also "—Other mandates").
The role of the Audit Committee is to:
BRU12274377/7 167729-0002 8 • inform the Board of Directors of the result of the audit of the financial statements and the manner in which the audit has contributed to the integrity of the financial reporting and the role that the Audit Committee has played in that process;
The Audit Committee regularly reports to the Board of Directors on the exercise of its missions, including when preparing the financial statements.
In principle, the Audit Committee meets as frequently as necessary for the efficiency of the operation of the Audit Committee, but at least four times a year. At least twice a year, the Audit Committee should meet the external and internal auditors to discuss matters relating to its terms of reference and any issues arising from the audit process, and in particular any material weaknesses in the internal control. As set out below, the Audit Committee has met the external and internal auditors at least twice in 2019. The members of the Audit Committee must have full access to the Interim Chief Financial Officer and to any other employee to whom they may require access in order to carry out their responsibilities. Following the completion of the Restructuring on 31 July 2019, the Company ceased to have an internal audit function.
During 2019, ten Audit Committee meetings were held.
The Nomination and Remuneration Committee consists of at least three directors. All members of the Nomination and Remuneration Committee are non-executive directors. In line with the Belgian Code of Companies and Associations, the Nomination and Remuneration Committee consists of a majority of independent, non-executive directors. The Nomination and Remuneration Committee is chaired by the Chairman of the Board of Directors or another non-executive director appointed by the committee. The following directors are currently members of the Nomination and Remuneration Committee: Jane Moriarty (Chairman, from March 2019 whilst Martyn Konig had an executive role within Nyrstar as described above), Carole Cable and Anne Fahy. Following the completion of the Restructuring, Martyn Konig has again become a member and Chairman of the Nomination and Remuneration Committee. Pursuant to the Code of Companies and Associations, the Nomination and Remuneration Committee must have the necessary expertise on remuneration policy, which is evidenced by the experience and previous roles of its current members.
The role of the Nomination and Remuneration Committee is to make recommendations to the Board of Directors with regard to the appointment of directors, make proposals to the Board of Directors on the remuneration policy and individual remuneration for directors and members of the management committee and to submit a remuneration report to the Board of Directors. In addition, the Nomination and Remuneration Committee each year submits the remuneration report to the Board of Directors for submission to the annual general shareholders' meeting.
In principle, the Nomination and Remuneration Committee meets as frequently as necessary for the efficiency of the operation of the committee, but at least twice a year.
During 2019, four Nomination and Remuneration Committee meetings were held.
BRU12274377/7 167729-0002 9 Until the completion of the Restructuring, the Health, Safety, Environment and Community Committee consisted of at least three directors. All members of the Health, Safety, Environment and Community Committee were non-executive directors, with at least one independent director. The Health, Safety, Environment and Community Committee was chaired by the Chairman of the Board of Directors or another non-executive director appointed by the committee. Up until the completion of the Restructuring, the current members of the Health, Safety, Environment and Community Committee are Christopher Cox (Chairman), Carole Cable and Anne Fahy. The only meeting of the Health, Safety, Environment and Community Committee in 2019 occurred on 19 February 2019 and at this time it was chaired by Mr. Christopher Cox and was attended by Mr. Konig, Ms. Cable and Ms. Fahy.
The role of the Health, Safety, Environment and Community Committee was to assist the Board of Directors in respect of health, safety, environment and community matters. In particular, its role was to ensure that the Company adopts and maintains appropriate health, safety, environment and community policies and procedures, as well as effective health, safety, environment and community internal control and risk management systems, and to make appropriate recommendations to the Board of Directors. Given that following completion of the Restructuring, the Company no longer actively manages any employees or operations, the activities of the Health, Safety, Environment and Community Committee are no longer required. Therefore, the Committee was dissolved.
In principle, the Health, Safety, Environment and Community Committee met as frequently as was necessary for the efficiency of the operation of the committee, but at least twice a year.
During 2019, one Health, Safety, Environment and Community Committee meetings was held. The Health, Safety, Environment and Community Committee was dissolved immediately following the completion of the Restructuring on 31 July 2019. The one meeting conducted in 2019 is below the minimum requirement of two meetings per year due to the H1 2019 results only becoming available following completion of the Restructuring when the committee had already been dissolved.
In October 2018, the Board installed a Special Committee to assist the Board in the day-to-day supervising and reviewing of strategic financing matters and any capital structure review or matter relating to the Restructuring. The members were Mike Corner-Jones (Chair), the former Chief Restructuring Officer of the Company, Martyn Konig, Carole Cable, Anne Fahy and Jane Moriarty. The Special Committee was responsible for supervising (i) the business plan, situation assessment and liquidity review, (ii) the recapitalisation proposal; (iii) the communication obligations and strategy; (iv) negotiations with and between the various creditors and their advisers; and (v) overall execution efforts between the Board, management, advisers and other parties. The Special Committee met frequently in Q4 2018 and H1 2019 for the efficient operation of the Special Committee and the Board. After the completion of the Restructuring, the Special Committee no longer had a purpose within the Company and was dissolved effective 31 July 2019.
The members of the Special Committee had full access to the Company's external advisers, to the Company's (interim) Chief Financial Officer, to the Company's General Counsel, to the Company's Head of Investor Relations and to any other employee to whom they may require access in order to carry out their responsibilities.
After meetings of the Special Committee, the Chair of the Special Committee presented (as appropriate) its findings and recommendations of the meeting to all members of the Board at its next Board meeting, thereby keeping the Board properly informed of the Restructuring process.
With exception to the Special Committee meetings, minutes were drafted of each meeting reflecting the issues which were discussed and, if applicable, the decisions which were taken. The Company is of the view that there is complete and accurate recordkeeping of the meetings of the Board of directors and Committees. It is noted that from 2018 until the completion of the Restructuring on 31 July 2019 a total of approximately seventy (70) formal meetings of the Board of Directors took place. All such minutes are kept at the registered office.
The table summarises the attendance of meetings of the Board of Directors and the respective committees of the Board of Directors by their members in person or by conference call during 2019. It does not take into account attendance via representation by proxy. It does not reflect the meetings of the Special Committee, as these have been conducted on a more informal basis.
| Name | Board Meeting Attended |
Audit | Nomination and remuneration |
Health, Safety, Environment and Community |
|---|---|---|---|---|
| Carole Cable(1) | 58 of 60 | 10 of 10 | 4 of 4 | 1 of 1 |
| Christopher Cox(1)(6) | 35 of 56 | 8 of 9 | N/A | 1 0f 1 |
| Martyn Konig(2) | 54 of 60 | N/A | 4 of 4 | N/A |
| Anne Fahy(3) | 59 of 60 | 10 of 10 | 4 of 4 | N/A |
| Jesús Fernandez(4) | 6 of 6 | N/A | N/A | 1 of 1 |
| Hilmar Rode (5) | 51 of 51 | N/A | N/A | N/A |
| Jane Moriarty(7) | 50 of 52 | 9 of 9 | 3 of 3 | N/A |
(1) During 2019, Ms Carole Cable and Mr Christopher Cox became members of the Audit Committee. Mr Cox's mandate as a director concluded on 5 November 2019.
(2) During 2019, Mr Martyn Konig temporarily stepped down as a member of the Audit Committee and Nomination and Remuneration Committee due to his executive role as described above.
(3) During 2019, Ms Anne Fahy became a member of the Health, Safety, Environment and Community Committee.
(4) Mr Jesús Fernandez resigned from the Board effective 25 February 2019 and is no longer a member of any of the Committees.
(5) Mr Rode resigned from the Board effective 30 September 2019 and is no longer a member of any of the Committees.
(6) Following discussions between the Company's Board of Directors and Christopher Cox, his reappointment was not proposed to the general
shareholders' meeting on 5 November 2019 resolving upon the annual accounts for the financial year ending 31 December 2018.
(7) Ms Jane Moriarty was only appointed as a director on 14 March 2019, which explains her lesser attendance at the Board meetings.
The topics discussed at the Board and Committee Meetings are in line with the role and responsibilities of the Board and its Committees as set out in the Corporate Governance Charter, such as for example, the determination of the Company's principal objectives and strategy and the approval of all major investments, divestments, business plans and annual budgets, and since October 2018, the recapitalisation and restructuring of the Group.
A director will only qualify as an independent director if he or she meets at least the criteria set out in the 2020 Code on Corporate Governance according to which an independent director must fulfil the following conditions:
The resolution appointing the director mentions the reasons on the basis of which the capacity of independent director is granted.
The Company discloses in its annual report which directors are independent directors. An independent director who ceases to satisfy the requirements of independence must immediately inform the Board of Directors.
The general shareholders meeting of the Company has now appointed Jane Moriarty, Carole Cable and Anne Fahy as independent directors.
Mr Konig's appointment in 2015 was upon the proposal of Trafigura, and he was, in accordance with Belgian law, appointed as independent director by the general shareholders' meeting. At the time of that general shareholders' meeting, Trafigura held 15.3% of the Company's share capital and did not have sufficient shares to constitute the majority of the shares present or represented. As disclosed on Nyrstar's website, he is currently, and since and indeed before his appointment with Nyrstar in 2015 has been, a consultant advisor to T Wealth Management SA, which has been separate from Galena Asset Management (a Trafigura affiliate) since June 2015. Mr Konig has not received any remuneration from Trafigura or its affiliates in respect of T Wealth Management SA, other than the limited remuneration he received from T Wealth Management SA between his appointment to Nyrstar at the end of April 2015 and the separation of T Wealth Management SA from Galena in June 2015. Separately, as also disclosed on Nyrstar's website, since May 2012 Mr Konig has been a director of Euromax Resources Ltd, a publicly listed Canadian company. Six years later, in April 2018, Galena became a shareholder and in March 2019 increased its holding to 53.1% (fully diluted 49.5%). Euromax's other shareholders include the European Bank of Reconstruction and Development, investment funds and management. Mr Konig does not receive any payment from Galena (or Trafigura) and his Euromax compensation is paid in deferred Euromax equity. This information is publicly disclosed, including on the Euromax website. For the avoidance of doubt, Mr Konig has not received any remuneration from Trafigura or its affiliates (including Galena), other than as referenced above. Prior to his appointment to Nyrstar, Mr Konig has had more than 35 years of commodity markets and banking experience including as President of European Goldfields until its sale to Eldorado Gold Corp, 15 years at the investment bank NM Rothschild and Sons Ltd. (9 years as a main board director), and senior positions in UBS and Goldman Sachs. Mr Konig is also the non-executive chairman of Stemcor Global Holdings Ltd, a leading independent service provider for the steel industry. All decisions of the Board, at least since Mr Konig became chairman, have been unanimous, taking into account the requirements of Belgian Company law and the Company's corporate governance charter, so he has never used or had cause to use the chairman's casting vote.
Martyn Konig was non-executive and independent director until 18 January 2019 when he took on the additional role of Executive Chairman in the context of the Restructuring. At the completion of the Restructuring on 31 July 2019, Mr. Konig again became a nonexecutive director. As described above, on 14 March 2019, Ms Jane Moriarty was appointed as additional independent director.
The Relationship Agreement between the Company and Trafigura provided that the proposal for appointment of any new independent director required the approval of a majority of the directors other than the Trafigura Directors, it being understood however, that the Relationship Agreement did not restrict the Trafigura group as shareholder to vote in favour of or against any proposed independent directors. See also "—Board of Directors". As mentioned above, the Relationship Agreement has been terminated upon completion of the Restructuring on 31 July 2019.
The Board of Directors evaluates its own size, composition, performance and interaction with executive management and that of its committees on a continuous basis.
The evaluation assesses how the Board of Directors and its committees operate, checks that important issues are effectively prepared and discussed, evaluate each director's contribution and constructive involvement, and assesses the present composition of the Board of Directors and its committees against the desired composition. This evaluation takes into account the members' general role as director, and specific roles as chairman, chairman or member of a board committee, as well as their relevant responsibilities and time commitment.
The evaluation exercise is usually performed by means of individual discussions between the Board members and the Company Secretary. Appropriate action is taken on those items that require improvement.
The Remuneration Committee further regularly reviews the composition, the size and the functioning of the Board of Directors and the different committees within the Board of Directors. The latest assessment took into account different elements, among others the composition and functioning of the Board of Directors and Committees, the thoroughness with which material subjects and decisions are prepared and discussed, the actual contribution of each director in terms of presence at Board and/or Committee meetings and the constructive involvement in the deliberation and resolutions, the evaluation whether the effective composition corresponds with the desirable or ideal composition, the application of the corporate governance rules within the Company and its bodies, and an evaluation of the specific roles such as Chairman of the Board and Chairman or member of a Board Committee. The Board of Directors acts on the results of the performance evaluation.
Non-executive directors assess their interaction with the executive management on a continuous basis.
Until the completion of the Restructuring on 31 July 2019, the Company's executive management was composed of the Executive Chairman (from 18 January 2019), Chief Executive Officer and the other members of the Management Committee, as detailed above in "—Management Committee". During H2 2019, the Company retained the services of Mr. Roman Matej as Interim Chief Financial Officer and Mr. Anthony Simms as Head of External Affairs under a secondment agreement from Nyrstar Sales & Marketing AG. The executive services which are provided by these two secondees are beyond the scope of executive services provided under the terms of the Sale Deed and, as such, the costs of these seconded services are borne by the Company. Certain other ongoing executive services are provided by NN2 Newco Limited under the terms of the Sale Deed at no charge.
The Chief Executive Officer, up until his resignation on 30 September 2019, was a member of the Board. The role was responsible for the leading and chairing the Management Committee and was accountable to the Board of Directors for the Management Committee's performance.
The role of the Chief Executive Officer was to implement the mission, strategy and targets set by the Board of Directors and to assume responsibility for the day-to-day management of the Company. The Chief Executive Officer reported directly to the Board of Directors.
Until the completion of the Restructuring on 31 July 2019 when the members of the Management Committee ceased to be employees of the Company or subsidiaries thereof, the Board of Directors had delegated the day-to-day management of the Company as well as certain management and operational powers to the Chief Executive Officer. The Chief Executive Officer was assisted by the Management Committee.
BRU12274377/7 167729-0002 13 The Management Committee was ordinarily composed of at least four members and included the Chief Executive Officer. Its members were appointed by the Board of Directors on the basis of a recommendation by the Nomination and Remuneration Committee. The Company's Management Committee did not qualify as a "directiecomité"/"comité de direction" within the meaning of Article 524bis of the Belgian Companies Code (then applicable). The Management Committee was responsible and accountable to the Board of Directors for the discharge of its responsibilities. On 31 July 2019, the Management Committee had been dissolved as it was no longer required post the restructuring of the Company where the 2% stake in the Nyrstar operating group is held passively.
The Management Committee was responsible for assisting the Chief Executive Officer in relation to:
Directors are expected to arrange their personal and business affairs so as to avoid conflicts of interest with the Company. Any director with a conflicting financial interest (as contemplated by Article 7:96 of the Belgian Code of Companies and Associations) on any matter before the Board of Directors must bring it to the attention of its fellow directors, and his statements about the nature of the conflict of interest is included in the minutes of the meeting of the Board of Directors. The director with a conflicting financial interest may not take part in any deliberations or voting related to such decision or transaction. The Board of Directors also includes in the minutes a description of the nature of the relevant decision or transaction and the financial consequences thereof for the Company. This part of the minutes is included in full in the annual report of the Company. The minutes are also shared with the statutory auditor of the Company who describes the financial consequences of such decisions in its report pursuant to Article 3:74 of the Belgian Code of Companies and Associations.
The Board of Directors has a policy in place for transactions or other contractual relationships between the Company, including its related companies, and its Board members, which are not covered by the legal provisions on conflict of interests. Section 1.4 of the Corporate Governance Charter sets out the procedure for transactions and other contractual relationships between Nyrstar, on the one hand, and the directors or related parties of directors, on the other hand, irrespective of whether or not falling within the scope of the legal provisions on conflicts of interest with directors or related parties of Nyrstar. Notably, such transactions or contractual relationships can only be entered into at market conditions, and the director concerned may only participate in the deliberation and decision-making process with regard to such transactions or contractual relationships if the Board of Directors votes to request or permit such participation and if permitted by law. Furthermore, if a director believes that such a conflict arises in respect of any material decision, operation or transaction, he or she must see to it that the Board of Directors is fully informed at the start of the meeting of the potential or perceived conflict of interest. Where applicable, the rules and procedures of articles 7:96 and/or 7:97 of the Belgian Code of Companies and Associations need to be complied with. For the purpose of the aforementioned rules, the following entities will qualify as a "related party" of a director: (a) a legal entity in which the director acts as a director, as a senior executive or in a similar capacity, and (b) a legal entity that is directly or indirectly under the control of the director concerned.
BRU12274377/7 167729-0002 14 Section 3.2.4 of the Corporate Governance Charter contained a separate procedure for transactions between Nyrstar and members of the management committee (other than the Chief Executive Officer). Notably, any transaction or other contractual relationship between Nyrstar, on the one hand, and any member of the Management Committee or a related party of such Management Committee member, on the other hand, required the prior approval of the CEO, which needed to be fully informed by the Management Committee member concerned of the terms and conditions of the transaction or contractual relationship, as well as of the corresponding interest of Nyrstar. Such transaction or contractual relationship could only be entered into at market conditions. For the purpose of the aforementioned rules, the following entities qualified as a "related party" of a Management Committee member: (a) a legal entity in which the Management Committee member acts as a director, as a senior executive or in a similar capacity, and (b) a legal entity that is directly or indirectly under the control of the Management Committee member.
There are no outstanding loans granted by the Company to any of the persons mentioned in "—Board of Directors" and in "— Management Committee", nor are there any guarantees provided by the Company for the benefit of any of the persons mentioned in "—Board of Directors" and in "—Management Committee".
None of the persons mentioned in "—Board of Directors" and in "—Management Committee" has a family relationship with any other of the persons mentioned in "—Board of Directors" and in "—Management Committee".
With a view to preventing market abuse (insider dealing and market manipulation), the Board of Directors has established a dealing code. The dealing code describes the declaration and conduct obligations of directors and certain other persons with respect to transactions in shares or other financial instruments of the Company. The dealing code sets limits on carrying out transactions in shares of the Company and allows dealing by the above-mentioned persons only during certain windows. A copy of the dealing code is available on the Company's website (www.nyrstar.be).
As a Belgian listed company and with a view to ensuring investors in shares of the Company have available all information necessary to ensure the transparency, integrity and good functioning of the market, the Board of Directors has established an information disclosure policy. The information disclosure policy is aimed at ensuring that inside information of which the Company is aware is immediately disclosed to the public. In addition, the information disclosure policy is aimed at ensuring information that is disclosed is fair, precise and sincere, and will enable the holders of shares in the Company and the public to assess the influence of the information on the Company's position, business and results.
The Nyrstar Board of Directors is responsible for the assessment of the effectiveness of Nyrstar's Risk Management Framework and internal controls. The Company takes a proactive approach to risk management. The Board of Directors is responsible for ensuring that the nature and extent of risks are identified on a timely basis with alignment to the Group's strategic objectives and activities.
The Audit Committee plays a key role in monitoring the effectiveness of the Risk Management Framework and is an important medium for bringing risks to the attention of the Board of Directors. If a critical risk or issue is identified by the Board or management, it may be appropriate for all directors to be a part of the relevant risk management process, and as such the Board of Directors will convene a sub-committee comprised of a mix of members Board of Directors and senior management. Each respective sub-committee further examines issues identified and reports back to the Board of Directors.
The Company's Risk Management Framework requires regular evaluation of the effectiveness of internal controls to ensure the Company's risks are being adequately managed. The Risk Management Framework is designed to achieving the Company's objectives. The Company acknowledges that risk is not just about losses and harm. Risk can have positive consequences too. Mitigation of some of the inherent business risks could lead to potential business improvements.
Effective risk management enables the Company to achieve an appropriate balance between realising opportunities while minimising adverse impacts.
This section first gives an overview of the main features of the Company's internal control and risk management systems, in accordance with the Belgian Corporate Governance Code and the Belgian Code of Companies and Associations, which were in place through to the completion of the Restructuring on 31 July 2019. In light of the applicability of the 2020 Belgian Code on Corporate Governance' as of 1 January 2020, the current operations of the Company, the Company's holding company status and the 9 December Resolution, the Company is also reviewing its internal control and risk management systems. The main features of the Company's internal control and risk management systems which are currently in place following completion of the Restructuring, are set out thereafter.
The Risk Management Framework pre-Restructuring was integrated in the management process and focused on the following key principles.
The key elements of the Risk Management Framework were:
1 Understanding the External and Internal Environment
Understanding the internal and external business environment and the effect this has on Nyrstar's business strategy and plans. This informs the Company's overall tolerance to risk.
2 Consistent Methods for Risk Identification and Analysis of Risks, Existing Controls and Control Effectiveness
Implementing systems and processes for the consistent identification and analysis of risks, existing controls and control effectiveness. Evaluating whether the level of risk being accepted is consistent with levels of risk acceptable to the Audit Committee.
3 Risk management and mitigation
Using innovative and creative thinking in responding to risks and taking action where it is determined that the Group is being exposed to unacceptable levels of risk.
4 Stakeholder Engagement and Communication
Involving all Nyrstar employees and relevant stakeholders in managing risks and communicating identified key risks and controls.
5 Monitoring and Review
Regularly monitoring and reviewing our risk management framework, our risks and control effectiveness.
The guideline for the Risk Management Framework has been written to comply with ISO 31000; 2009. Compliance with the guideline is mandatory within Nyrstar.
The Risk Management Framework post-Restructuring is focuses on the following key principles:
1 Understanding the External and Internal Environment
Understanding the internal and external business environment and the effect this has on Nyrstar's business strategy and plans. This informs the Company's overall tolerance to risk.
2 Consistent Methods for Risk Identification and Analysis of Risks, Existing Controls and Control Effectiveness
Implementing systems and processes for the consistent identification and analysis of risks, existing controls and control effectiveness. Evaluating whether the level of risk being accepted is consistent with levels of risk acceptable to the Audit Committee.
Using innovative and creative thinking in responding to risks and taking action where it is determined that the Company is being exposed to unacceptable levels of risk.
Involving all Nyrstar stakeholders, such as shareholders, in managing risks and communicating identified key risks and controls.
Regularly monitoring and reviewing our risk management framework, our risks and control effectiveness.
The guideline for the Risk Management Framework has been written to comply with ISO 31000; 2009. Compliance with the guideline is mandatory within Nyrstar.
The following is a summary of Nyrstar's critical internal controls which were in place through to the completion of the Restructuring on 31 July 2019. Given the role of the Company as a holding company after the Restructuring and the lack of employees or operations, such critical internal controls are no longer applicable, as the Board of Directors is responsible for all control and decision-making.
There is a sound organisational structure with clear procedures, delegation and accountabilities for both the business side and the support and control functions, such as human resources, legal, finance, internal audit, etc.
The organisational structure is monitored on an ongoing basis, e.g. through benchmarking the organisational structure with industry standards and competitors. Responsibilities are delegated to business units, by business plans and accompanying budgets approved by management and the Board of Directors within set authorization levels.
The Company has established internal policies and procedures to manage various risks across the Group. These policies and procedures are available on the Company's intranet-site, and distributed for application across the whole Group. Every policy has an owner, who periodically reviews and updates if necessary.
The Board of Directors has approved a Corporate Governance Charter and a Code of Business Conduct, including a framework for ethical decision making. Given the role of the Company as a holding company after the Restructuring and the lack of employees or operations, the Code of Business Conduct is however no longer applied. The Board however still applies corporate governance principles in all its decision-making. The Board performs its daily activities and their business objectives according to the strictest ethical standards and principles.
Up until the completion of the Restructuring, Nyrstar also had a whistle blower procedure in place, allowing staff to confidentially raise concerns about any irregularities in financial reporting, possible fraudulent actions, bribery and other areas. Following the completion of the Restructuring, the Company no longer has employees and, as such, does not need to operate a whistleblowing procedure.
Up until the completion of the Restructuring, Nyrstar was ISO 9001 certified for the smelting and refining of zinc and zinc alloys, lead and lead alloys, silver, gold and other by-products. All of its major processes and the controls that they encompass were formalized and published on the Company's intranet. After the completion of the Restructuring, such quality control is no longer needed.
Nyrstar applies a comprehensive standard for financial reporting. The standard is in accordance with applicable International Accounting Standards. These include International Financial Reporting Standards (IFRS) and the related interpretations issued by the International Accounting Standards Board (IASB) and the IFRS Interpretations Committee (IFRIC) as adopted by the European Union. The effectiveness and compliance with the standard for financial reporting is consistently reviewed and monitored by the Audit Committee.
In order to ensure adequate financial planning and follow up, a financial budgeting procedure describing the planning, quantification, the implementation and the review of the budget in alignment with forecasts, is closely followed.
Before the Restructuring, Nyrstar conducted Group wide budgeting process, which is centrally coordinated and consists of the following steps:
After the Restructuring, Nyrstar still applies a financial budgeting procedure. Nyrstar continues to communicate the actual financial results to its shareholders bi-annually, but this is no longer supplemented on a quarterly basis by interim management statements.
Various management committees were established and actively used, until the completion of the restructuring on 31 July 2019, as a control to manage various risks Nyrstar was exposed to:
The metal price risk committee comprised the Chief Financial Officer, the Group Treasurer, the Group Controller and the Group Manager Financial Planning & Analysis. Nyrstar's metal price risk committee established policies and procedures on how Nyrstar manages its exposure to the commodity prices and foreign exchange rates.
The Group's performance against plan was monitored internally and relevant action was taken throughout the year. This included, weekly and monthly reporting of key performance indicators for the current period together with information on critical risk areas.
Comprehensive monthly board reports that included detailed consolidated management accounts for the period together with an executive summary from the Chief Financial Officer were prepared and circulated to the Board of Directors by the Company Secretary on a monthly basis.
Management was responsible for evaluating existing controls and the control effectiveness and determining whether the level of risk being accepted was consistent with the level of risk approved by the Board of Directors. Management took action where it was determined that the Company was being exposed to unacceptable levels of risk and actively encouraged all Nyrstar employees to communicate freely risks and opportunities identified.
Internal audit was an important element in the overall process of evaluating the effectiveness of the Risk Management Framework and internal controls. The internal audits were based on risk based plans, approved by the Audit Committee. The internal audit findings were presented to the Audit Committee and management, identifying areas of improvement. Progress of implementation of the actions was monitored by the Audit Committee on a regular basis. The Group internal audit function is managed internally. The Audit Committee supervised the internal audit function.
The Board of Directors paid specific attention to the oversight of risk and internal controls. On a yearly basis, the Board of Directors reviewed the effectiveness of the Group's risk management and internal controls. The Audit Committee assisted the Board of Directors in this assessment. The Audit Committee also reviews the declarations relating to internal supervision and risk management included in the annual report of the Company. The Audit Committee reviewed the specific arrangements to enable staff to express concerns in confidence about any irregularities in financial reporting and other areas e.g., whistleblower arrangements.
To support the protocols described above, both internal resources and external contractors are engaged to perform compliance checks, and reports are provided to the Audit Committee.
The Company is committed to the ongoing review and improvement of its policies, systems and processes.
The Company has a wide shareholder base, mainly composed of institutional investors in the United Kingdom, the United States, Belgium and other European countries, but also comprising Belgian retail investors. The free float of the Company as at the date of this report was 70.5%.
The table below provides an overview of the shareholders that notified the Company pursuant to applicable transparency disclosure rules, up to the date of this report. Although the applicable transparency disclosure rules require that a disclosure be made by each person passing or falling under one of the relevant thresholds, it is possible that the information below in relation to a shareholder is no longer up-to-date.
| Date of Notification |
% of the voting rights attached to shares before dilution(1) |
% of the voting rights attached to shares on a fully diluted basis |
|
|---|---|---|---|
| Urion Holdings (Malta) Ltd(3) |
18 Jan 2019 | 24.42% | 24.42% |
| RSQ Investors (division of Quanteus Group BV), Kris Vansanten BVBA, Kris Vansanten, E3V & Partners BV and an unnamed physical person |
15 Jan 2020 | 5.01% | 5.01% |
The above shareholders have no special voting rights nor control rights.
No other shareholders, alone or in concert with other shareholders, notified the Company of a participation or an agreement to act in concert in relation to 3% or more of the current total existing voting rights attached to the voting securities of the Company.
On the date of this report, the share capital of the Company amounts to EUR 114,134,760.97 and is fully paid-up. It is represented by 109,873,001 ordinary shares, each representing a fractional value of (rounded) EUR 1.04 and representing one 109,873,001th of the share capital. The Company's shares do not have a nominal value.
On 25 September 2013, the Company issued 4.25% senior unsecured convertible bonds due 2018 (the "2018 Convertible Bonds") for an aggregate principal amount of € 120,000,000. The possibility to convert the 2018 Convertible Bonds into new shares of the Company was approved by the extraordinary general shareholders' meeting of the Company held on 23 December 2013. The 2018 Convertible Bonds can be converted into new or existing shares of the Company at any time. During the course of 2017 Nyrstar conducted two buybacks of the 2018 Convertible Bonds. In September 2018, the EUR 29 million of the 2018 Convertible Bonds that had remained outstanding with third parties was repaid by the Company.
On 11 July 2016, Nyrstar issued 5% senior guaranteed unsecured convertible bonds due 2022 (the "2022 Convertible Bonds") for an aggregate principal amount of € 115,000,000. The possibility to convert the 2022 Convertible Bonds into new shares of the Company was approved by the extraordinary general shareholders' meeting of the Company held on 17 November 2016. The 2022 Convertible Bonds have been released in exchange for the issuance of new securities to the holders of such by the Trafigura Group, following completion of the Restructuring on 31 July 2019.
The shares of the Company can take the form of registered shares and dematerialized shares. All the Company's shares are fully paidup and are freely transferable.
The Company's shares do not have a nominal value,but reflect the same fraction of the Company's share capital, which is denominated in euro.
Each shareholder of the Company is entitled to one vote per share. Shareholders may vote by proxy, subject to the rules described in the Company's articles of association.
Voting rights can be mainly suspended in relation to shares:
• which are not fully paid up, notwithstanding the request thereto of the Board of Directors of the Company;
Pursuant to the Belgian Code of Companies and Associations, the voting rights attached to shares owned by the Company are suspended.
All shares are entitled to an equal right to participate in the Company's profits (if any). Pursuant to the Belgian Code of Companies and Associations, the shareholders can in principle decide on the distribution of profits with a simple majority vote at the occasion of the annual shareholders' meeting, based on the most recent statutory audited financial statements, prepared in accordance with the generally accepted accounting principles in Belgium and based on a (non-binding) proposal of the Company's Board of Directors. The Company's articles of association also authorise the Board of Directors to declare interim dividends subject to the terms and conditions of the Belgian Code of Companies and Associations.
The Company's ability to distribute dividends is subject to availability of sufficient distributable profits as defined under Belgian law on the basis of the Company's statutory unconsolidated financial statements rather than its consolidated financial statements. In particular dividends can only be distributed if following the declaration and issuance of the dividends the amount of the Company's net assets on the date of the closing of the last financial year as follows from the statutory (non-consolidated) financial statements (i.e., summarized, the amount of the assets as shown in the balance sheet, decreased with provisions and liabilities, all as summarized in accordance with Belgian accounting rules), decreased with the non-amortized costs of incorporation and extension and the non-amortized costs for research and development, does not fall below the amount of the paid-up capital (or, if higher, the issued capital), increased with the amount of non-distributable reserves. In addition, prior to distributing dividends, 5% of the net profits must be allotted to a legal reserve, until the legal reserve amounts to 10% of the Company's share capital. The Company's legal reserve currently meets this requirement.
In view of the Restructuring that was completed on 31 July 2019, the Board of Directors have taken the decision not to propose to shareholders a distribution for the financial year 2019. Any future dividends or other distributions will depend on any distributions made to the Company on (or proceeds from a potential sale of) the 2% participation that the Company holds in the Operating Group through the one B Ordinary Share held by the Company in NN2 Newco Limited and the financial situation in which the Company finds itself at that time, including elements such as repayment obligations under its loans.
Consistent with the diversity requirements specified by the Belgian Code of Companies and Associations, at least one third of the members of the Nyrstar Board of Directors is of the opposite gender.
Nyrstar believes in retaining a diverse workforce with staff of different genders, ages, cultures and professional backgrounds. However, as of yet this belief has not been formalized into a diversity policy applicable below Board level. At the end of 2019, the Company no longer had a workforce as these employees had become part of the Nyrstar Operating Group from 31 December 2019 with the completion of the restructuring.
The Company provides the following information in accordance with Article 34 of the Royal Decree dated 14 November 2007:
No takeover bid has been instigated by third parties in respect of the Company's equity during the previous financial year and the current financial year.
The Annual General Meeting of Shareholders will take place in Antwerp (Bluepoint, Filip Wiliotstraat, 2600 Antwerp) on [16 April] 2020. At this meeting shareholders will be asked to consider and, where applicable, approve amongst others the following matters:
Annual General Meeting:
The Company prepares a remuneration report relating to the remuneration of directors and the members of the Management Committee. This remuneration report is part of the Corporate Governance Statement, which is a part of the annual report. The remuneration report will be submitted to the annual general shareholders' meeting for approval.
Nyrstar's remuneration policy is designed to:
Nyrstar obtains independent advice from external professionals to ensure the remuneration structure represents industry best practice, and achieves the twin goals of retaining talented employees and meeting shareholder expectations.
The remuneration policy that has been determined in relation to the directors and members of the Management Committee is further described below.
The remuneration policy and remuneration has substantially changed following the implementation of the restructuring that was announced by the Company on 15 April 2019 and completed on 31 July 2019 (the "Restructuring"). All members of the Executive Management were employees of Nyrstar Sales & Marketing AG, a legal entity which is part of the operating group that was transferred to NN2 Newco Limited on the Restructuring. Immediately following the Restructuring, the Company no longer had an Executive Management.
At the extraordinary shareholders' meeting that was held by the Company on 9 December 2019 to deliberate on the continuation of the Company's activities, the shareholders rejected the continuation of the Company's activities such that the Company is now preparing to convene the extraordinary shareholders' meeting to deliberate upon the dissolution of the Company. On this basis and the fact that the Company no longer has any employees, the Company does not expect to make any changes to its remuneration policy in 2020. In the event that the Company is not placed into liquidation during 2020, steps will be taken to amend the Company's remuneration policy to ensure that it is aligned with the Corporate Governance Code 2020 and the Belgian law Shareholders' Rights Directive II, once such law enters into force..
Upon recommendation and proposal of the Nomination and Remuneration Committee, the Board of Directors determines the remuneration of the directors to be proposed to the general shareholders' meeting.
The proposed remuneration that the Board of Directors submits to the general shareholders' meeting is in principle benchmarked against the remuneration of similar positions in companies included in the Bel20® Index. The Bel20® Index is an index composed of the 20 companies with the highest free float market capitalization having shares trading on the continuous trading segment of the regulated market of Euronext Brussels. The remuneration is set to attract, retain and motivate directors who have the profile determined by the Nomination and Remuneration Committee.
Pursuant to Belgian law, the general shareholders' meeting approves the remuneration of the directors, including inter alia, each time as relevant, (i) in relation to the remuneration of executive and non-executive directors, the exemption from the rule that Share based awards can only vest after a period of at least three years as of the grant of the awards; (ii) in relation to the remuneration of executive directors, the exemption from the rule that (unless the variable remuneration is a quarter or less of the annual remuneration) at least one quarter of the variable remuneration must be based on performance criteria that have been determined in advance and that can be measured objectively over a period of at least two years and that at least another quarter of the variable remuneration must be based on performance criteria that have been determined in advance and that can be measured objectively over a period of at least three years; (iii) in relation to the remuneration of non-executive directors, any variable part of the remuneration; and (iv) any provision of service agreements to be entered into with executive directors providing for severance payments exceeding twelve months' remuneration (or, subject to a motivated opinion by the Nomination and Remuneration Committee, eighteen months' remuneration). The general shareholders' meeting of the Company has not approved any of the matters referred to in paragraphs (i) to (iv) with respect to the remuneration of the directors of the Company.
The directors of the Company (excluding the Chief Executive Officer, if appointed) receive a fixed remuneration in consideration for their membership of the Board of Directors. In addition, the directors (excluding the Chief Executive Officer, if appointed) receive fixed fees for their membership and/or chairmanship of any board committees. No attendance fees are paid. The Chief Executive Officer, if appointed, is also a member of the board but this role does not receive any additional remuneration in his capacity of board member.
Non-executive directors do not receive any performance related remuneration. The remuneration of Non-Executive Directors takes into account their general role as director, and specific roles as chairman, chairman or member of a board committee, as well as their relevant responsibilities and time commitment and is set as follows:
On 19 April 2018 the general shareholders' meeting approved that each of the non-executive directors referred to below (the "Eligible Directors") will be remunerated for his or her Director's mandate for the period as of this general shareholders' meeting until the annual general shareholders' meeting of 2019 in the form of "deferred shares units" of the Company, and not in cash, subject to the conditions set out below. The remuneration in shares is for each Eligible Director limited to the portion set out next to his or her name below (the "Eligible Share Remuneration") of the aggregate remuneration that applies to the director's mandate of the relevant Eligible Director in accordance with the principles that have been determined by the annual general shareholders' meeting of the Company held on 27 April 2011 and that otherwise would have been payable in cash (the "Eligible Remuneration"). The shares will not vest immediately, but will effectively vest and be delivered on the earlier of (i) the end of the Director's mandate of the Eligible Director, or (ii) a change of control over the Company. The shares are granted for free (i.e. for no additional consideration). The number of shares to be granted to an Eligible Director shall be equal to (i) the amount of the Eligible Share Remuneration that would otherwise have been paid in cash (save for this decision by the general shareholders' meeting), divided by (ii) the average closing price of the Company's shares during the ten trading days preceding the date of this general shareholders' meeting, whereby the result is rounded down to the nearest whole number. The Eligible Directors and their respective Eligible Share Remuneration that will be payable in deferred shares are as follows: (i) Ms. Anne Fahy: EUR 10,000 of her Eligible Remuneration; (ii) Ms. Carole Cable: 50% of her Eligible Remuneration; (iii) Mr. Martyn Konig: 100% of his Eligible Remuneration; and (iv) Mr. Christopher Cox: 100% of his Eligible Remuneration. The general shareholders' meeting approved that the shares can be definitively and fully acquired by an Eligible Director prior to the end of the third year referred to in Article 520ter of the Belgian Companies Code (as then applicable). The general shareholders' meeting also approved, as far as needed and applicable in accordance with Article 556 of the Belgian Companies Code (as then applicable), that the shares can be delivered upon the occurrence of a change of control over the Company. As far as needed and applicable, the general shareholders' meeting acknowledged that the shares shall not be considered as "variable remuneration" pursuant to Article 554, seventh paragraph, of the Belgian Companies Code (as then applicable) and Provision 7.7 of the Belgian Corporate Governance Code of 12 March 2009. The Company's Nomination and Remuneration Committee was authorised to further document the grant and to determine the terms and conditions of the grant, which contain customary adjustment clauses to take into account and mitigate the effect of corporate actions, dilutive transactions and similar events, such as (but not limited to) stock splits, reverse stock splits, mergers and de-mergers, dividend payments, other distributions on shares, rights offerings, and share buy-backs.
The Board did not propose a remuneration in deferred share units of the Company for the non-executive directors at the annual general shareholders' meeting of the Company that was held on 5 November 2019.
Taking into account the advice of the Nomination and Remuneration Committee, the Board proposed to the annual general shareholders' meeting of the Company on 5 November 2019 to approve that Ms. Jane Moriarty is paid additional remuneration as independent director and Mr. Martyn Konig as executive chairman, given the substantial time and effort Ms. Moriarty and Mr. Martyn Konig specifically have dedicated to the implementation of the Restructuring, including as director of the English incorporated direct subsidiary of the Company ("NewCo 1") and the English incorporated direct subsidiary of NewCo 1 (and thus indirect subsidiary of the Company) ("NewCo 2"), in the following amount: £130,000 for each. This proposal for additional remuneration was approved at the annual general shareholders' meeting on 5 November 2019, given the completion of the Restructuring on 31 July 2019.
As part of the Capital Structure Review process and the Chairman taking up the role of Executive Chairman, the Executive Chairman was paid CHF 135,000 (EUR 119,646) in first quarter of 2019 and a further ex gratia payment of CHF 765,000 (EUR 677,994) was paid as the retention condition of the Chairman not having resigned until the earlier of (a) 31 December 2019 or (b) the successful conclusion of the Restructuring, was met on 31 July 2019, being the successful conclusion of the Restructuring. These payments were made to the Chairman as remuneration for his executive functions and not his function as a director. The remuneration for the Executive Chairmanship role was agreed by the Company's Nomination and Remuneration committee and the Board of Directors with appropriate conflict of interest procedures being applied.
During 2019 the following gross remuneration was paid to the directors1 :
| Remuneration cost | Paid in cash | Paid in Deferred Share Units5 |
Additional remuneration |
|
|---|---|---|---|---|
| Martyn Konig | € 200,000 | € 33,333 | 34,361 DSU | 2 € 951,040 |
| Carole Cable | € 94,961 | € 59,008 | 6,013 DSU | |
| Christopher Cox4 | € 58,333 | - | 10,022 DSU | |
| Jesús Fernandez | € 12,381 | € 12,381 | - | |
| Anne Fahy | € 110,040 | € 100,040 | 1,718 DSU | |
| Jane Moriarty | € 73,809 | € 73,809 | €153,4003 | |
| Hilmar Rode | - | - | - | - |
1These payments include remuneration for Board and all Committees, including the Special Committee. The Chief Executive Officer is also a member of the board but he does not receive any additional remuneration in his capacity of board member. Payments to directors that joined the board or resigned from the board during the course of the year are pro-rated. The amounts paid to the directors is reflective of the changes to committee memberships during the course of the year and post the general shareholder's meeting on 5 November 2019. Ms. Fahy, Ms Cable and Ms Moriarty each received an additional payment of € 10,000 each in March 2019 as members of the Special Committee for the Restructuring.
Including the payment of £130,000 (€153,400) approved for payment by the Annual general Meeting of the Company on 5 November 2019 and the additional remuneration for the Executive Chairman role of CHF 900,000 which was paid CHF 135,000 (€119,646) in the first quarter of 2019 and a further ex gratia payment of CHF 765,000 (€ 677,994) on 31 July 2019. The CHF 900,000 payment to Mr. Konig for his Executive Chairman role was paid by Nyrstar Sales & Marketing AG and was not recharged to the Company.
The payment of £130,000 (€153,400) approved for payment by the Annual General Meeting of the Company on 5 November 2019.
Following discussions between the Company's Board of Directors and Mr. Christopher Cox, his reappointment was not proposed to the general shareholders' meeting on 5 November 2019 resolving upon the annual accounts for the financial year ending 31 December 2018. Immediately following Mr. Cox's departure from the Board of Directors, his accrued DSUs were paid out in cash by the Company.
Under the terms of the DSUs, the number of shares to be granted to an Eligible Director shall be equal to (i) the amount of the Eligible Share Remuneration that would otherwise have been paid in cash (save for the decision by the general shareholders' meeting of 19 April 2018), divided by (ii) the average closing price of the Company's shares during the ten trading days preceding the date of the general shareholders' meeting held on 19 April2018 (being €5.82), whereby the result is rounded down to the nearest whole number.
The remuneration of the Chief Executive Officer and the other members of the Management Committee is based on recommendations made by the Nomination and Remuneration Committee. The chief executive officer participates to the meetings of the Nomination and Remuneration Committee in an advisory capacity each time the remuneration of another member of the Management Committee is being discussed.
The remuneration is determined by the Board of Directors. As an exception to the foregoing rule, pursuant to Belgian law the general shareholders' meeting must approve, as relevant: (i) in relation to the remuneration of members of the Management Committee and other executives, an exemption from the rule that share based awards can only vest after a period of at least three years as of the grant of the awards; (ii) in relation to the remuneration of members of the Management Committee and other executives, an exemption from the rule that (unless the variable remuneration is less than a quarter of the annual remuneration) at least one quarter of the variable remuneration must be based on performance criteria that have been determined in advance and that can be measured objectively over a period of at least two years and that at least another quarter of the variable remuneration must be based on performance criteria that have been determined in advance and that can be measured objectively over a period of at least three years; and (iii) any provisions of service agreements to be entered into with members of the Management Committee and other executives providing (as the case may be) for severance payments exceeding twelve months' remuneration (or, subject to a motivated opinion by the Nomination and Remuneration Committee, eighteen months' remuneration). The general shareholders' meeting of the Company has not approved any of the matters referred to in paragraphs (i) to (iii) with respect to the outstanding remuneration of the members of the Management Committee of the Company, except that in previous years, the approval by the general shareholders' meeting was obtained with respect to:
An appropriate portion of the remuneration is linked to corporate and individual performance. The remuneration is set to attract, retain and motivate executive management who have the profile determined by the Nomination and Remuneration Committee.
The remuneration of the Executive Management consists of the following main remuneration components:
In 2019 all members left the Management Committee following the completion of the Restructuring and the Management Committee was disssolved. Immediately following the Restructuring on 31 July 2019, the Company ceased to have any direct employees. All payments made to members of the Management Committee after 31 July 2019 were done so by Nyrstar Sales & Marketing AG and do not impact the income statement or balance sheet of the Company. Under the terms of the deed for the sale by the Company of assets and shares to NN2 Newco Limited that was executed as part of the Restructuring (the "Sale Deed"), certain ongoing executive services are provided to the Company by NN2 Newco Limited. These ongoing executive services are provided to the Company at no charge and include finance, tax, corporate counsel, IT and administration services. In addition, the Company during H2 2019 retained the services of Mr. Matej as Chief Financial Officer and Mr. Simms as Head of External Affairs under a secondment agreement from Nyrstar Sales & Marketing AG. The executive services which are provided by these two secondees are beyond the scope of executive services provided under the terms of the Sale Deed and, as such, the costs of these seconded services are borne by the Company.
The respective elements of the remuneration package of the Management Committee until its dissolution upon completion of the Restructuring are further described below. There is no provision for claw back of variable remuneration due to incorrect financial information.
The Annual Base Salary constitutes a fixed remuneration. The reference base salary structures are determined with the support of external market data and analysis of economic trends for the different countries. Included in this analysis are the base salaries for various job descriptions paid by a group of peer companies of Nyrstar in several countries. On the basis of this survey, a number of grades are determined. The midpoint for each grade is the 50% percentile to reflect an optimal alignment with the market.
Nyrstar's policy is to pay senior staff members at 100% of the midpoint for their grade, subject to continued above average performance. However, there is discretion to set the fixed remuneration between 80% and 120% of the midpoint, based on experience, job, location, industry demand, unique technical skills, performance, etc.
The annual incentive is a variable part of the remuneration in function of individual performance below, at or above average standard during a given year. The terms and conditions are reflected in the Annual Incentive Plan (AIP), which is subject to revision on an annual basis.
The AIP aims to attract and retain talented employees, to make a connection between performance and reward, to reward achievement in line with Nyrstar's financial success, to reward employees for adhering to the Nyrstar Values & Behaviours, and to reward employees in a similar manner to the Company's shareholders.
The AIP is designed around delivering and exceeding the Nyrstar annual plan and budget. The relevant performance year for eligibility under the AIP is 1 January to 31 December, and payments, if any, are usually made in March of the following year.
In order to be eligible under the AIP, the beneficiary must be employed on 31 December of the relevant performance year. The respective criteria and their relative weight to determine eligibility under the AIP are:
Every year the Board of Directors revises and approves the performance criteria both for Nyrstar on a group level and the members of the Management Committee.
The AIP performance criteria for the members of the Management Committee includes:
The incentive under the AIP only becomes available if Nyrstar meets the performance threshold as approved by the Board in the beginning of the performance year.
The eligibility under the AIP is assessed and determined by the Nomination and Remuneration Committee, and any payment of the annual incentive is subject to final board approval.
For further information on the AIP and other share plans, please see "Description of Share Plans".
The members of the Management Committee participate in a Swiss compulsory and additional Überobligatorium pension scheme. The contributions by Nyrstar to the pension scheme amount to 20% of the Annual Base Salary (capped at a maximum annual base salary of CHF 846'000 (EUR 749,782)).
The Management Committee members participate in a medical benefit plan that includes amongst other things private hospital and dental medical care. They also receive a representation allowance, a car allowance and benefit from statutory accident and health insurance. In addition, some Management Committee members receive housing assistance and dependent schooling support for a limited time period.
As noted above, all payments made to the members of the Management Committee after the completion of the Restructuring on 31 July 2019, including retention payments, were made by Nyrstar Sales & Marketing AG and do not have any impact on the income statement or balance sheet of the Company. The following remuneration and compensation other than share based awards that are mentioned further was paid to the Chief Executive Officer and other members of the Management Committee in 2019 (between 1 January 2019 and 31 December 2019):
| Chief Executive Officer(4) (€) |
Members other (on an aggregate basis) (€) |
of than |
the the |
Chief | Management Executive |
Committee Officer |
|
|---|---|---|---|---|---|---|---|
| Annual Base Salary Incentives, including retention payments and ex gratia payments for Restructuring work Pension Benefits(1) |
689,640 | 1,813,395 | |||||
| 1,351,351 | 1,174,342 | ||||||
| 125,638 304,992 |
|||||||
| LTIP (Cash Payment) | — | - | |||||
| Other Components of the Remuneration(2) | 57,901 | 439,619 | |||||
| Severance Payments(3) | 900,901 | 180180 | |||||
| Total | 3,125,431 | 3,912,529 | |||||
Note: EUR/CHF @ 2019 average of 1.11
Each member of the Management Committee is entitled to a severance payment equivalent to twelve months of Annual Base Salary (inclusive of any contractual notice period) in case of termination of his agreement by Nyrstar. In addition, the agreement with the Chief Executive Officer provides that upon a change of control, his agreement with Nyrstar will be terminated. In that event, the Chief Executive Officer is entitled to a severance payment equivalent to twelve months of Annual Base Salary (inclusive of any contractual notice period). The above applies to all current and former members of the management committee and current and former Chief Executive Officers.
As part of Capital Structure Review process the CEO was paid an ex gratia payment in the amount of CHF 250,000 (EUR 221,567) in the first quarter of 2019. A further ex gratia payment in the amount of CHF 1,250,000 (EUR 1,107,834) was paid as the retention condition of the CEO not having resigned, nor having been dismissed for cause under Swiss law, until the earlier of (a) 31 December 2019 or (b) the successful conclusion of the Restructuring, was met on 31 July 2019 being the successful conclusion of the Restructuring. These payments were agreed by the Company's Nomination and Remuneration committee and the Board of Directors with appropriate conflict of interest procedures being applied.
(1) Includes a contribution of up to 20% of reported annual base salary (capped at a maximum salary of CHF 846'000 (EUR 776,146)) as savings contributions as well as risks contributions.
As part of the Capital Structure Review process and the Chairman taking up the role of Executive Chairman, the Executive Chairman was paid CHF 135,000 (EUR 119,646) in first quarter of 2019 and a further ex gratia payment of CHF 765,000 (EUR 677,994) was paid as the retention the condition of the Chairman not having resigned until the earlier of (a) 31 December 2019 or (b) the successful conclusion of the Restructuring, was met on 31 July 2019, being the successful conclusion of the Restructuring.
To secure continuity during the Capital Restructure process three members of the Management Committee were paid an aggregate amount of CHF 550,000 (EUR 487,465) at the end of September 2019 as they had not resigned from the Company at the time when the payment became due. The Interim Chief Financial Officer was paid an amount of CHF 233,520 (EUR 206,969) of which 50% was paid at the end of June 2019 and a further 50% was paid at the end of December 2019, as he satisfied the condition that he had not resigned from the Company at the time when the payment became due.
As permitted by the Company's articles of association and without prejudice to mandatory provisions of Belgian law, the Company has entered into a customary liability indemnification arrangements with the directors and relevant members of the Management Committee and has implemented directors' and officers' insurance coverage.
Prior to 2019 the Company had a Long Term Incentive Plan (LTIP) with a view to align shareholder and senior management objectives as well as attracting, retaining and motivating the employees and Executive Management of the Company and its wholly owned subsidiaries. There were no new awards granted under the LTIP in 2019.
The key terms of the LTIP are described below.
Under the LTIP, the Executives selected by the Board of Directors may be granted conditional awards to receive ordinary shares in the Company at a future date ("Executive Share Awards") or their equivalent in cash ("Executive Phantom Awards") (Executive Share Awards and Executive Phantom Awards together referred to as "Executive Awards"). There were no LTIP grants in 2019 and following the Restructuring, the performance conditions of the pre-existing grants can no longer be met and will thus expire without vesting.
The terms of the LTIP may vary from country to country to take into account local tax and other regulations and requirements in the jurisdictions where eligible Executives are employed or resident.
The Nomination and Remuneration Committee makes recommendations to the Board of Directors in relation to the operation and administration of the LTIP.
The current LTIP rules were approved by a general shareholders' meeting of the Company held on 19 April 2018.
The Board of Directors determines which Executives are eligible to participate in the LTIP (the "Participating Executives").
The value of the conditional Executive Awards under the LTIP varies, depending on the role, responsibility and seniority of the relevant Participating Executive. The maximum value of the conditional Executive Awards granted to any Participating Executive in any financial year of the Company will not exceed 150% of his or her base salary at the time of the grant.
Executive Awards will cliff vest after a three-year rolling performance period.
In the event of cessation of employment before the normal vesting due to retirement or death, the Board of Directors may determine that a number of Executive Awards will vest, taking into account such factors as the Board of Directors determines, including the proportion of the performance period which has elapsed and the extent that performance conditions have been satisfied up to the date of leaving.
The Board of Directors determines the LTIP performance conditions and whether they have been met. Executive Awards are made to the extent that predetermined scaling thresholds for each of the performance conditions are met.
For the Executive Awards to vest under the grants made in 2016 (Grant 9), 2017 (Grant 10), and 2018 (Grant 11) the two following performance measurements must be achieved:
A volume weighted average out-performance is calculated for each year. These are averaged over the performance period and compared to the vesting schedule. Given the weak EBITDA performance of the Company against the targets set by the Nomination and Remuneration Committee and the poor performance of the Company's share price in recent years, the outstanding grants under the LTIP will not vest.
Since April 2008, grants have been made annually in accordance with the rules and conditions of the LTIP. There were no grants made during 2019 due to the Restructuring. Grants in place during 2019 are shown below:
| Grant 10 | Grant 11 | |
|---|---|---|
| Effective grant date | 30 April 2017 | 30 April 2018 |
| Performance period | 1 January 2017 to 31 December 2019 |
1 January 2018 to 31 December 2020 |
| Performance criteria | — Nyrstar EBITDA 70% —MSCI 30% —Executive remains in service to 31 December 2019 |
— Nyrstar EBITDA 70% —MSCI 30% — Executive remains in service to 31 December 2020 |
| Vesting date | 31 December 2019 | 31 December 2020 |
During the period between the satisfaction of the performance conditions and when the participating employee receives the relevant payment, the employee will be entitled to a payment equal to the cash equivalent of any dividends paid.
The following table sets out the movement in the number of equity instruments granted during the specified periods in relation to the LTIP (including all participants):
| Grant 8 | Grant 9 | Grant 10 | Grant 11 | Total | ||
|---|---|---|---|---|---|---|
| As at 1 Jan 2019 | 303,018 | 900,994 | 1,376,091 | 1,565,826 | 2,580,103 | |
| Dilutive impact / adjustment | - | 7,451 | 11,814 | - | 19,265 | |
| Forfeitures | (303,018) | (66,621) | (144,961) | (39,293) | (553,893) | |
| Additions | 84,277 | 195,590 | - | 279,867 | ||
| Expired | - | (926,101) | (1,438,534) | - | (2,364,635) | |
| Settlements | - | - | - | - | - | |
| As at 31 Dec 2019 | - | - | - | 1,526,533 | 1,526,533 | |
The table below reflects the Share awards that during 2019 have been granted or delivered under the LTIP to the members of the Management Committee, and those that have expired:
| LTIP (as of 31 December 2019) | ||||||
|---|---|---|---|---|---|---|
| Name | Title | Share Awards delivered in 2019 under the LTIP of which the performance conditions have been met |
Share Awards granted, but lapsed in 2019(1) |
Share Awards granted in 2019 or in prior years under LTIP of which the performance conditions have not been met(2) |
||
| Hilmar Rode | Chief Executive Officer | 0 | 117,975 | — | ||
| Michel Abaza (from July 2018) |
Chief Financial Officer | 0 | 67,217 | — | ||
| Christopher Eger | Chief Financial Officer | 0 | 63,706 | |||
| Willie Smit | Chief HR Officer | 0 | 63,706 | — | ||
| Frank Rittner | Chief Technical Officer | 0 | 44,831 | — | ||
| Sebastião Balbino | Chief Commercial Officer | 0 | 47,170 | — | ||
| Cristiano Melcher(3) | Chief Commercial Officer | 0 | 13,757 |
Notes:
(1) Share awards include adjusted forfeitures under other grants related to end of employment.
(2) Vesting is subject to performance conditions.
(3) Cristiano Melcher was appointed as CCO in December 2018.
In 2019, Deferred Share Units were granted to certain directors as approved by the AGM 2018. The number of DSUs granted to the eligible director is equal to the amount of remuneration that would otherwise been paid in cash divided by the average closing price of the Company's shares during the ten trading days preceding the date of the general shareholders' meeting. The average share price for the period prior to the general shareholders' meeting that was held on 5 November 2019 was €0.1945/share. There were no Deferred Share Units granted to the directors following the AGM 2019. The 2016, 2017 and 2018 AGM granted the following Deferred Share Units to directors (excluding the CEO):
| AGM 2016 | AGM 2017 | AGM 2018 for year 2018 |
AGM 2018 for year 2019 |
Total | |
|---|---|---|---|---|---|
| Martyn Konig | 27,285 DSU | 37,282 DSU | 34,494 DSU | 34,361 DSU | 133,422 DSU |
| Carole Cable | 4,774 DSU | 6,524 DSU | 6,036 DSU | 6,013DSU | 23,347 DSU |
| Christopher Cox | 9,549 DSU | 13,049 DSU | 12,073 DSU | 10,022 DSU | 44,693 DSU(1) |
| Jesús Fernandez | - | - | - | - | - |
| Anne Fahy | 1,364 DSU | 1,864 DSU | 1,725 DSU | 1,718 DSU | 6,671 DSU |
| Jane Moriarty | - | - | - | - | - |
(1) Following resignation as a director on 5 November 2019, Mr Cox's accrued DSUs were paid out in cash.
Shares and share awards under the AIP
During 2019, no share awards were delivered nor granted under the AIP to the members of the Management Committee at that time.
As at 31 December 2019, none of the directors in office held any Nyrstar shares. All members of the Management Committee ceased to be employees of the Company as at the completion of the Restructuring. As at 31 December 2019, there were no members employed of Nyrstar's Management Committee and, as such, no shareholdings to be disclosed.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.